mp:V9.2.0 testgegevens medicatiegegevens repo addendum: verschil tussen versies
Naar navigatie springen
Naar zoeken springen
(Nieuwe pagina aangemaakt met ' __NUMBEREDHEADINGS__ {{DISPLAYTITLE:Medicatiegegevens MP9 2.0: addendum inhoudelijke gegevens kwalificatie}} =Addenda voor inhoudelijke gegevens= ==Patiënt S. XX...') |
|||
(3 tussenliggende versies door 2 gebruikers niet weergegeven) | |||
Regel 4: | Regel 4: | ||
=Addenda voor inhoudelijke gegevens= | =Addenda voor inhoudelijke gegevens= | ||
− | ==Patiënt | + | ==Patiënt B. van XXX_Kester== |
− | <section begin= | + | <section begin=XXX_Kester /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 15: | Regel 15: | ||
|colspan="5"|Naamgegevens | |colspan="5"|Naamgegevens | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|B. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 25: | Regel 25: | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan="2"| | + | |rowspan="3"| |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Voorvoegsels | ||
+ | |style="background-color: white;"|van | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Kester |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999911557 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 aug 1954 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
− | |}<section end= | + | |}<section end=XXX_Kester /><section begin=ALLMBHS_XXX_Kester /><section begin=MBH_MBH_920_mg_example-1-KST /> |
− | ====Medicamenteuze behandeling | + | ====Medicamenteuze behandeling MBH_920_mg_example-1-KST ==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_mg_example-1_VV1 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 49: | Regel 52: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_mg_example-1_VV1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekkingsverzoek datum | |colspan="4"|Verstrekkingsverzoek datum | ||
Regel 81: | Regel 84: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_mg_example-1_MA1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_mg_example-1-KST (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_mg_example-1-KST /><section begin=MBH_MBH_920_mg_example-2 /> |
+ | ====Medicamenteuze behandeling MBH_920_mg_example-2 ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Wisselend doseerschema MBH_920_mg_example-2-WDS-1 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 94: | Regel 99: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_mg_example-2-WDS-1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Wisselend doseerschema datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen om 08:00 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T - 15 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 15 dagen |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
Regel 139: | Regel 121: | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#UZI-000001111-PeterVanPulver|Zorgverlener: UZI-000001111-PeterVanPulver]] | |style="background-color: white;"|Zie [[#UZI-000001111-PeterVanPulver|Zorgverlener: UZI-000001111-PeterVanPulver]] | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T - 15 dagen, eerst gedurende 7 dagen 1 maal per dag om 20:00 1 stuk, dan gedurende 3 dagen 1 maal per dag om 20:00 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie 1 | ||
+ | |style="background-color: white;"|eerst gedurende 7 dagen 1 maal per dag om 20:00 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Doseerinstructie | + | |colspan="3"|Doseerinstructie 2 |
− | |style="background-color: white;"| | + | |style="background-color: white;"|dan gedurende 3 dagen 1 maal per dag om 20:00 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 164: | Regel 143: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_mg_example-2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |}<section end= | + | |}<section end=MBH_MBH_920_mg_example-2 /><section begin=MBH_MBH_920_mg_example-3 /> |
+ | ====Medicamenteuze behandeling MBH_920_mg_example-3 ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_920_mg_example-3-MTD-1 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="4" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Identificatie |
+ | |style="background-color: white;"|MBH_920_mg_example-3-MTD-1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedienings datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 30 dagen om 10:30 uur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Afgesproken datum tijd | ||
+ | |style="background-color: white;"|T - 30 dagen om 10:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Toegediende hoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aantal | ||
+ | |style="background-color: white;"|1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Eenheid | ||
+ | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Afgesproken hoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Aantal |
− | |style="background-color: white;"| | + | |style="background-color: white;"|4 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Eenheid | ||
+ | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsweg | ||
+ | |style="background-color: white;"|ORAAL (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Toediener | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#UZI-000001111-PeterVanPulver|Zorgverlener: UZI-000001111-PeterVanPulver]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie wisselend doseerschema | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA1_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_mg_example-3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
+ | |}<section end=MBH_MBH_920_mg_example-3 /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|<span id="UZI-000001111-PeterVanPulver" title="Intern ID = UZI-000001111-PeterVanPulver">Zorgverlener UZI-000001111-PeterVanPulver</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener identificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgegevens |
|style="background-color: white;"|Peter van Pulver | |style="background-color: white;"|Peter van Pulver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Specialisme |
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Zorgaanbieder |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgaanbieder |
|style="background-color: white;"|Zie [[#URA-00001111-HuisartsenpraktijkPulverPartners|Zorgaanbieder: URA-00001111-HuisartsenpraktijkPulverPartners]] | |style="background-color: white;"|Zie [[#URA-00001111-HuisartsenpraktijkPulverPartners|Zorgaanbieder: URA-00001111-HuisartsenpraktijkPulverPartners]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|<span id="URA-00001111-HuisartsenpraktijkPulverPartners" title="Intern ID = URA-00001111-HuisartsenpraktijkPulverPartners">Zorgaanbieder URA-00001111-HuisartsenpraktijkPulverPartners</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder identificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Adresgegevens |
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|<span id="URA-01236578-ApoGulleGaper" title="Intern ID = URA-01236578-ApoGulleGaper">Zorgaanbieder URA-01236578-ApoGulleGaper</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder identificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Adresgegevens |
|style="background-color: white;"|Werkadres: Dorpsstraat 10 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 10 A 1234AA Ons Dorp | ||
− | |}<section end= | + | |}<section end=ALLMBHS_XXX_Kester /> |
− | ==Patiënt | + | ==Patiënt S. XXX_Jankie== |
− | <section begin= | + | <section begin=XXX_Jankie /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 276: | Regel 289: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|S. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 286: | Regel 299: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Jankie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999910437 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|8 mei 1954 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end= | + | |}<section end=XXX_Jankie /><section begin=ALLMBHS_XXX_Jankie /><section begin=MBH_MBH_920_MtdWds /> |
− | ====Medicamenteuze behandeling | + | ====Medicamenteuze behandeling MBH_920_MtdWds ==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Wisselend doseerschema MBH_920_MtdWds_WDS1 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 307: | Regel 320: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_MtdWds_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Wisselend doseerschema datum tijd |
|style="background-color: white;"|T - 20 dagen om 08:00 uur | |style="background-color: white;"|T - 20 dagen om 08:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
Regel 323: | Regel 336: | ||
|style="background-color: white;"|T + 9 dagen | |style="background-color: white;"|T + 9 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#UZI-000001111-PeterVanPulver|Zorgverlener: UZI-000001111-PeterVanPulver]] |
− | |||
− | | | ||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 341: | Regel 348: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, | + | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 1 maal per dag 2 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Kopie indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Nee |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toelichting |
− | |style="background-color: white;"| | + | |style="background-color: white;"|toelichting WDS in vrije tekst |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_MtdWds_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Relatie wisselend doseerschema |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_MtdWds_WDS0 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_MtdWds (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Wisselend doseerschema MBH_920_MtdWds_WDS2 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 402: | Regel 387: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_MtdWds_WDS2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Wisselend doseerschema datum tijd |
− | |style="background-color: white;"|T - 20 dagen om | + | |style="background-color: white;"|T - 20 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 3 weken'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 415: | Regel 400: | ||
|style="background-color: white;"|T - 20 dagen | |style="background-color: white;"|T - 20 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksduur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 weken |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Wisselend doseerschema stop type | ||
+ | |style="background-color: white;"|definitief gestopt met medicatie (situatie) (code = '113371000146109' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#UZI-000001111-PeterVanPulver|Zorgverlener: UZI-000001111-PeterVanPulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Reden wijzigen of staken |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Opname (code = '305335007' in codeSystem 'SNOMED CT') |
− | + | |-style="vertical-align:top; background-color: #E3E3E3;;" | |
− | + | |colspan="5"|Gebruiksinstructie | |
− | |||
− | |||
− | |||
− | |||
− | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - 20 dagen, | + | |style="background-color: white;"|Vanaf T - 20 dagen, gedurende 3 weken, 1 maal per dag 2 stuks, Oraal, definitief gestopt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 2 stuks |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Kopie indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toelichting | ||
+ | |style="background-color: white;"|toelichting WDS in vrije tekst | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 452: | Regel 440: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_MtdWds_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Relatie wisselend doseerschema |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_MtdWds_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_MtdWds (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Medicatietoediening MBH_920_MtdWds_MTD_1 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="5" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_MtdWds_MTD_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Toedienings datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 jun 2021, om 12:35 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Afgesproken datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 jun 2021, om 12:00 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Volgens afspraak indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="6"|Toegediende hoeveelheid |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Aantal |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Eenheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="6"|Afgesproken hoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Aantal |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 |
− | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="5"| | + | |colspan="4"|Eenheid |
+ | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Prik plak locatie | ||
+ | |style="background-color: white;"|toch maar oraal gegeven | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Toediener | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Mantelzorger | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Contactpersoon |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#ContactPersoonAnnetteDeVries|Contactpersoon: ContactPersoonAnnetteDeVries]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Geneesmiddel - primaire code |
− | |||
− | |||
− | |||
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Geneesmiddel - generiekere code |
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Toelichting | ||
+ | |style="background-color: white;"|toelichting in vrije tekst | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="6"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_MtdWds_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Relatie toedieningsafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Identificatie |
− | |style="background-color: white;"|2 | + | |style="background-color: white;"|MBH_920_MtdWds_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="6"|Relatie wisselend doseerschema |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_MtdWds_WDS_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.999.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_MtdWds (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Medicatietoediening MBH_920_MtdWds_MTD_2 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="5" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_MtdWds_MTD_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Toedienings datum tijd | ||
+ | |style="background-color: white;"|30 jun 2021, om 16:15 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Afgesproken datum tijd | ||
+ | |style="background-color: white;"|30 jun 2021, om 16:00 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Nee | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Geannuleerd indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="6"|Toegediende hoeveelheid |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Aantal |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Eenheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="6"|Afgesproken hoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Aantal |
− | |style="background-color: white;"| | + | |style="background-color: white;"|6 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Eenheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="6"|Toedieningssnelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Nominale waarde |
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Eenheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Tijdseenheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Prik plak locatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|toch maar oraal gegeven |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="6"|Toediener |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#UZI-000001111-PeterVanPulver|Zorgverlener: UZI-000001111-PeterVanPulver]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Medicatie toediening reden van afwijken | ||
+ | |style="background-color: white;"|Behandeling met geneesmiddel stopgezet (situatie) (code = '274512008' in codeSystem 'SNOMED CT') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Toelichting |
− | |style="background-color: white;"| | + | |style="background-color: white;"|toelichting in vrije tekst |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Relatie medicatieafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_MtdWds_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="6"|Relatie toedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_MtdWds_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Relatie wisselend doseerschema | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_MtdWds_WDS_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.999.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_MtdWds (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Medicatietoediening MBH_920_MtdWds_MTD_3 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="5" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_MtdWds_MTD_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Toedienings datum tijd | ||
+ | |style="background-color: white;"|30 jun 2021, om 16:35 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Afgesproken datum tijd | ||
+ | |style="background-color: white;"|30 jun 2021, om 16:00 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Nee | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Geannuleerd indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="6"|Toegediende hoeveelheid |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Aantal |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Eenheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="6"|Afgesproken hoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Aantal |
− | |style="background-color: white;"| | + | |style="background-color: white;"|6 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Eenheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Toedieningssnelheid | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="6"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Waarde |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Nominale waarde |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Eenheid | ||
+ | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Tijdseenheid | ||
+ | |style="background-color: white;"|1 minuut | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Prik plak locatie |
− | |style="background-color: white;"|oraal | + | |style="background-color: white;"|toch maar oraal gegeven |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Toediener | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Patient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Toediener is patient |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Medicatie toediening reden van afwijken | ||
+ | |style="background-color: white;"|Niet in staat om medicatie te gebruiken (bevinding) (code = '408366001' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Toelichting |
− | |style="background-color: white;"| | + | |style="background-color: white;"|toelichting in vrije tekst |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="6"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_MtdWds_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Relatie toedieningsafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_MtdWds_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Relatie wisselend doseerschema | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_MtdWds_WDS_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.999.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|MBH identificatie |
− | + | |style="background-color: white;"|MBH_920_MtdWds (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
− | + | |}<section end=MBH_MBH_920_MtdWds /> | |
− | |||
− | |style="background-color: white;"| | ||
− | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="ContactPersoonAnnetteDeVries" title="Intern ID = ContactPersoonAnnetteDeVries">Contactpersoon ContactPersoonAnnetteDeVries</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Annette de Vries |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Rol |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eerste relatie/contactpersoon (code = '01' in codeSystem 'COD821-VEKT') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="UZI-000001111-PeterVanPulver" title="Intern ID = UZI-000001111-PeterVanPulver">Zorgverlener UZI-000001111-PeterVanPulver</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="7"| |
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Zorgverlener identificatienummer |
+ | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Zorgaanbieder |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#URA-00001111-HuisartsenpraktijkPulverPartners|Zorgaanbieder: URA-00001111-HuisartsenpraktijkPulverPartners]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|<span id="URA-00001111-HuisartsenpraktijkPulverPartners" title="Intern ID = URA-00001111-HuisartsenpraktijkPulverPartners">Zorgaanbieder URA-00001111-HuisartsenpraktijkPulverPartners</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
− | | | + | |}<section end=ALLMBHS_XXX_Jankie /> |
− | + | ==Patiënt S. XXX_Jankie== | |
− | |style="background-color: white;"| | + | <section begin=XXX_Jankie /> |
− | |-style=" | + | {| class="wikitable" width="85%" |
− | |colspan="4"| | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt |
− | | | + | |-style="background-color: #1F497D;; color: white; text-align:left;" |
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Naamgegevens |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Initialen |
− | |style="background-color: white;"| | + | |style="background-color: white;"|S. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgebruik |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geslachtsnaam |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Achternaam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Jankie |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatienummer | ||
+ | |style="background-color: white;"|999910437 [BSN] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geboortedatum | ||
+ | |style="background-color: white;"|8 mei 1954 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
− | |}<section end= | + | |}<section end=XXX_Jankie /><section begin=ALLMBHS_XXX_Jankie /><section begin=MBH_MBH_920_TestVVs /> |
− | ====Medicamenteuze behandeling | + | ====Medicamenteuze behandeling MBH_920_TestVVs ==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_arianne_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 858: | Regel 856: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_arianne_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieafspraak datum tijd | |colspan="4"|Medicatieafspraak datum tijd | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|12 dec 2020, om 08:00 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf | + | |style="background-color: #E3E3E3;;"|''Vanaf 12 dec 2020, tot en met 10 jan 2021, om 23:59'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|12 dec 2020 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|10 jan 2021, om 23:59 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 882: | Regel 880: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 892: | Regel 890: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf 12 dec 2020, tot en met 10 jan 2021, om 23:59, 2 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 898: | Regel 896: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|2 maal per dag | + | |style="background-color: white;"|2 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie contact | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatienummer | ||
+ | |style="background-color: white;"|contact#arianne1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.2709) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie zorgepisode | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatienummer | ||
+ | |style="background-color: white;"|episode#arianne1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.9200) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_TestVVs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_TestVVs_VV1geannuleerd |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 911: | Regel 923: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_TestVVs_VV1geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekkingsverzoek datum | |colspan="4"|Verstrekkingsverzoek datum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 08:53 uur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geannuleerd indicator | ||
+ | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
Regel 924: | Regel 939: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Te verstrekken hoeveelheid | |colspan="4"|Te verstrekken hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|20 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Beoogd verstrekker | |colspan="5"|Beoogd verstrekker | ||
Regel 937: | Regel 952: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#URA-01236578-ApoGulleGaper|Zorgaanbieder: URA-01236578-ApoGulleGaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_TestVVs_MA1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_TestVVs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_inf_pers_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 953: | Regel 968: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_inf_pers_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T - 100 dagen om 07:59:59 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 130 dagen, tot en met T - 101 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 130 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 101 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatie gebruik stop type | ||
+ | |style="background-color: white;"|definitief gestopt met medicatie (situatie) (code = '113371000146109' in codeSystem 'SNOMED CT') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Informant | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Contactpersoon | ||
+ | |style="background-color: white;"|Zie [[#ContactPersoonBartJansen|Contactpersoon: ContactPersoonBartJansen]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 990: | Regel 1.025: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 130 dagen, tot en met T - 101 dagen, 2 maal per dag 1 dosis, inhalatie, definitief gestopt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|2 maal per dag | + | |style="background-color: white;"|2 maal per dag 1 dosis |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 1.003: | Regel 1.038: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_TestVVs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_TestVVs /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="ContactPersoonBartJansen" title="Intern ID = ContactPersoonBartJansen">Contactpersoon ContactPersoonBartJansen</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgegevens | ||
+ | |style="background-color: white;"|Bart Jansen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Rol | ||
+ | |style="background-color: white;"|Mantelzorger (code = '100001' in codeSystem 'ExtraRolcodes') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="7"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener identificatienummer | ||
+ | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Zorgaanbieder |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder identificatienummer | ||
+ | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Adresgegevens |
− | |style="background-color: | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="URA-01236578-ApoGulleGaper" title="Intern ID = URA-01236578-ApoGulleGaper">Zorgaanbieder URA-01236578-ApoGulleGaper</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek de Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 10 A 1234AA Ons Dorp |
− | |} | + | |}<section end=ALLMBHS_XXX_Jankie /> |
+ | ==Patiënt B. XXX_Blik== | ||
+ | <section begin=XXX_Blik /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="6"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Initialen |
− | |style="background-color: white;"| | + | |style="background-color: white;"|B. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="3"|Naamgebruik |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslachtsnaam | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Achternaam | ||
+ | |style="background-color: white;"|XXX_Blik | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatienummer | ||
+ | |style="background-color: white;"|999900389 [BSN] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geboortedatum | ||
+ | |style="background-color: white;"|13 okt 1963 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslacht | ||
+ | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
+ | |}<section end=XXX_Blik /><section begin=ALLMBHS_XXX_Blik /><section begin=MBH_MBH_920_QA1 /> | ||
+ | ====Medicamenteuze behandeling MBH_920_QA1 ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_QA1_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 20 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 9 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
Regel 1.094: | Regel 1.175: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 1.107: | Regel 1.185: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|2 maal per dag | + | |style="background-color: white;"|2 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_QA1_VV | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_QA1_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T - 20 dagen om 08:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Te verstrekken hoeveelheid | ||
+ | |style="background-color: white;"|60 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Beoogd verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_QA1_MA | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_QA1_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 1.142: | Regel 1.246: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen om 09:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 9 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 1.176: | Regel 1.283: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 1.182: | Regel 1.289: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_QA1_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 1.195: | Regel 1.309: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA1_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen om 09:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|60 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geneesmiddel - generiekere code |
+ | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Relatie verstrekkingsverzoek | |
− | + | |style="background-color: white;"|MBH_920_QA1_VV | |
− | |||
− | |colspan="4"|Relatie | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_QA1_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 1.237: | Regel 1.347: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA1_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T - 1 dag om 10:04:23 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 9 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur is patient |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 1.274: | Regel 1.397: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|Relatie | + | |colspan="5"|Relatie toedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_QA1 /><section begin=MBH_MBH_920_QA2 /> |
+ | ====Medicamenteuze behandeling MBH_920_QA2 ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_QA2_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 1.300: | Regel 1.425: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 100 dagen om 08:04 uur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen, tot en met T - 72 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 100 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T - 72 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|SENNOSIDEN A+B STROOP 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|SENNOSIDEN A+B STROOP 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 ml, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 10 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_QA2_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 1.338: | Regel 1.478: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA2_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekkingsverzoek datum |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 100 dagen om 08:04 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="5"|Auteur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
Regel 1.366: | Regel 1.489: | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Te verstrekken hoeveelheid |
+ | |style="background-color: white;"|300 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|SENNOSIDEN A+B STROOP 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|SENNOSIDEN A+B STROOP 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Beoogd verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4 | + | |colspan="4"|Relatie medicatieafspraak |
− | + | |style="background-color: white;"|MBH_920_QA2_MA | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_QA2_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 1.420: | Regel 1.520: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 100 dagen om 09:04 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen, tot en met T - 72 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 100 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 72 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 1.454: | Regel 1.557: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 ml, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 1.460: | Regel 1.563: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 10 ml |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_QA2_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 1.473: | Regel 1.583: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA2_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 100 dagen om 09:04 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|300 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geneesmiddel - generiekere code |
+ | |style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Relatie verstrekkingsverzoek | |
− | + | |style="background-color: white;"|MBH_920_QA2_VV | |
− | |||
− | |colspan="4"|Relatie | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_QA2_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 1.515: | Regel 1.621: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA2_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T - 68 dagen om 12:13:55 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen, tot en met T - 72 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 100 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T - 72 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur is patient |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 1.552: | Regel 1.671: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 millimeter, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 10 millimeter |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|Relatie | + | |colspan="5"|Relatie toedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_QA2 /><section begin=MBH_MBH_920_QA3 /> |
− | + | ====Medicamenteuze behandeling MBH_920_QA3 ==== | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_QA3_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 1.616: | Regel 1.699: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 50 dagen om 08:10 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 1.635: | Regel 1.712: | ||
|style="background-color: white;"|T - 50 dagen | |style="background-color: white;"|T - 50 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 11 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
Regel 1.660: | Regel 1.723: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 1.673: | Regel 1.733: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - 50 dagen, | + | |style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 50 ml |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_QA3_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 1.754: | Regel 1.752: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA3_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekkingsverzoek datum | |colspan="4"|Verstrekkingsverzoek datum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 50 dagen om 08:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
Regel 1.767: | Regel 1.765: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Te verstrekken hoeveelheid | |colspan="4"|Te verstrekken hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|4000 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Beoogd verstrekker | |colspan="5"|Beoogd verstrekker | ||
Regel 1.783: | Regel 1.781: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA3_MA |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_QA3_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 1.796: | Regel 1.794: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 50 dagen om 09:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 50 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 11 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 1.820: | Regel 1.818: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 1.833: | Regel 1.831: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 1.839: | Regel 1.837: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 50 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 1.846: | Regel 1.844: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_QA3_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 1.859: | Regel 1.857: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA3_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieverstrekkings datum tijd | |colspan="4"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 50 dagen om 09:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 1.872: | Regel 1.870: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekte hoeveelheid | |colspan="4"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|4000 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie verstrekkingsverzoek | |colspan="4"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA3_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_QA3_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 1.897: | Regel 1.895: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA3_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatiegebruik datum tijd | |colspan="4"|Medicatiegebruik datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 9 dagen om 07:59:59 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruik indicator | |colspan="4"|Gebruik indicator | ||
Regel 1.909: | Regel 1.907: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 50 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 11 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 1.925: | Regel 1.923: | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
Regel 1.941: | Regel 1.932: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 1.951: | Regel 1.945: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 1.957: | Regel 1.951: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 50 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 1.964: | Regel 1.958: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie toedieningsafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_QA3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |}<section end= | + | |}<section end=MBH_MBH_920_QA3 /><section begin=MBH_MBH_920_QA4 /> |
+ | ====Medicamenteuze behandeling MBH_920_QA4 ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_QA4_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 10 dagen om 08:12 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 19 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|MBH identificatie | |
− | + | |style="background-color: white;"|MBH_920_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
− | |colspan=" | + | |} |
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
− | |} | ||
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_QA4_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_QA4_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T - 10 dagen om 08:12 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
− | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan=" | + | |colspan="4"|Te verstrekken hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Beoogd verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Relatie medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA4_MA |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|MBH identificatie |
− | |style="background-color: white;"|16 | + | |style="background-color: white;"|MBH_920_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | + | |} | |
− | |||
− | |||
− | |} | ||
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_QA4_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 2.064: | Regel 2.075: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T - 10 dagen om | + | |style="background-color: white;"|T - 10 dagen om 09:12 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 2.078: | Regel 2.089: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 19 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 2.098: | Regel 2.112: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - 10 dagen, tot en met T | + | |style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_QA4_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 2.117: | Regel 2.138: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA4_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T - 10 dagen om | + | |style="background-color: white;"|T - 10 dagen om 09:12 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geneesmiddel - generiekere code |
+ | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Relatie verstrekkingsverzoek | |
− | + | |style="background-color: white;"|MBH_920_QA4_VV | |
− | |||
− | |colspan="4"|Relatie | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_QA4_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 2.159: | Regel 2.176: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA4_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T - 2 dagen om 08:12 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 2.173: | Regel 2.196: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T - 5 | + | |style="background-color: white;"|T + 19 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Informant | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Informant is patient | ||
+ | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 2.196: | Regel 2.230: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - 10 dagen, tot en met T | + | |style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 2.209: | Regel 2.243: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_QA4 /><section begin=MBH_MBH_920_QA5 /> |
+ | ====Medicamenteuze behandeling MBH_920_QA5 ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_QA5_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 2.222: | Regel 2.258: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA5_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 50 dagen om 08:15 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 7 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 50 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksduur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|7 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 50 dagen, gedurende 7 dagen, 4 maal per dag 2 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|4 maal per dag 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_QA5_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 2.260: | Regel 2.311: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA5_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekkingsverzoek datum |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 50 dagen om 08:15 uur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Te verstrekken hoeveelheid |
+ | |style="background-color: white;"|56 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Beoogd verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_QA5_MA | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_QA5_TA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_QA5_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 50 dagen om 09:15 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 7 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 50 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksduur | ||
+ | |style="background-color: white;"|7 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL SANDOZ TABLET 500MG (code = '665800' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 2.310: | Regel 2.390: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 50 dagen, gedurende 7 dagen, 4 maal per dag 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|4 maal per dag 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|Relatie | + | |colspan="5"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA5_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_QA5_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 2.338: | Regel 2.416: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA5_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 50 dagen om 09:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Verstrekker |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|56 stuks |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geneesmiddel - primaire code |
+ | |style="background-color: white;"|PARACETAMOL SANDOZ TABLET 500MG (code = '665800' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Geneesmiddel - generiekere code | |
− | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | |
− | |||
− | |colspan="4"|Geneesmiddel - | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Relatie verstrekkingsverzoek |
− | + | |style="background-color: white;"|MBH_920_QA5_VV | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_QA5_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 2.391: | Regel 2.454: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA5_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T - 43 dagen om 08:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 7 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 50 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksduur | ||
+ | |style="background-color: white;"|7 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Informant | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Informant is patient |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
Regel 2.402: | Regel 2.496: | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL SANDOZ TABLET 500MG (code = '665800' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 50 dagen, gedurende 7 dagen, 4 maal per dag 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Relatie | + | |colspan="3"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|4 maal per dag 2 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie toedieningsafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_QA5_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_QA5 /><section begin=MBH_MBH_920_QA6 /> |
+ | ====Medicamenteuze behandeling MBH_920_QA6 ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_QA6_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 2.436: | Regel 2.539: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen om 08:18 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 1 dag'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 2.473: | Regel 2.573: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 1 dag, 3 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_QA6_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 2.499: | Regel 2.592: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA6_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekkingsverzoek datum |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen om 08:18 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Te verstrekken hoeveelheid |
|style="background-color: white;"|21 stuks | |style="background-color: white;"|21 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Relatie | + | |colspan="4"|Relatie medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA6_MA |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_QA6_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 2.537: | Regel 2.634: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA6_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen om 09:18 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 1 dag'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Einddatum | |
− | + | |style="background-color: white;"|T + 1 dag | |
− | |colspan="3"| | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
− | | | ||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geneesmiddel - primaire code |
+ | |style="background-color: white;"|OXAZEPAM ACTAVIS TABLET 10MG (code = '613401' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Geneesmiddel - generiekere code | |
− | + | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | |
− | |||
− | |colspan="4"|Geneesmiddel - | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 2.588: | Regel 2.671: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 1 dag, 3 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 2.601: | Regel 2.684: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_QA6_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 2.616: | Regel 2.697: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA6_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen om 09:18 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Verstrekker |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
− | | | ||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Verstrekte hoeveelheid | |
− | + | |style="background-color: white;"|21 stuks | |
− | |colspan=" | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|OXAZEPAM ACTAVIS TABLET 10MG (code = '613401' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geneesmiddel - generiekere code |
+ | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie verstrekkingsverzoek |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA6_VV |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_QA6_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 2.666: | Regel 2.735: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA6_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T - 2 dagen om 08:59:59 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 1 dag'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 5 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
Regel 2.677: | Regel 2.763: | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Informant | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Informant is patient |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 1 dag, 3 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_QA6 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgegevens | ||
+ | |style="background-color: white;"|Peter van Pulver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Zorgaanbieder |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Zorgaanbieder | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Organisatie naam | ||
+ | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
+ | |}<section end=ALLMBHS_XXX_Blik /> | ||
+ | ==Patiënt C. XXX_Brugge== | ||
+ | <section begin=XXX_Brugge /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Naamgegevens |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Initialen |
− | |style="background-color: white;"| | + | |style="background-color: white;"|C. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgebruik |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geslachtsnaam |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Achternaam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Brugge |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatienummer | ||
+ | |style="background-color: white;"|999900419 [BSN] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geboortedatum | ||
+ | |style="background-color: white;"|16 okt 1963 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
− | |} | + | |}<section end=XXX_Brugge /><section begin=ALLMBHS_XXX_Brugge /><section begin=MBH_MBH_920_start_eind /> |
+ | ====Medicamenteuze behandeling MBH_920_start_eind ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_start_eind_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 2.810: | Regel 2.902: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen om 11:20 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T - 5 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 5 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 10 dagen, tot en met T - 5 dagen, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_start_eind_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 2.848: | Regel 2.955: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_eind_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekkingsverzoek datum |
− | |style="background-color: white;"|T - 10 dagen om | + | |style="background-color: white;"|T - 10 dagen om 11:20 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Te verstrekken hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|5 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Relatie | + | |colspan="4"|Relatie medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_eind_MA |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_start_eind_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 2.886: | Regel 2.997: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen om 12:20 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T - 5 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Einddatum | |
− | + | |style="background-color: white;"|T - 5 dagen | |
− | |colspan="3"| | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 2.933: | Regel 3.034: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 10 dagen, tot en met T - 5 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|Relatie | + | |colspan="5"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_start_eind_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 2.961: | Regel 3.060: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_eind_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 12:20 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Verstrekker |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|5 stuks |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geneesmiddel - generiekere code |
+ | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie verstrekkingsverzoek |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_eind_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|MBH identificatie | |
− | + | |style="background-color: white;"|MBH_920_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_start_eind_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 3.014: | Regel 3.098: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_eind_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T - 4 dagen om 10:59:59 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T - 5 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 10 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
Regel 3.025: | Regel 3.126: | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur is patient |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 10 dagen, tot en met T - 5 dagen, 1 stuk, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Relatie toedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_start_eind /><section begin=MBH_MBH_920_start_duur /> |
+ | ====Medicamenteuze behandeling MBH_920_start_duur ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_start_duur_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 3.056: | Regel 3.176: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen om 11:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 3 weken'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksduur | |colspan="3"|Gebruiksduur | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 weken |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 3.093: | Regel 3.210: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 20 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 3.100: | Regel 3.217: | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_start_duur_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 3.119: | Regel 3.229: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekkingsverzoek datum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 11:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Auteur |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Te verstrekken hoeveelheid | |
− | + | |style="background-color: white;"|21 stuks | |
− | |||
− | |colspan="4"| | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Beoogd verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur_MA |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|MBH identificatie | |
− | + | |style="background-color: white;"|MBH_920_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_start_duur_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 3.185: | Regel 3.274: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen om 12:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 3 weken'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksduur | |colspan="3"|Gebruiksduur | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 weken |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 3.207: | Regel 3.296: | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan="3"| | + | |rowspan="4"| |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 20 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 3.235: | Regel 3.324: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_start_duur_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 3.248: | Regel 3.337: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieverstrekkings datum tijd | |colspan="4"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen om 12:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 3.261: | Regel 3.350: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekte hoeveelheid | |colspan="4"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|21 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie verstrekkingsverzoek | |colspan="4"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_start_duur_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 3.286: | Regel 3.375: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T - 1 dag om 12:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 20 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |rowspan="2"| | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
Regel 3.357: | Regel 3.416: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 3.367: | Regel 3.426: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|1 maal per dag 1 stuk, oraal | + | |style="background-color: white;"|Vanaf T - 20 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 3.380: | Regel 3.439: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |}<section end= | + | |}<section end=MBH_MBH_920_start_duur /><section begin=MBH_MBH_920_chronisch /> |
− | ====Medicamenteuze behandeling | + | ====Medicamenteuze behandeling MBH_920_chronisch ==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_chronisch_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 3.395: | Regel 3.454: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieafspraak datum tijd | |colspan="4"|Medicatieafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 30 dagen om 11:32 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 30 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 3.419: | Regel 3.475: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 3.429: | Regel 3.485: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 30 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_chronisch_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 3.448: | Regel 3.504: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_chronisch_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T - 30 dagen om 11:32 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Te verstrekken hoeveelheid | ||
+ | |style="background-color: white;"|21 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_chronisch_MA | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_chronisch_VV_extraVVbestaandeMA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_chronisch_VV_extraVVbestaandeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekkingsverzoek datum | |colspan="4"|Verstrekkingsverzoek datum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen om 11:35 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
Regel 3.461: | Regel 3.559: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Te verstrekken hoeveelheid | |colspan="4"|Te verstrekken hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|90 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Beoogd verstrekker | |colspan="5"|Beoogd verstrekker | ||
Regel 3.477: | Regel 3.575: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_chronisch_MA |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_chronisch_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 3.490: | Regel 3.588: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 30 dagen om 12:32 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 30 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 3.514: | Regel 3.609: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 3.527: | Regel 3.622: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 30 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 3.540: | Regel 3.635: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_chronisch_MVE | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_chronisch_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T - 30 dagen om 12:32 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|21 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_chronisch_VV | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_chronisch_MVE_extraMVEbestaandeTA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 3.553: | Regel 3.686: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_chronisch_MVE_extraMVEbestaandeTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieverstrekkings datum tijd | |colspan="4"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen om 12:35 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 3.566: | Regel 3.699: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekte hoeveelheid | |colspan="4"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|90 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie verstrekkingsverzoek | |colspan="4"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_chronisch_VV_extraVVbestaandeMA |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_chronisch_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 3.591: | Regel 3.724: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_chronisch_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatiegebruik datum tijd | |colspan="4"|Medicatiegebruik datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen om 11:43:12 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruik indicator | |colspan="4"|Gebruik indicator | ||
Regel 3.602: | Regel 3.735: | ||
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 30 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
Regel 3.620: | Regel 3.754: | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur is patient |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 3.634: | Regel 3.771: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 30 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|Relatie | + | |colspan="5"|Relatie toedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |}<section end= | + | |}<section end=MBH_MBH_920_chronisch /><section begin=MBH_MBH_920_start_duur2 /> |
− | ====Medicamenteuze behandeling | + | ====Medicamenteuze behandeling MBH_920_start_duur2 ==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_start_duur2_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 3.662: | Regel 3.799: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 60 dagen om 11:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, gedurende 28 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 60 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksduur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|28 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 3.699: | Regel 3.833: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 60 dagen, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 3.705: | Regel 3.839: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_start_duur2_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 3.718: | Regel 3.852: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur2_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekkingsverzoek datum |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 60 dagen om 11:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Te verstrekken hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|28 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |rowspan="2"| |
− | |style="background-color: | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_start_duur2_MA | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_start_duur2_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 3.753: | Regel 3.894: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 60 dagen om 12:30 uur |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, gedurende 28 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 60 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksduur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|28 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 3.793: | Regel 3.931: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 60 dagen, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 3.799: | Regel 3.937: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|Relatie | + | |colspan="5"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_start_duur2_TA_techstaken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_start_duur2_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 50 dagen om 12:30 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T - 51 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 60 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 51 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Toedieningsafspraak stop type |
− | |style="background-color: white;"| | + | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geneesmiddel - primaire code |
+ | |style="background-color: white;"|PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 60 dagen, tot en met T - 51 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
− | |||
− | = | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Doseerinstructie | |
− | + | |style="background-color: white;"|1 maal per dag 1 stuk | |
− | |colspan="3"| | ||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | + | |} | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |} | ||
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_start_duur2_TA_anderePRK |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 3.906: | Regel 4.023: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur2_TA_anderePRK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 50 dagen om 12:35 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 18 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 50 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksduur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|18 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Reden afspraak | ||
+ | |style="background-color: white;"|Pantozol niet leverbaar | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 3.943: | Regel 4.063: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 50 dagen, gedurende 18 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_start_duur2_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 3.962: | Regel 4.089: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur2_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 60 dagen om 12:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|28 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Relatie verstrekkingsverzoek | |
− | + | |style="background-color: white;"|MBH_920_start_duur2_VV | |
− | |||
− | |||
− | |||
− | |colspan="4"|Relatie | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_start_duur2_MVE_anderePRK |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 4.007: | Regel 4.127: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur2_MVE_anderePRK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 50 dagen om 12:36 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Verstrekker |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="4"|Verstrekte hoeveelheid |
− | |style="background-color: white;"|T - 21 | + | |style="background-color: white;"|28 stuks |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_start_duur2_VV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_start_duur2_MGB | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_start_duur2_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T - 55 dagen om 15:21:33 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Informant | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Informant is patient | ||
+ | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 4.044: | Regel 4.208: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 4.057: | Regel 4.221: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_start_duur2 /><section begin=MBH_MBH_920_dosis_stuks /> |
+ | ====Medicamenteuze behandeling MBH_920_dosis_stuks ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_dosis_stuks_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 4.070: | Regel 4.236: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 130 dagen om 11:35 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T'' | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 130 dagen, tot en met T - 101 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 130 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 101 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 4.136: | Regel 4.258: | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 4.158: | Regel 4.270: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T, | + | |style="background-color: white;"|Vanaf T - 130 dagen, tot en met T - 101 dagen, 2 maal per dag 1 dosis, inhalatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 dosis |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_dosis_stuks_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 4.179: | Regel 4.289: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_dosis_stuks_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekkingsverzoek datum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 130 dagen om 11:35 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
Regel 4.251: | Regel 4.302: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Te verstrekken hoeveelheid | |colspan="4"|Te verstrekken hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Beoogd verstrekker | |colspan="5"|Beoogd verstrekker | ||
Regel 4.273: | Regel 4.318: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_dosis_stuks_MA |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_dosis_stuks_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 4.286: | Regel 4.331: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_dosis_stuks_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 130 dagen om 12:35 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 130 dagen, tot en met T - 101 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 130 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 101 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 4.310: | Regel 4.355: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FLIXOTIDE DISKUS INHPDR 100MCG 60DO (code = '1029754' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 4.326: | Regel 4.368: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T | + | |style="background-color: white;"|Vanaf T - 130 dagen, tot en met T - 101 dagen, 2 maal per dag 1 dosis, inhalatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 dosis |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 4.339: | Regel 4.381: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_dosis_stuks_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 4.352: | Regel 4.394: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_dosis_stuks_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieverstrekkings datum tijd | |colspan="4"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 130 dagen om 12:35 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 4.365: | Regel 4.407: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekte hoeveelheid | |colspan="4"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FLIXOTIDE DISKUS INHPDR 100MCG 60DO (code = '1029754' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie verstrekkingsverzoek | |colspan="4"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_dosis_stuks_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_dosis_stuks_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 4.393: | Regel 4.432: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_dosis_stuks_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatiegebruik datum tijd | |colspan="4"|Medicatiegebruik datum tijd | ||
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 100 dagen om 07:59:59 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruik indicator | |colspan="4"|Gebruik indicator | ||
Regel 4.403: | Regel 4.442: | ||
|colspan="4"|Volgens afspraak indicator | |colspan="4"|Volgens afspraak indicator | ||
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 4.422: | Regel 4.450: | ||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Informant |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Informant is patient |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Geneesmiddel - | + | |colspan="4"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 4.446: | Regel 4.475: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 dosis, inhalatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 dosis |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|MBH identificatie | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
− | |}<section end= | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_dosis_stuks /><section begin=MBH_MBH_920_nieuweMBHobvTA /> | ||
+ | ====Medicamenteuze behandeling MBH_920_nieuweMBHobvTA ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_nieuweMBHobvTA_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_nieuweMBHobvTA_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 10 dagen om 10:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T - 5 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 5 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|PARACETAMOL APOTEX TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|PARACETAMOL TABLET 500MG (code = '67903' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|PARACETAMOL TABLET 500MG (code = '2194' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 10 dagen, tot en met T - 5 dagen, Zo nodig 3 maal per dag 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zo nodig 3 maal per dag 2 stuks |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|MBH identificatie | |
− | + | |style="background-color: white;"|MBH_920_nieuweMBHobvTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
− | |colspan=" | + | |} |
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
− | |} | ||
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_nieuweMBHobvTA_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Identificatie |
+ | |style="background-color: white;"|MBH_920_nieuweMBHobvTA_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 10 dagen om 10:00 uur |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|30 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|PARACETAMOL APOTEX TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL TABLET 500MG (code = '67903' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL TABLET 500MG (code = '2194' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_nieuweMBHobvTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_nieuweMBHobvTA_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 4.552: | Regel 4.594: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_nieuweMBHobvTA_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T - 3 dagen om 16:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen om 10:00 uur, tot en met T - 3 dagen om 16:00 uur'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen om 10:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 3 dagen om 16:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur is patient |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL APOTEX TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|PARACETAMOL TABLET 500MG (code = '67903' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL TABLET 500MG (code = '2194' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 4.586: | Regel 4.634: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 10 dagen om 10:00 uur, tot en met T - 3 dagen om 16:00 uur, 3 maal per dag 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 2 stuks |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie toedieningsafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_nieuweMBHobvTA_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_nieuweMBHobvTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_nieuweMBHobvTA /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="7"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Naamgegevens |
+ | |style="background-color: white;"|Peter van Pulver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Zorgaanbieder |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |} | + | |}<section end=ALLMBHS_XXX_Brugge /> |
+ | ==Patiënt M. XXX_Niesing== | ||
+ | <section begin=XXX_Niesing /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Initialen |
− | |style="background-color: white;"| | + | |style="background-color: white;"|M. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgebruik |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geslachtsnaam |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Achternaam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Niesing |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900845 [BSN] |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geboortedatum |
+ | |style="background-color: white;"|29 okt 1985 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geslacht |
− | + | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |
− | + | |}<section end=XXX_Niesing /><section begin=ALLMBHS_XXX_Niesing /><section begin=MBH_MBH_920_HPKvoorschrijven /> | |
− | + | ====Medicamenteuze behandeling MBH_920_HPKvoorschrijven ==== | |
− | + | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
− | | | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_HPKvoorschrijven_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 4.732: | Regel 4.747: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_HPKvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 170 dagen om 13:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 170 dagen, tot en met T - 21 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 170 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 21 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 170 dagen, tot en met T - 21 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Doseerinstructie | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_HPKvoorschrijven_VV | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_HPKvoorschrijven_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Verstrekkingsverzoek datum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 170 dagen om 13:00 uur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Te verstrekken hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|150 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geneesmiddel - generiekere code |
+ | |style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Beoogd verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_HPKvoorschrijven_MA | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_HPKvoorschrijven_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 4.814: | Regel 4.848: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_HPKvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 170 dagen om 14:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 170 dagen, tot en met T - 21 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 170 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 21 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 170 dagen, tot en met T - 21 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Doseerinstructie | + | |colspan="3"|Doseerinstructie |
− | + | |style="background-color: white;"|1 maal per dag 1 stuk | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 4.864: | Regel 4.898: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_HPKvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_HPKvoorschrijven_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 4.884: | Regel 4.911: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_HPKvoorschrijven_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 170 dagen om 14:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|150 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geneesmiddel - generiekere code |
+ | |style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Relatie verstrekkingsverzoek | |
− | + | |style="background-color: white;"|MBH_920_HPKvoorschrijven_VV | |
− | |||
− | |colspan="4"|Relatie | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_HPKvoorschrijven_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 4.926: | Regel 4.949: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_HPKvoorschrijven_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T om 22:08 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur is patient |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 4.963: | Regel 4.999: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, tot en met T, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|Relatie | + | |colspan="5"|Relatie toedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_HPKvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_HPKvoorschrijven /><section begin=MBH_MBH_920_ZINRvoorschrijven /> |
+ | ====Medicamenteuze behandeling MBH_920_ZINRvoorschrijven ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_ZINRvoorschrijven_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 4.989: | Regel 5.027: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 13:05 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 150 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 150 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_ZINRvoorschrijven_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 5.027: | Regel 5.086: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_ZINRvoorschrijven_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekkingsverzoek datum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 13:05 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Te verstrekken hoeveelheid | ||
+ | |style="background-color: white;"|150 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geneesmiddel - generiekere code |
+ | |style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Beoogd verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_ZINRvoorschrijven_MA | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_ZINRvoorschrijven_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 5.099: | Regel 5.134: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_ZINRvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 14:05 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 150 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 150 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geneesmiddel - primaire code |
+ | |style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"|2 | + | |style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 5.154: | Regel 5.187: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_ZINRvoorschrijven_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 5.174: | Regel 5.200: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_ZINRvoorschrijven_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 14:05 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|150 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geneesmiddel - generiekere code |
+ | |style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Relatie verstrekkingsverzoek | |
− | + | |style="background-color: white;"|MBH_920_ZINRvoorschrijven_VV | |
− | |colspan=" | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_ZINRvoorschrijven_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 5.255: | Regel 5.241: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_ZINRvoorschrijven_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T om 22:08 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Volgens afspraak indicator | |colspan="4"|Volgens afspraak indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur is patient |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, tot en met T, 1 maal per dag 1 stuk, oraal |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Toedieningsweg |
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|Relatie | + | |colspan="5"|Relatie toedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_ZINRvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |}<section end= | + | |}<section end=MBH_MBH_920_ZINRvoorschrijven /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | ||
Regel 5.340: | Regel 5.339: | ||
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|<span id=" | + | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Organisatie naam |
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
+ | |}<section end=ALLMBHS_XXX_Niesing /> | ||
+ | ==Patiënt M. XXX_Pherai== | ||
+ | <section begin=XXX_Pherai /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="6"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Initialen |
− | |style="background-color: white;"| | + | |style="background-color: white;"|M. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgebruik |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geslachtsnaam |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Achternaam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Pherai |
− | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan=" | + | |colspan="4"|Identificatienummer |
+ | |style="background-color: white;"|999900870 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geboortedatum |
+ | |style="background-color: white;"|1 nov 1985 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
+ | |}<section end=XXX_Pherai /><section begin=ALLMBHS_XXX_Pherai /><section begin=MBH_MBH_920_wdsmtd1 /> | ||
+ | ====Medicamenteuze behandeling MBH_920_wdsmtd1 ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_wdsmtd1_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 20 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Ingangsdatum |
+ | |style="background-color: white;"|T - 20 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 9 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 1 maal per dag 2 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 2 stuks |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|MBH identificatie | |
− | + | |style="background-color: white;"|MBH_920_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
− | |colspan=" | + | |} |
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |} | ||
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Wisselend doseerschema MBH_920_wdsmtd1_WDS_opstartschema |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Wisselend doseerschema datum tijd | ||
+ | |style="background-color: white;"|T - 20 dagen om 08:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T - 15 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 15 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T - 15 dagen, eerst gedurende 3 dagen 1 maal per dag om 20:00 2 stuks, dan gedurende 3 dagen 1 maal per dag om 20:00 1 stuk, Oraal |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie 1 | ||
+ | |style="background-color: white;"|eerst gedurende 3 dagen 1 maal per dag om 20:00 2 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie 2 | ||
+ | |style="background-color: white;"|dan gedurende 3 dagen 1 maal per dag om 20:00 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Wisselend doseerschema MBH_920_wdsmtd1_WDS_trombosedienst |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 5.506: | Regel 5.517: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1_WDS_trombosedienst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Wisselend doseerschema datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 15 dagen om 14:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T - 5 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 14 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Tanja_de_Bakker|Zorgverlener: Tanja_de_Bakker]] |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 14 dagen, tot en met T - 5 dagen, cyclus van 5 dagen: steeds eerst gedurende 2 dagen 1 maal per dag 2 stuks 's avonds, dan gedurende 2 dagen 1 maal per dag 2 stuks 's avonds, dan gedurende 1 dag 1 maal per dag 0 stuks 's avonds, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Doseerinstructie | + | |colspan="3"|Doseerinstructie 1 |
− | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|eerst gedurende 2 dagen 1 maal per dag 2 stuks 's avonds |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Doseerinstructie 2 |
− | |style="background-color: white;"| | + | |style="background-color: white;"|dan gedurende 2 dagen 1 maal per dag 2 stuks 's avonds |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Doseerinstructie 3 |
− | |style="background-color: white;"| | + | |style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 0 stuks 's avonds |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Herhaalperiode cyclisch schema |
− | |style="background-color: white;"| | + | |style="background-color: white;"|5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="5"|Relatie medicatieafspraak | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="5"|Relatie wisselend doseerschema | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="5"|Relatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Wisselend doseerschema MBH_920_wdsmtd1_WDS_technischestop |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 5.625: | Regel 5.587: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1_WDS_technischestop (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Wisselend doseerschema datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 7 dagen om 10:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T - 7 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 14 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 7 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Wisselend doseerschema stop type | ||
+ | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Tanja_de_Bakker|Zorgverlener: Tanja_de_Bakker]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Reden wijzigen of staken |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="7"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 14 dagen, tot en met T - 7 dagen, cyclus van 5 dagen: steeds eerst gedurende 2 dagen 1 maal per dag 2 stuks 's avonds, dan gedurende 2 dagen 1 maal per dag 2 stuks 's avonds, dan gedurende 1 dag 1 maal per dag 0 stuks 's avonds, Oraal, definitief gestopt |
− | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan=" | + | |colspan="3"|Toedieningsweg |
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie 1 | ||
+ | |style="background-color: white;"|eerst gedurende 2 dagen 1 maal per dag 2 stuks 's avonds | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie 2 | ||
+ | |style="background-color: white;"|dan gedurende 2 dagen 1 maal per dag 2 stuks 's avonds | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Doseerinstructie 3 |
+ | |style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 0 stuks 's avonds | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Herhaalperiode cyclisch schema |
− | |style="background-color: white;"| | + | |style="background-color: white;"|5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Kopie indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Nee |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Toelichting |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Dosering aangepast i.v.m. te lage INR waarde. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 5.675: | Regel 5.649: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie wisselend doseerschema | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_wdsmtd1_WDS_trombosedienst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Wisselend doseerschema MBH_920_wdsmtd1_WDS_verhoging |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 5.688: | Regel 5.669: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1_WDS_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Wisselend doseerschema datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 7 dagen om 10:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 6 dagen, tot en met T + 6 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 6 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 6 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Tanja_de_Bakker|Zorgverlener: Tanja_de_Bakker]] |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 6 dagen, tot en met T + 6 dagen, cyclus van 5 dagen: steeds eerst gedurende 3 dagen 1 maal per dag om 19:00 2 stuks, dan gedurende 2 dagen 1 maal per dag om 19:00 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Doseerinstructie | + | |colspan="3"|Doseerinstructie 1 |
− | |style="background-color: white;"|1 maal per dag 1 stuk | + | |style="background-color: white;"|eerst gedurende 3 dagen 1 maal per dag om 19:00 2 stuks |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie 2 | ||
+ | |style="background-color: white;"|dan gedurende 2 dagen 1 maal per dag om 19:00 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Herhaalperiode cyclisch schema | ||
+ | |style="background-color: white;"|5 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Kopie indicator | ||
+ | |style="background-color: white;"|Nee | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 5.741: | Regel 5.719: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie wisselend doseerschema | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_wdsmtd1_WDS_trombosedienst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_wdsmtd1_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 5.756: | Regel 5.739: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekkingsverzoek datum |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Auteur |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
− | | | ||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Te verstrekken hoeveelheid | |
− | + | |style="background-color: white;"|60 stuks | |
− | |colspan=" | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Beoogd verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1_MA |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_wdsmtd1_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 5.806: | Regel 5.781: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen om 09:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 9 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Geneesmiddel - | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 5.840: | Regel 5.818: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 1 maal per dag 2 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 5.846: | Regel 5.824: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 5.853: | Regel 5.831: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_wdsmtd1_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 5.866: | Regel 5.844: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen om 09:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Verstrekker |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|60 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Geneesmiddel - generiekere code | |
− | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |
− | |||
− | |||
− | |||
− | |colspan="4"|Geneesmiddel - | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Relatie verstrekkingsverzoek |
+ | |style="background-color: white;"|MBH_920_wdsmtd1_VV | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Medicatietoediening MBH_920_wdsmtd1_MTD1 | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="5" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1_MTD1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Toedienings datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 20 dagen om 20:30 uur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Afgesproken datum tijd | ||
+ | |style="background-color: white;"|T - 20 dagen om 20:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="6"|Toegediende hoeveelheid |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Aantal | ||
+ | |style="background-color: white;"|1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Eenheid |
+ | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Afgesproken hoeveelheid | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Aantal |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Eenheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ORAAL (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="6"|Toediener |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Mantelzorger |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Contactpersoon |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Toos_de_Bakker|Contactpersoon: Toos_de_Bakker]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="6"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Identificatie |
− | + | |style="background-color: white;"|MBH_920_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="6"|Relatie wisselend doseerschema |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA1_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_920_wdsmtd1_MTD2 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 5.989: | Regel 5.958: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1_MTD2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedienings datum tijd | ||
+ | |style="background-color: white;"|T - 19 dagen om 20:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Afgesproken datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 19 dagen om 20:00 uur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Nee | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Toegediende hoeveelheid |
− | |style="background-color: #E3E3E3;;"|'' | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aantal | ||
+ | |style="background-color: white;"|1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Eenheid | ||
+ | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Afgesproken hoeveelheid | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aantal | ||
+ | |style="background-color: white;"|2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Eenheid |
+ | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Toediener |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Jantien_Toedien|Zorgverlener: Jantien_Toedien]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatie toediening reden van afwijken | ||
+ | |style="background-color: white;"|Toediening van medicatie geweigerd (code = '406149000' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|Relatie | + | |colspan="5"|Relatie wisselend doseerschema |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA1_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Medicatietoediening MBH_920_wdsmtd1_MTD3 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="5" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1_MTD3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Toedienings datum tijd | ||
+ | |style="background-color: white;"|T - 17 dagen om 20:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Afgesproken datum tijd | ||
+ | |style="background-color: white;"|T - 17 dagen om 20:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Nee | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Geannuleerd indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="6"|Toegediende hoeveelheid |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="4"|Aantal |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Eenheid | ||
+ | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Afgesproken hoeveelheid | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Aantal | ||
+ | |style="background-color: white;"|1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Eenheid | ||
+ | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Toediener | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Patient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Toediener is patient |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Medicatie toediening reden van afwijken | ||
+ | |style="background-color: white;"|Niet in staat om medicatie te gebruiken (code = '408366001' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Toelichting |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Geprobeerd, maar niet gelukt met de tablet |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="6"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Identificatie |
− | + | |style="background-color: white;"|MBH_920_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="6"|Relatie toedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_920_wdsmtd1_MTD4 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 6.117: | Regel 6.118: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1_MTD4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedienings datum tijd | ||
+ | |style="background-color: white;"|T - 16 dagen om 20:05 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Afgesproken datum tijd | ||
+ | |style="background-color: white;"|T - 16 dagen om 20:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Nee |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Toegediende hoeveelheid |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Aantal |
− | |style="background-color: white;"| | + | |style="background-color: white;"|0 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Eenheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Afgesproken hoeveelheid |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aantal | ||
+ | |style="background-color: white;"|1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Eenheid | ||
+ | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Toediener | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Marleen_van_der_Brand|Zorgverlener: Marleen_van_der_Brand]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatie toediening reden van afwijken | ||
+ | |style="background-color: white;"|Zorgafnemer is niet beschikbaar om medicatie in ontvangst te nemen (code = '153241000146104' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Relatie toedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie wisselend doseerschema | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"|1 | + | |style="background-color: white;"|MBH_920_QA1_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_wdsmtd1 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|<span id="Toos_de_Bakker" title="Intern ID = Toos_de_Bakker">Contactpersoon Toos_de_Bakker</span> |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Toos de Bakker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Rol |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Mantelzorger (code = '100001' in codeSystem '2.16.840.1.113883.2.4.3.11.60.40.4.23.1') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span> |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Zorgverlener identificatienummer |
+ | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgaanbieder | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|<span id="Tanja_de_Bakker" title="Intern ID = Tanja_de_Bakker">Zorgverlener Tanja_de_Bakker</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|222221111 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Tanja de Bakker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Zorgaanbieder |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgaanbieder |
− | + | |style="background-color: white;"|Zie [[#Trombosedienst_Ons_Dorp|Zorgaanbieder: Trombosedienst_Ons_Dorp]] | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | | | ||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | | | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|<span id="Jantien_Toedien" title="Intern ID = Jantien_Toedien">Zorgverlener Jantien_Toedien</span> |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Jantien Toedien |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Zorgaanbieder |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Thuiszorg_Om_en_Bij|Zorgaanbieder: Thuiszorg_Om_en_Bij]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Marleen_van_der_Brand" title="Intern ID = Marleen_van_der_Brand">Zorgverlener Marleen_van_der_Brand</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="7"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|111110000 (in identificerend systeem: UZI Personen) |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Naamgegevens |
+ | |style="background-color: white;"|Marleen van der Brand | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Zorgaanbieder |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Thuiszorg_Om_en_Bij|Zorgaanbieder: Thuiszorg_Om_en_Bij]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Adresgegevens | |
− | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |
− | |colspan="3"| | ||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|<span id="Trombosedienst_Ons_Dorp" title="Intern ID = Trombosedienst_Ons_Dorp">Zorgaanbieder Trombosedienst_Ons_Dorp</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Zorgaanbieder | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|11112222 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Trombosedienst Ons Dorp |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afdeling specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|: Kerkstraat 28 d 1332GH Ons Dorp |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|<span id="Thuiszorg_Om_en_Bij" title="Intern ID = Thuiszorg_Om_en_Bij">Zorgaanbieder Thuiszorg_Om_en_Bij</span> |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="5"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder identificatienummer | ||
+ | |style="background-color: white;"|11110000 (in identificerend systeem: URA) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Organisatie naam | ||
+ | |style="background-color: white;"|Thuiszorg Om en Bij | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Adresgegevens | ||
+ | |style="background-color: white;"|: Voorstraat 1 1223BA Ons Dorp | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Organisatie type | ||
+ | |style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '2.16.840.1.113883.2.4.15.1060') | ||
+ | |}<section end=ALLMBHS_XXX_Pherai /> | ||
+ | ==Patiënt C. XXX_Dijk== | ||
+ | <section begin=XXX_Dijk /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="6"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Initialen | ||
+ | |style="background-color: white;"|C. | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgebruik | ||
+ | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Achternaam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Dijk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatienummer | ||
+ | |style="background-color: white;"|999900456 [BSN] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geboortedatum | ||
+ | |style="background-color: white;"|20 okt 1963 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
− | |} | + | |}<section end=XXX_Dijk /><section begin=ALLMBHS_XXX_Dijk /><section begin=MBH_MBH_920_gestopt /> |
+ | ====Medicamenteuze behandeling MBH_920_gestopt ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_gestopt_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 6.359: | Regel 6.392: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 4 maanden om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T + 5 maanden'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 4 maanden |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 5 maanden |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 6.396: | Regel 6.426: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 4 maanden, tot en met T + 5 maanden, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 6.402: | Regel 6.432: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag 1 stuk |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_gestopt_MA_staken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 6.422: | Regel 6.445: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gestopt_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen om 18:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T - 10 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 4 maanden |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak stop type |
|style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Reden wijzigen of staken | ||
+ | |style="background-color: white;"|Geneesmiddelinteractie (code = '79899007' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 6.462: | Regel 6.485: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 4 maanden, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 6.475: | Regel 6.498: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_gestopt_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 6.488: | Regel 6.511: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gestopt_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 4 maanden om 09:00 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T + 5 maanden'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 4 maanden |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 5 maanden |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geneesmiddel - primaire code |
+ | |style="background-color: white;"|OMEPRAZOL SANDOZ CAPSULE MSR 20MG (code = '1500570' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Geneesmiddel - generiekere code | |
− | + | |style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK') | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Geneesmiddel - | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 6.542: | Regel 6.548: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 4 maanden, tot en met T + 5 maanden, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 6.555: | Regel 6.561: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_gestopt_TA_staken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 6.568: | Regel 6.574: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gestopt_TA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 10 dagen om 19:00 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T - 10 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 4 maanden |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Toedieningsafspraak stop type | |
− | + | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |
− | |colspan=" | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|OMEPRAZOL SANDOZ CAPSULE MSR 20MG (code = '1500570' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 6.615: | Regel 6.614: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 4 maanden, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 6.628: | Regel 6.627: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gestopt_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |}<section end= | + | |}<section end=MBH_MBH_920_gestopt /><section begin=MBH_MBH_920_gewijzigd /> |
− | ====Medicamenteuze behandeling | + | ====Medicamenteuze behandeling MBH_920_gewijzigd ==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_gewijzigd_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 6.643: | Regel 6.642: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieafspraak datum tijd | |colspan="4"|Medicatieafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 21 dagen om 08:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 21 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 6.667: | Regel 6.663: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 6.677: | Regel 6.673: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 6.686: | Regel 6.682: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_gewijzigd_MA_wijziging |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 6.696: | Regel 6.692: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigd_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieafspraak datum tijd | |colspan="4"|Medicatieafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen om 08:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 2 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 6.723: | Regel 6.713: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Reden wijzigen of staken | |colspan="4"|Reden wijzigen of staken | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 6.736: | Regel 6.726: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 2 dagen, 2 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 6.749: | Regel 6.739: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_gewijzigd_MA_techstaken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 6.762: | Regel 6.752: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigd_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen om 08:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen, tot en met T - 3 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 21 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 3 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak stop type | ||
+ | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 6.799: | Regel 6.789: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 21 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 6.812: | Regel 6.802: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_gewijzigd_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 6.825: | Regel 6.815: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 21 dagen om 09:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 21 dagen |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 6.852: | Regel 6.836: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 6.865: | Regel 6.849: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 6.878: | Regel 6.862: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_gewijzigd_TA_wijziging |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 6.893: | Regel 6.875: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigd_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen om 09:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 2 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 6.927: | Regel 6.909: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 2 dagen, 2 maal per dag 2 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 6.933: | Regel 6.915: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 2 stuks |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_gewijzigd_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_gewijzigd_TA_techstaken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 6.946: | Regel 6.935: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigd_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen om 09:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen, tot en met T - 3 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 21 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 3 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak stop type | ||
+ | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 6.970: | Regel 6.962: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 6.983: | Regel 6.975: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 21 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 6.996: | Regel 6.988: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigd_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_gewijzigd /><section begin=MBH_MBH_920_gewijzigddoorander /> |
+ | ====Medicamenteuze behandeling MBH_920_gewijzigddoorander ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_gewijzigddoorander_MA_eigen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 7.009: | Regel 7.003: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T - 60 dagen om 08:05 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T + 14 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 60 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 14 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
Regel 7.053: | Regel 7.027: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 7.063: | Regel 7.037: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 60 dagen, tot en met T + 14 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_gewijzigddoorander_MA_wijzigingdoorander |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 7.089: | Regel 7.056: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 3 dagen om 08:10 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 3 dagen, tot en met T + 30 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 3 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 30 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 7.116: | Regel 7.077: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Reden wijzigen of staken | |
− | + | |style="background-color: white;"|Gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT') | |
− | |colspan=" | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 7.136: | Regel 7.093: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 3 dagen, tot en met T + 30 dagen, 1 maal per dag 2 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 7.149: | Regel 7.106: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_gewijzigddoorander_MA_techstakendoorander |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 7.164: | Regel 7.119: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigddoorander_MA_techstakendoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieafspraak datum tijd | |colspan="4"|Medicatieafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 3 dagen om 08:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T - 4 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 60 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T - 4 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Medicatieafspraak stop type |
− | |style="background-color: white;"| | + | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 7.185: | Regel 7.143: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 7.198: | Regel 7.156: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 60 dagen, tot en met T - 4 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|MBH identificatie | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_gewijzigddoorander_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 7.217: | Regel 7.182: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigddoorander_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 60 dagen om 09:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T + 14 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 60 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 14 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 7.241: | Regel 7.206: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 7.254: | Regel 7.219: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 60 dagen, tot en met T + 14 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 7.260: | Regel 7.225: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 7.267: | Regel 7.232: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_gewijzigddoorander_TA_wijziging |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 7.282: | Regel 7.245: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigddoorander_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 3 dagen om 09:10 uur |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 3 dagen, tot en met T + 30 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 3 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 30 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
− | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan=" | + | |colspan="4"|Geneesmiddel - primaire code |
+ | |style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geneesmiddel - generiekere code |
+ | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 7.320: | Regel 7.282: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 3 dagen, tot en met T + 30 dagen, 1 maal per dag 2 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag 2 stuks |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|MBH identificatie | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
− | |} | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | + | |colspan="4"|MBH identificatie | |
− | + | |style="background-color: white;"|MBH_920_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
+ | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_gewijzigddoorander_TA_techstaken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 7.341: | Regel 7.308: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigddoorander_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 3 dagen om 09:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T - 4 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 60 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T - 4 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak stop type | ||
+ | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 7.372: | Regel 7.348: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 60 dagen, tot en met T - 4 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_gewijzigddoorander_MA_techstakendoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_gewijzigddoorander_MGB_zv |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 7.391: | Regel 7.374: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigddoorander_MGB_zv (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T - 3 dagen om 08:08 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T - 3 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 60 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T - 3 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Informant | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Informant is patient | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 7.425: | Regel 7.428: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 60 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 7.438: | Regel 7.441: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_gewijzigddoorander_MGB_pat |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 7.453: | Regel 7.454: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigddoorander_MGB_pat (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T om 08:08 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 3 dagen, tot en met T - 1 dag'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 3 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 7.474: | Regel 7.481: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur is patient | ||
+ | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 7.487: | Regel 7.501: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T - 3 dagen, tot en met T - 1 dag, 1 maal per dag 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag 2 stuks |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|MBH identificatie | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
− | |} | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_gewijzigddoorander /><section begin=MBH_MBH_920_onderbroken /> | ||
+ | ====Medicamenteuze behandeling MBH_920_onderbroken ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_onderbroken_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 7.506: | Regel 7.529: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 153 dagen om 08:06 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 153 dagen, tot en met T + 20 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 153 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 7.543: | Regel 7.563: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T - 153 dagen, tot en met T + 20 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 7.550: | Regel 7.570: | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_onderbroken_MA_onderbreken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 7.571: | Regel 7.582: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_onderbroken_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieafspraak datum tijd | |colspan="4"|Medicatieafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 100 dagen om 18:12 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 153 dagen, tot en met T - 100 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 153 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 100 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak stop type | ||
+ | |style="background-color: white;"|tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 7.592: | Regel 7.606: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Reden wijzigen of staken | ||
+ | |style="background-color: white;"|Verrichting gepland (code = '405613005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 7.605: | Regel 7.622: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 153 dagen, tot en met T - 100 dagen, 1 maal per dag 1 stuk, Oraal, tijdelijk gestopt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_onderbroken_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 7.624: | Regel 7.648: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_onderbroken_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 153 dagen om 09:06 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 153 dagen, tot en met T + 20 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 153 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 20 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE CF TABLET 20MG (code = '1099469' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Geneesmiddel - | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 7.664: | Regel 7.685: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 153 dagen, tot en met T + 20 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 7.677: | Regel 7.698: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_onderbroken_TA_onderbreken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 7.690: | Regel 7.711: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_onderbroken_TA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 100 dagen om 19:12 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 153 dagen, tot en met T - 100 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 153 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 100 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak stop type | ||
+ | |style="background-color: white;"|tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 7.711: | Regel 7.735: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE CF TABLET 20MG (code = '1099469' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 7.727: | Regel 7.751: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 153 dagen, tot en met T - 100 dagen, 1 maal per dag 1 stuk, Oraal, tijdelijk gestopt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 7.740: | Regel 7.764: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_onderbroken_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_onderbroken /><section begin=MBH_MBH_920_eigen1 /> |
+ | ====Medicamenteuze behandeling MBH_920_eigen1 ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_eigen1_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 7.753: | Regel 7.779: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_eigen1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T - 10 dagen om | + | |style="background-color: white;"|T - 10 dagen om 18:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T + 15 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 9 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 15 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 7.793: | Regel 7.813: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 9 dagen, tot en met T + 15 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 7.800: | Regel 7.820: | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_eigen1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_eigen1_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_eigen1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 10 dagen om 18:45 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T + 15 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 9 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 15 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geneesmiddel - primaire code |
+ | |style="background-color: white;"|PANTOPRAZOL TEVA TABLET MSR 20MG (code = '2002914' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 9 dagen, tot en met T + 15 dagen, 1 maal per dag 1 stuk, Oraal |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Toedieningsweg |
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_eigen1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="4"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_eigen1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_eigen1_MGB_zv | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_eigen1_MGB_zv (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Medicatiegebruik datum tijd |
+ | |style="background-color: white;"|T om 08:08 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 9 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Zorgverlener |
+ | |style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Informant | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Informant is patient |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Zorgverlener |
+ | |style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="5"|Gebruiksinstructie |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 9 dagen, tot en met T, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Toedieningsweg |
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_eigen1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_eigen1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_eigen1_MGB_pat |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 7.949: | Regel 7.975: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_eigen1_MGB_pat (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T om 18:08 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 9 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 7.970: | Regel 8.002: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Geneesmiddel - primaire code | + | |rowspan="2"| |
− | |style="background-color: white;"| | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |colspan="3"|Auteur is patient | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 9 dagen, tot en met T, 1 maal per dag 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 2 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"|1 | + | |style="background-color: white;"|MBH_920_eigen1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_eigen1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_eigen1 /><section begin=MBH_MBH_920_eigen2 /> |
+ | ====Medicamenteuze behandeling MBH_920_eigen2 ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_eigen2_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 8.005: | Regel 8.050: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_eigen2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 159 dagen om 08:15 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 159 dagen, gedurende 1 week'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 159 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksduur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 week |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Gebruiksinstructie |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Omschrijving |
+ | |style="background-color: white;"|Vanaf T - 159 dagen, gedurende 1 week, 3 maal per dag 1 stuk, Oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_eigen2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_eigen2_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 8.047: | Regel 8.103: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_eigen2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 159 dagen om 09:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 159 dagen, gedurende 1 week'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 159 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksduur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 week |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 8.071: | Regel 8.127: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 159 dagen, gedurende 1 week, 3 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 8.100: | Regel 8.153: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_eigen2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_eigen2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_eigen2 /><section begin=MBH_MBH_920_gebruik /> |
+ | ====Medicamenteuze behandeling MBH_920_gebruik ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_gebruik_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 8.113: | Regel 8.168: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gebruik_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T - 1 dag om 08:12 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T - 2 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 10 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur is patient |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Geneesmiddel - Product specificatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Product naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Paracetamol 500mg |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 10 dagen, tot en met T - 2 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gebruik (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |}<section end= | + | |}<section end=MBH_MBH_920_gebruik /><section begin=MBH_MBH_920_andermans /> |
− | ====Medicamenteuze behandeling | + | ====Medicamenteuze behandeling MBH_920_andermans ==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_andermans_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 8.153: | Regel 8.227: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_andermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieafspraak datum tijd | |colspan="4"|Medicatieafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen om 18:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 9 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 8.171: | Regel 8.245: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 8.184: | Regel 8.258: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 9 dagen, 2 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 8.190: | Regel 8.264: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 stuk |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_andermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_andermans_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 8.206: | Regel 8.277: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_andermans_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen om 19:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 9 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 9 dagen, 2 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|MBH identificatie | + | |rowspan="2"| |
− | |style="background-color: white;"| | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |} | + | |colspan="3"|Identificatie |
+ | |style="background-color: white;"|MBH_920_andermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_andermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_andermans /><section begin=MBH_MBH_920_toekomstig /> | ||
+ | ====Medicamenteuze behandeling MBH_920_toekomstig ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_toekomstig_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 8.251: | Regel 8.339: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toekomstig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag om 08:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 15 dagen, tot en met T + 51 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T + 15 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 51 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DOXYCYCLINE 100MG TABLET (code = '19844' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DOXYCYCLINE 100MG TABLET (code = '22179' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 8.285: | Regel 8.373: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T + 15 dagen, tot en met T + 51 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 8.292: | Regel 8.380: | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_toekomstig_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 8.314: | Regel 8.392: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toekomstig_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 1 dag om 09:15 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T + 15 dagen, tot en met T + 51 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T + 15 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 51 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 8.325: | Regel 8.414: | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DOXYCYCLINE PCH TABLET 100MG (code = '1141317' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DOXYCYCLINE 100MG TABLET (code = '19844' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DOXYCYCLINE 100MG TABLET (code = '22179' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |rowspan="4"| |
− | |style="background-color: white;"| | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T + 15 dagen, tot en met T + 51 dagen, 1 maal per dag 1 stuk, Oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toekomstig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_toekomstig /><section begin=MBH_MBH_920_gestoptandermans /> |
+ | ====Medicamenteuze behandeling MBH_920_gestoptandermans ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_gestoptandermans_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 8.355: | Regel 8.457: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 20 dagen om 08:00 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 7 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 7 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 8.382: | Regel 8.478: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 8.405: | Regel 8.491: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 7 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | | | + | |} |
− | |colspan=" | + | {| class="wikitable" width="85%" |
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_gestoptandermans_MA_staken | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Identificatie | |
− | + | |style="background-color: white;"|MBH_920_gestoptandermans_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieafspraak datum tijd | |colspan="4"|Medicatieafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen om 18:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T - 10 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 10 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak stop type | ||
+ | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 8.457: | Regel 8.534: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Reden wijzigen of staken |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Geneesmiddelinteractie (code = '79899007' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 8.473: | Regel 8.550: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 8.479: | Regel 8.556: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_gestoptandermans_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 8.492: | Regel 8.576: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gestoptandermans_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen om 09:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 7 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 7 dagen |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Relatie medicatieafspraak | + | |colspan="4"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 7 dagen, 1 maal per dag 1 stuk, Oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_gestoptandermans_TA_staken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 8.534: | Regel 8.639: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gestoptandermans_TA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen om 19:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T - 10 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 10 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak stop type | ||
+ | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 8.555: | Regel 8.663: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 8.571: | Regel 8.679: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 8.577: | Regel 8.685: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 8.584: | Regel 8.692: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gestoptandermans_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_gestoptandermans /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Marcha_van_Partners" title="Intern ID = Marcha_van_Partners">Zorgverlener Marcha_van_Partners</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|000001115 (in identificerend systeem: UZI Personen) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgegevens | ||
+ | |style="background-color: white;"|Marcha van Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Zorgaanbieder |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Itis|Zorgaanbieder: Huisartsenpraktijk_Itis]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="7"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgaanbieder | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] |
− | + | |-style="vertical-align:top; background-color: #E3E3E3;;" | |
− | + | |colspan="5"|<span id="Huisartsenpraktijk_Itis" title="Intern ID = Huisartsenpraktijk_Itis">Zorgaanbieder Huisartsenpraktijk_Itis</span> | |
− | |style="background-color: # | ||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|00005111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsenpraktijk Itis |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Langelaan 1 1234ZZ Onze Stad |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Organisatie naam |
+ | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|<span id="Apotheek_Jansen_en_Co" title="Intern ID = Apotheek_Jansen_en_Co">Zorgaanbieder Apotheek_Jansen_en_Co</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|99901111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek Jansen en Co |
− | | | + | |}<section end=ALLMBHS_XXX_Dijk /> |
− | + | ==Patiënt H. XXX_Hoek== | |
− | |style="background-color: white;"| | + | <section begin=XXX_Hoek /> |
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Naamgegevens |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Initialen |
− | |style="background-color: white;"| | + | |style="background-color: white;"|H. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgebruik |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geslachtsnaam |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Achternaam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hoek |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatienummer | ||
+ | |style="background-color: white;"|999900638 [BSN] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geboortedatum | ||
+ | |style="background-color: white;"|5 nov 1963 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
− | |}<section end= | + | |}<section end=XXX_Hoek /><section begin=ALLMBHS_XXX_Hoek /><section begin=MBH_MBH_920_contactepisode /> |
− | ====Medicamenteuze behandeling | + | ====Medicamenteuze behandeling MBH_920_contactepisode ==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_contactepisode_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 8.717: | Regel 8.835: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_contactepisode_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieafspraak datum tijd | |colspan="4"|Medicatieafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 9 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 8.738: | Regel 8.856: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 8.751: | Regel 8.869: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 1 maal per dag 2 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 8.757: | Regel 8.875: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 2 stuks |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie contact | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatienummer | ||
+ | |style="background-color: white;"|MBH_920_contactepisode_CONTACT1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.2709) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie zorgepisode | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_contactepisode_EPISODE1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.9200) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_contactepisode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Wisselend doseerschema MBH_920_contactepisode_WDS_opstartschema |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 8.773: | Regel 8.902: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_contactepisode_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Wisselend doseerschema datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen om 08:00 uur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T - 15 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 20 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T - 15 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
Regel 8.783: | Regel 8.923: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="5"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T - 15 dagen, eerst gedurende 3 dagen 1 maal per dag om 20:00 2 stuks, dan gedurende 3 dagen 1 maal per dag om 20:00 1 stuk, Oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie 1 | ||
+ | |style="background-color: white;"|eerst gedurende 3 dagen 1 maal per dag om 20:00 2 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie 2 | ||
+ | |style="background-color: white;"|dan gedurende 3 dagen 1 maal per dag om 20:00 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie contact | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatienummer | ||
+ | |style="background-color: white;"|MBH_920_contactepisode_CONTACT1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.2709) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie zorgepisode | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatienummer | ||
+ | |style="background-color: white;"|MBH_920_contactepisode_EPISODE1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.9200) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_contactepisode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_contactepisode_VV | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_contactepisode_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T - 20 dagen om 08:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Te verstrekken hoeveelheid | |colspan="4"|Te verstrekken hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|60 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Beoogd verstrekker | |colspan="5"|Beoogd verstrekker | ||
Regel 8.800: | Regel 9.000: | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wdsmtd1_MA |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_contactepisode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_contactepisode_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 8.818: | Regel 9.015: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_contactepisode_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen om 09:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 9 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 8.842: | Regel 9.039: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 8.855: | Regel 9.052: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 1 maal per dag 2 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 8.861: | Regel 9.058: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 8.868: | Regel 9.065: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_contactepisode_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_contactepisode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_contactepisode_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 8.881: | Regel 9.078: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_contactepisode_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieverstrekkings datum tijd | |colspan="4"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen om 09:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 8.894: | Regel 9.091: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekte hoeveelheid | |colspan="4"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|60 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie verstrekkingsverzoek | |colspan="4"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_contactepisode_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_contactepisode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_contactepisode_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 8.921: | Regel 9.116: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_contactepisode_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T - 10 dagen om 09:56:05 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T - 9 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 9 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 8.942: | Regel 9.143: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Informant | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Informant is patient | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T - 9 dagen, 1 maal per dag 2 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 2 stuks |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | + | |style="background-color: white;"|MBH_920_contactepisode_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Relatie contact |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_contactepisode_CONTACT3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.2709) |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Relatie zorgepisode |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_contactepisode_EPISODE1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.9200) |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_contactepisode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_920_contactepisode_MTD1 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 9.022: | Regel 9.210: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_contactepisode_MTD1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedienings datum tijd | ||
+ | |style="background-color: white;"|T - 20 dagen om 20:30 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Afgesproken datum tijd | ||
+ | |style="background-color: white;"|T - 20 dagen om 20:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Toegediende hoeveelheid | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aantal | ||
+ | |style="background-color: white;"|2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Eenheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Afgesproken hoeveelheid |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Aantal |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Eenheid | ||
+ | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ORAAL (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Toediener |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Identificatie | |
− | + | |style="background-color: white;"|MBH_920_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="3"| | ||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|Relatie | + | |colspan="5"|Relatie wisselend doseerschema |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_QA1_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie contact | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | | | ||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_contactepisode_CONTACT2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.2709) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Relatie zorgepisode |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_contactepisode_EPISODE1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.9200) |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_contactepisode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |}<section end= | + | |}<section end=MBH_MBH_920_contactepisode /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | ||
Regel 9.125: | Regel 9.295: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|<span id=" | + | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener identificatienummer | |colspan="3"|Zorgverlener identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgegevens | |colspan="3"|Naamgegevens | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Specialisme | |colspan="3"|Specialisme | ||
Regel 9.160: | Regel 9.330: | ||
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> | |colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder identificatienummer | |colspan="3"|Zorgaanbieder identificatienummer | ||
Regel 9.167: | Regel 9.337: | ||
|colspan="3"|Organisatie naam | |colspan="3"|Organisatie naam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
− | |}<section end= | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |colspan="3"|Adresgegevens | ||
+ | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
+ | |}<section end=ALLMBHS_XXX_Hoek /> | ||
==Patiënt C. XXX_Coenen== | ==Patiënt C. XXX_Coenen== | ||
<section begin=XXX_Coenen /> | <section begin=XXX_Coenen /> | ||
Regel 9.206: | Regel 9.379: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_aanvullendeinstructie_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 9.213: | Regel 9.386: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinstructie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieafspraak datum tijd | |colspan="4"|Medicatieafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 4 maanden om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T + 8 maanden'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 9.227: | Regel 9.400: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 8 maanden |
− | + | |-style="vertical-align:top; background-color: #E3E3E3;;" | |
− | |||
− | |||
− | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
Regel 9.238: | Regel 9.408: | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
Regel 9.253: | Regel 9.420: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - 4 maanden, tot en met T | + | |style="background-color: white;"|Vanaf T - 4 maanden, tot en met T + 8 maanden, 1 maal per dag 1 stuk, Bij het eten innemen, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 9.263: | Regel 9.430: | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_aanvullendeinstructie_VV | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_aanvullendeinstructie_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T - 4 maanden om 08:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Te verstrekken hoeveelheid | ||
+ | |style="background-color: white;"|180 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_aanvullendeinstructie_MA | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
Regel 9.275: | Regel 9.477: | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_aanvullendeinstructie_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 9.282: | Regel 9.484: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinstructie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 4 maanden om 09:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T + 8 maanden'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 9.296: | Regel 9.498: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 8 maanden |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 9.306: | Regel 9.505: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
Regel 9.322: | Regel 9.521: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - 4 maanden, tot en met T | + | |style="background-color: white;"|Vanaf T - 4 maanden, tot en met T + 8 maanden, 1 maal per dag 1 stuk, Bij het eten innemen, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 9.338: | Regel 9.537: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinstructie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"|MBH_920_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_aanvullendeinstructie_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 9.353: | Regel 9.550: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinstructie_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 4 maanden om 09:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Verstrekker |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
− | | | ||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Verstrekte hoeveelheid | |
− | + | |style="background-color: white;"|180 stuks | |
− | |||
− | |||
− | |||
− | |colspan="4"| | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geneesmiddel - generiekere code |
+ | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie verstrekkingsverzoek |
− | + | |style="background-color: white;"|MBH_920_aanvullendeinstructie_VV | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_aanvullendeinstructie /><section begin=MBH_MBH_920_toelichting /> |
+ | ====Medicamenteuze behandeling MBH_920_toelichting ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_toelichting_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 9.413: | Regel 9.590: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieafspraak datum tijd | |colspan="4"|Medicatieafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 21 dagen om 08:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 21 | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T - 21 dagen | |style="background-color: white;"|T - 21 dagen | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 9.450: | Regel 9.621: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - 21 | + | |style="background-color: white;"|Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Toelichting | |
− | + | |style="background-color: white;"|In overleg met specialist | |
− | |colspan=" | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
Regel 9.469: | Regel 9.636: | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_toelichting_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 9.476: | Regel 9.643: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekkingsverzoek datum | |colspan="4"|Verstrekkingsverzoek datum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 21 dagen om 08:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
Regel 9.489: | Regel 9.656: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Te verstrekken hoeveelheid | |colspan="4"|Te verstrekken hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
Regel 9.503: | Regel 9.670: | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toelichting | ||
+ | |style="background-color: white;"|Extra verstrekkingsverzoek omdat patient medicatie is kwijtgeraakt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_MA |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
Regel 9.511: | Regel 9.681: | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_toelichting_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 9.518: | Regel 9.688: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 21 dagen om 09:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 21 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 9.539: | Regel 9.709: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"|FUROSEMIDE | + | |style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
Regel 9.552: | Regel 9.722: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 9.558: | Regel 9.728: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toelichting | ||
+ | |style="background-color: white;"|In overleg met specialist | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 9.565: | Regel 9.738: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
Regel 9.571: | Regel 9.744: | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_toelichting_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 9.578: | Regel 9.751: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 21 dagen om 09:02 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 9.602: | Regel 9.761: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"|FUROSEMIDE | + | |style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
Regel 9.612: | Regel 9.774: | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Toelichting |
+ | |style="background-color: white;"|Extra verstrekkingsverzoek omdat patient medicatie is kwijtgeraakt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie verstrekkingsverzoek |
− | + | |style="background-color: white;"|MBH_920_toelichting_VV | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
Regel 9.637: | Regel 9.785: | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_toelichting_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 9.644: | Regel 9.792: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T om 10:14 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruik indicator |
− | |style="background-color: white;"|T - 2 | + | |style="background-color: white;"|Ja |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Nee | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 7 dagen, tot en met T - 1 dag'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 7 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T - 1 dag | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Informant |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Informant is patient |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"|FUROSEMIDE | + | |style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
Regel 9.667: | Regel 9.843: | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Relatie | + | |rowspan="4"| |
− | |style="background-color: white;"| | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 7 dagen, tot en met T - 1 dag, 2 maal per dag 1 stuk, Oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|2 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toelichting | ||
+ | |style="background-color: white;"|In verband met bijwerking de afgelopen week minder vaak genomen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
Regel 9.677: | Regel 9.873: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_redenvanvoorschrijven_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 9.684: | Regel 9.880: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieafspraak datum tijd | |colspan="4"|Medicatieafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 13 dagen om 08:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T + 14 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 13 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
Regel 9.707: | Regel 9.903: | ||
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Reden | + | |colspan="4"|Reden van voorschrijven |
− | |||
− | |||
− | |||
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Reumatoide artritis | |style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Reumatoide artritis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = ' | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = ' | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 9.724: | Regel 9.917: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 13 dagen, tot en met T + 14 dagen, 1 maal per week 5 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 9.730: | Regel 9.923: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per week | + | |style="background-color: white;"|1 maal per week 5 stuks |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|MBH identificatie | |
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"|MBH_920_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_redenvanvoorschrijven_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 9.750: | Regel 9.936: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekkingsverzoek datum |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 13 dagen om 08:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="5"|Auteur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
Regel 9.776: | Regel 9.948: | ||
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Te verstrekken hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|20 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = ' | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = ' | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Beoogd verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
− | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_MA | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_MA | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
Regel 9.809: | Regel 9.971: | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_redenvanvoorschrijven_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 9.816: | Regel 9.978: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 13 dagen om 09:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T + 14 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 13 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
Regel 9.837: | Regel 9.999: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
Regel 9.843: | Regel 10.005: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = ' | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = ' | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 9.853: | Regel 10.015: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 13 dagen, tot en met T + 14 dagen, 1 maal per week 5 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 9.859: | Regel 10.021: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per week | + | |style="background-color: white;"|1 maal per week 5 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 9.866: | Regel 10.028: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
Regel 9.872: | Regel 10.034: | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_redenvanvoorschrijven_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 9.879: | Regel 10.041: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 13 dagen om 09:05 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 9.903: | Regel 10.051: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|20 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
Regel 9.909: | Regel 10.060: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = ' | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = ' | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Relatie verstrekkingsverzoek |
− | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_VV | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"|MBH_920_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_redenvanvoorschrijven_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 9.947: | Regel 10.079: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T om 15:05 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Nee | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Nee |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T - 2 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatie gebruik stop type |
|style="background-color: white;"|tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT') | |style="background-color: white;"|tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
Regel 9.972: | Regel 10.110: | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Informant | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Informant is patient |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Geneesmiddel - generiekere code | + | |rowspan="2"| |
− | |style="background-color: white;"| | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 5 dagen, tot en met T - 2 dagen, geneesmiddel niet in gebruik, tijdelijk gestopt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Reden wijzigen of stoppen gebruik | |
− | + | |style="background-color: white;"|Verrichting gepland (code = '405613005' in codeSystem 'SNOMED CT') | |
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"| | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 10.003: | Regel 10.146: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_redenvanvoorschrijven /><section begin=MBH_MBH_920_aanvullendeinformatiewensen /> |
+ | ====Medicamenteuze behandeling MBH_920_aanvullendeinformatiewensen ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_aanvullendeinformatiewensen_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 10.016: | Regel 10.161: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen om 08:06 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T + 5 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 10.030: | Regel 10.175: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 5 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |||
− | |||
− | |||
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"|FENETICILLINE CAPSULE | + | |style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 10.056: | Regel 10.195: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - 4 dagen, tot en met T | + | |style="background-color: white;"|Vanaf T - 4 dagen, tot en met T + 5 dagen, 3 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|3 maal per dag 1 stuk | |style="background-color: white;"|3 maal per dag 1 stuk | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Aanvullende informatie | |
− | + | |style="background-color: white;"|Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') | |
− | |colspan=" | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"|MBH_920_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
− | |} | + | |} |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_aanvullendeinformatiewensen_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Identificatie |
+ | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Verstrekkingsverzoek datum |
− | + | |style="background-color: white;"|T - 5 dagen om 08:06 uur | |
− | + | |-style="vertical-align:top; background-color: #E3E3E3;;" | |
− | + | |colspan="5"|Auteur | |
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
− | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Te verstrekken hoeveelheid |
+ | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Beoogd verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Zorgaanbieder | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Aanvullende wensen |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Bezorgen (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2051') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Relatie medicatieafspraak |
+ | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_MA | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | + | |} | |
− | |||
− | |||
− | |} | ||
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_aanvullendeinformatiewensen_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 5 dagen om 09:06 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T + 5 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 4 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Geneesmiddel - generiekere code | |
− | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Geneesmiddel - | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 10.210: | Regel 10.299: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 4 dagen, tot en met T + 5 dagen, 3 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_aanvullendeinformatiewensen_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 10.229: | Regel 10.325: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen om 09:06 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Verstrekker |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="4"|Verstrekte hoeveelheid |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|30 stuks |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_VV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_aanvullendeinformatiewensen /><section begin=MBH_MBH_920_Toedieningsweg /> | ||
+ | ====Medicamenteuze behandeling MBH_920_Toedieningsweg ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_Toedieningsweg_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_Toedieningsweg_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 5 dagen om 08:15 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 2 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 5 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 2 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 10.253: | Regel 10.386: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 2 dagen, 2 maal per dag 1 druppel, In het rechter oog, oculair |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aanvullende instructie | ||
+ | |style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): In het rechter oog | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 druppel |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Aanvullende informatie | |
− | + | |style="background-color: white;"|Bewust afwijkende toedieningsweg (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') | |
− | |colspan=" | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_Toedieningsweg_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 10.295: | Regel 10.424: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Toedieningsweg_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekkingsverzoek datum | |colspan="4"|Verstrekkingsverzoek datum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen om 08:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
Regel 10.305: | Regel 10.434: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Te verstrekken hoeveelheid | |colspan="4"|Te verstrekken hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Beoogd verstrekker | |colspan="5"|Beoogd verstrekker | ||
Regel 10.324: | Regel 10.453: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Toedieningsweg_MA |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_Toedieningsweg_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 10.337: | Regel 10.466: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Toedieningsweg_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen om 09:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 2 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 2 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 10.358: | Regel 10.490: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|SOFRADEX OORDRUPPELS (code = '644781' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 2 dagen, 2 maal per dag 1 druppel, In het rechter oog, oculair |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aanvullende instructie | ||
+ | |style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): In het rechter oog | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 druppel |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 10.384: | Regel 10.519: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Toedieningsweg_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_Toedieningsweg_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 10.397: | Regel 10.532: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Toedieningsweg_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen om 09:15 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 10.421: | Regel 10.542: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|SOFRADEX OORDRUPPELS (code = '644781' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geneesmiddel - generiekere code |
+ | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie verstrekkingsverzoek |
− | + | |style="background-color: white;"|MBH_920_Toedieningsweg_VV | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | + | |}<section end=MBH_MBH_920_Toedieningsweg /> | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |}<section end= | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | ||
Regel 10.497: | Regel 10.569: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|<span id=" | + | |colspan="5"|<span id="Bertine_van_Doorn" title="Intern ID = Bertine_van_Doorn">Zorgverlener Bertine_van_Doorn</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener identificatienummer | |colspan="3"|Zorgverlener identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgegevens | |colspan="3"|Naamgegevens | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Bertine van Doorn |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Specialisme | |colspan="3"|Specialisme | ||
Regel 10.539: | Regel 10.611: | ||
|colspan="3"|Organisatie naam | |colspan="3"|Organisatie naam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
− | + | |}<section end=ALLMBHS_XXX_Coenen /> | |
− | + | ==Patiënt C. XXX_Coenen== | |
− | + | <section begin=XXX_Coenen /> | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |}<section end= | ||
− | ==Patiënt | ||
− | <section begin= | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 10.564: | Regel 10.626: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|C. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 10.574: | Regel 10.636: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Coenen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900420 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|17 okt 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
− | |}<section end= | + | |}<section end=XXX_Coenen /><section begin=ALLMBHS_XXX_Coenen /><section begin=MBH_MBH_920_aanvullendeinstructie /> |
− | ====Medicamenteuze behandeling | + | ====Medicamenteuze behandeling MBH_920_aanvullendeinstructie ==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_aanvullendeinstructie_MA_staken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 10.595: | Regel 10.657: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinstructie_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieafspraak datum tijd | |colspan="4"|Medicatieafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen om 18:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T - 10 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 4 maanden |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak stop type | ||
+ | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 10.616: | Regel 10.681: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Reden wijzigen of staken | ||
+ | |style="background-color: white;"|Geneesmiddelinteractie (code = '79899007' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 4 maanden, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Bij het eten innemen, Oraal, definitief gestopt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aanvullende instructie | ||
+ | |style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Bij het eten innemen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_aanvullendeinstructie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_aanvullendeinstructie_TA_staken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 10.648: | Regel 10.726: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinstructie_TA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen om 19:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T - 10 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 4 maanden |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak stop type |
− | + | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Relatie medicatieafspraak | + | |colspan="4"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="5"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 4 maanden, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Bij het eten innemen, Oraal, definitief gestopt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aanvullende instructie | ||
+ | |style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Bij het eten innemen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_aanvullendeinstructie_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_aanvullendeinstructie /><section begin=MBH_MBH_920_toelichting /> |
+ | ====Medicamenteuze behandeling MBH_920_toelichting ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_toelichting_MA_wijzigingmetVV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 10.690: | Regel 10.797: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_MA_wijzigingmetVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen om 08:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 2 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Reden wijzigen of staken | ||
+ | |style="background-color: white;"|Gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 10.724: | Regel 10.831: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 2 dagen, 1 maal per dag 2 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 10.737: | Regel 10.844: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_toelichting_MA_techstaken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 10.750: | Regel 10.857: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen om 08:02 uur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen, tot en met T - 3 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 21 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T - 3 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak stop type | ||
+ | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 21 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_toelichting_VV_extra |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Identificatie |
+ | |style="background-color: white;"|MBH_920_toelichting_VV_extra (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Verstrekkingsverzoek datum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 2 dagen om 08:02 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Te verstrekken hoeveelheid |
+ | |style="background-color: white;"|60 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Beoogd verstrekker |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Relatie medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_MA_wijzigingmetVV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | + | |} | |
− | |||
− | |||
− | |} | ||
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_toelichting_TA_wijzigingmetMVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 10.872: | Regel 10.962: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_TA_wijzigingmetMVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen om 09:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 2 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 10.906: | Regel 10.996: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 2 dagen, 1 maal per dag 2 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 2 stuks | |style="background-color: white;"|1 maal per dag 2 stuks | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_MA_wijzigingmetVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_toelichting_TA_techstaken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 10.967: | Regel 11.022: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen om 09:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen, tot en met T - 3 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 21 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T - 3 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Toedieningsafspraak stop type |
− | |style="background-color: white;"| | + | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 10.988: | Regel 11.046: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 11.004: | Regel 11.062: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 21 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 11.017: | Regel 11.075: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_toelichting_MVE_extra |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 11.030: | Regel 11.088: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_MVE_extra (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieverstrekkings datum tijd | |colspan="4"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen om 09:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 11.043: | Regel 11.101: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekte hoeveelheid | |colspan="4"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|60 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie verstrekkingsverzoek | |colspan="4"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_VV_extra |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_toelichting /><section begin=MBH_MBH_920_redenvanvoorschrijven /> |
+ | ====Medicamenteuze behandeling MBH_920_redenvanvoorschrijven ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_redenvanvoorschrijven_MA_wijzigingzonderVV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 11.068: | Regel 11.128: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_MA_wijzigingzonderVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag om 08:10 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 1 dag, tot en met T + 14 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 14 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 11.095: | Regel 11.149: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Reden wijzigen of staken |
+ | |style="background-color: white;"|Te sterk effect van medicatie (code = '112251000146103' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Reden van voorschrijven |
− | |style="background-color: white;"| | + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Reumatoide artritis |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 11.118: | Regel 11.168: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 1 dag, tot en met T + 14 dagen, 1 maal per week 4 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per week 4 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"|Relatie | + | |colspan="5"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_redenvanvoorschrijven_MA_techstaken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 11.146: | Regel 11.194: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieafspraak datum tijd | |colspan="4"|Medicatieafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag om 08:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T - 2 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 13 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T - 2 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak stop type | ||
+ | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 11.164: | Regel 11.218: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Reden van voorschrijven | ||
+ | |style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Reumatoide artritis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 11.177: | Regel 11.234: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 13 dagen, tot en met T - 2 dagen, 1 maal per week 5 stuks, Oraal, definitief gestopt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per week 5 stuks |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_redenvanvoorschrijven_TA_wijzigingzonderMVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 11.196: | Regel 11.260: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_TA_wijzigingzonderMVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 1 dag om 09:10 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 1 dag, tot en met T + 14 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 1 dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 14 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|METHOTREXAAT PCH TABLET 2,5MG (code = '1421778' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Geneesmiddel - | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 1 dag, tot en met T + 14 dagen, 1 maal per week 4 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Relatie medicatieafspraak | + | |colspan="3"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per week 4 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_MA_wijzigingzonderVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_redenvanvoorschrijven_TA_techstaken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 11.238: | Regel 11.323: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag om 09:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T - 2 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 13 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T - 2 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak stop type | ||
+ | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 11.256: | Regel 11.347: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METHOTREXAAT PCH TABLET 2,5MG (code = '1421778' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 11.272: | Regel 11.363: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 13 dagen, tot en met T - 2 dagen, 1 maal per week 5 stuks, Oraal, definitief gestopt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per week 5 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 11.285: | Regel 11.376: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_redenvanvoorschrijven /><section begin=MBH_MBH_920_aanvullendeinformatiewensen /> |
+ | ====Medicamenteuze behandeling MBH_920_aanvullendeinformatiewensen ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_aanvullendeinformatiewensen_MA_onderbreken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 11.298: | Regel 11.391: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag om 18:12 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T - 1 dag'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 4 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Geneesmiddel - primaire code | + | |colspan="4"|Medicatieafspraak stop type |
− | |style="background-color: white;"| | + | |style="background-color: white;"|tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Reden wijzigen of staken | ||
+ | |style="background-color: white;"|Opname in instelling (code = '305335007' in codeSystem 'SNOMED CT') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 4 dagen, tot en met T - 1 dag, 3 maal per dag 1 stuk, Oraal, tijdelijk gestopt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|3 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Aanvullende informatie | ||
+ | |style="background-color: white;"|Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_aanvullendeinformatiewensen_TA_onderbreken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 11.336: | Regel 11.460: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_TA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T - 19 | + | |style="background-color: white;"|T - 1 dag om 19:12 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T - 1 dag'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 4 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Toedieningsafspraak stop type | |
− | + | |style="background-color: white;"|tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT') | |
− | |colspan=" | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 11.383: | Regel 11.500: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 4 dagen, tot en met T - 1 dag, 3 maal per dag 1 stuk, Oraal, tijdelijk gestopt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 11.396: | Regel 11.513: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |}<section end= | + | |}<section end=MBH_MBH_920_aanvullendeinformatiewensen /> |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Bertine_van_Doorn" title="Intern ID = Bertine_van_Doorn">Zorgverlener Bertine_van_Doorn</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="7"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener identificatienummer | ||
+ | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Bertine van Doorn |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Zorgaanbieder |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|<span id="Apotheek_Jansen_en_Co" title="Intern ID = Apotheek_Jansen_en_Co">Zorgaanbieder Apotheek_Jansen_en_Co</span> |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Zorgaanbieder identificatienummer |
+ | |style="background-color: white;"|99901111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek Jansen en Co |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |} | + | |}<section end=ALLMBHS_XXX_Coenen /> |
+ | ==Patiënt E. XXX_Doppen== | ||
+ | <section begin=XXX_Doppen /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Initialen |
− | |style="background-color: white;"| | + | |style="background-color: white;"|E. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgebruik |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geslachtsnaam |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Achternaam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Doppen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900511 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geboortedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|24 okt 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
− | | | + | |}<section end=XXX_Doppen /><section begin=ALLMBHS_XXX_Doppen /><section begin=MBH_MBH_920_Lengte_Gewicht /> |
− | + | ====Medicamenteuze behandeling MBH_920_Lengte_Gewicht ==== | |
− | + | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_Lengte_Gewicht_MA_1 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 11.503: | Regel 11.623: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 jaar om 07:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 1 jaar'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 jaar |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '103039' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 11.537: | Regel 11.654: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 1 jaar, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_Lengte_Gewicht_MA_onderbreken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 11.563: | Regel 11.673: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 80 dagen om 15:00 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 1 jaar, tot en met T - 80 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 jaar |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 80 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak stop type |
|style="background-color: white;"|tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT') | |style="background-color: white;"|tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
Regel 11.632: | Regel 11.698: | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Reden wijzigen of staken | |
− | + | |style="background-color: white;"|Verrichting gepland (code = '405613005' in codeSystem 'SNOMED CT') | |
− | |colspan=" | ||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '103039' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 1 jaar, tot en met T - 80 dagen, 1 maal per dag 1 stuk, Oraal, tijdelijk gestopt |
− | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="5"|Relatie | + | |colspan="3"|Toedieningsweg |
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_Lengte_Gewicht_VV_1 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 11.679: | Regel 11.739: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekkingsverzoek datum |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 jaar om 07:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="5"|Auteur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
Regel 11.698: | Regel 11.750: | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Te verstrekken hoeveelheid | ||
+ | |style="background-color: white;"|180 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '103039' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Beoogd verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht_MA_1 |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_Lengte_Gewicht_TA_1 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 11.729: | Regel 11.781: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 jaar om 08:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 1 jaar'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 jaar |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Geneesmiddel - | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '103039' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 11.769: | Regel 11.815: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 1 jaar, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
Regel 11.782: | Regel 11.828: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_Lengte_Gewicht_TA_onderbreken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 11.795: | Regel 11.841: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht_TA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 80 dagen om 16:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 1 jaar, tot en met T - 80 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 1 jaar | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T - 80 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak stop type |
− | |style="background-color: white;"| | + | |style="background-color: white;"|tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]] |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '103039' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 1 jaar, tot en met T - 80 dagen, 1 maal per dag 1 stuk, Oraal, tijdelijk gestopt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_Lengte_Gewicht_MVE_1 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 11.837: | Regel 11.904: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 jaar om 08:05 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 11.856: | Regel 11.915: | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|180 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '103039' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Relatie verstrekkingsverzoek |
− | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht_VV_1 | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_Lengte_Gewicht /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span> |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Zorgaanbieder |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Adresgegevens | ||
+ | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|<span id="Apotheek_Jansen_en_Co" title="Intern ID = Apotheek_Jansen_en_Co">Zorgaanbieder Apotheek_Jansen_en_Co</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|99901111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek Jansen en Co |
− | |} | + | |}<section end=ALLMBHS_XXX_Doppen /> |
+ | ==Patiënt E. XXX_Doppen== | ||
+ | <section begin=XXX_Doppen /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |rowspan="6"| |
− | |style="background-color: white;"| | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |colspan="3"|Initialen | ||
+ | |style="background-color: white;"|E. | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgebruik |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geslachtsnaam |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Achternaam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Doppen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900511 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geboortedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|24 okt 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
− | | | + | |}<section end=XXX_Doppen /><section begin=ALLMBHS_XXX_Doppen /><section begin=MBH_MBH_920_Lengte_Gewicht_2 /> |
− | + | ====Medicamenteuze behandeling MBH_920_Lengte_Gewicht_2 ==== | |
− | + | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_Lengte_Gewicht_2_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 12.001: | Regel 12.039: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht_2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 jaar om 07:05 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 1 jaar, tot en met T - 120 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 jaar |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 120 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 12.029: | Regel 12.061: | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '103039' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 1 jaar, tot en met T - 120 dagen, 1 maal per dag 1 stuk, Oraal |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Toedieningsweg |
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_Lengte_Gewicht_2_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 12.070: | Regel 12.092: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht_2_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekkingsverzoek datum |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 jaar om 07:05 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
Regel 12.093: | Regel 12.101: | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Te verstrekken hoeveelheid | ||
+ | |style="background-color: white;"|125 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '103039' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Beoogd verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht_2_MA |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_Lengte_Gewicht_2_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_Lengte_Gewicht_2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 1 jaar om 08:05 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 1 jaar, tot en met T - 120 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 1 jaar |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 120 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '103039' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 1 jaar, tot en met T - 120 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht_2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_Lengte_Gewicht_2_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Identificatie |
+ | |style="background-color: white;"|MBH_920_Lengte_Gewicht_2_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 1 jaar om 08:05 uur |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|125 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '103039' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Relatie verstrekkingsverzoek |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht_2_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Lengte_Gewicht_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |}<section end= | + | |}<section end=MBH_MBH_920_Lengte_Gewicht_2 /> |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="7"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Naamgegevens |
+ | |style="background-color: white;"|Peter van Pulver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Zorgaanbieder |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Organisatie naam |
+ | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |} | + | |}<section end=ALLMBHS_XXX_Doppen /> |
+ | ==Patiënt M. XXX_Raamsdonk== | ||
+ | <section begin=XXX_Raamsdonk /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Naamgegevens |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Initialen |
− | |style="background-color: white;"| | + | |style="background-color: white;"|M. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgebruik |
− | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geslachtsnaam |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Achternaam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Raamsdonk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatienummer | ||
+ | |style="background-color: white;"|999900924 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geboortedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|6 nov 1985 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
− | |} | + | |}<section end=XXX_Raamsdonk /><section begin=ALLMBHS_XXX_Raamsdonk /><section begin=MBH_MBH_920_volgens_afspraak /> |
+ | ====Medicamenteuze behandeling MBH_920_volgens_afspraak ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_volgens_afspraak_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 12.311: | Regel 12.316: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_volgens_afspraak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 20 dagen om 10:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T, | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 10 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksduur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '86991' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '129720' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 12.348: | Regel 12.350: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T - 20 dagen, gedurende 10 dagen, 1 maal per dag 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|maal per dag | + | |style="background-color: white;"|1 maal per dag 2 stuks |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_volgens_afspraak_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 12.374: | Regel 12.369: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_volgens_afspraak_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekkingsverzoek datum |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 20 dagen om 10:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Te verstrekken hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|20 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '86991' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '129720' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Relatie | + | |colspan="4"|Relatie medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_volgens_afspraak_MA |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_volgens_afspraak_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 12.412: | Regel 12.411: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_volgens_afspraak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 20 dagen om 10:30 uur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 10 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |rowspan="3"| | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksduur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geneesmiddel - primaire code |
+ | |style="background-color: white;"|PRADAXA CAPSULE 110MG (code = '1929461' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Geneesmiddel - generiekere code | |
− | + | |style="background-color: white;"|DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '86991' in codeSystem 'G-Standaard PRK') | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Geneesmiddel - | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '129720' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 12.466: | Regel 12.448: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T - 20 dagen, gedurende 10 dagen, 1 maal per dag 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|maal per dag | + | |style="background-color: white;"|1 maal per dag 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 12.479: | Regel 12.461: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_volgens_afspraak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_volgens_afspraak_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 12.501: | Regel 12.474: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_volgens_afspraak_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 20 dagen om 10:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Verstrekker |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
− | | | ||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Verstrekte hoeveelheid |
+ | |style="background-color: white;"|20 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|PRADAXA CAPSULE 110MG (code = '1929461' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Geneesmiddel - | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '86991' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '129720' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Relatie verstrekkingsverzoek |
− | + | |style="background-color: white;"|MBH_920_volgens_afspraak_VV | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_volgens_afspraak_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 12.551: | Regel 12.512: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_volgens_afspraak_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T - 5 dagen om 18:20:05 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 10 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 20 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksduur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
Regel 12.562: | Regel 12.540: | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |rowspan="2"| |
− | |style="background-color: white;"| | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |colspan="3"|Auteur is patient | ||
+ | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PRADAXA CAPSULE 110MG (code = '1929461' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '86991' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '129720' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 20 dagen, gedurende 10 dagen, 1 maal per dag 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|MBH identificatie | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 2 stuks |
− | |} | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |colspan="5"|Relatie toedieningsafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_volgens_afspraak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_volgens_afspraak /><section begin=MBH_MBH_920_niet_volgens_afspraak /> | ||
+ | ====Medicamenteuze behandeling MBH_920_niet_volgens_afspraak ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_niet_volgens_afspraak_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 12.593: | Regel 12.590: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_niet_volgens_afspraak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 30 dagen om 15:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T'' | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 30 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|SIMVASTATINE TABLET FO 20MG (code = '67814' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|SIMVASTATINE TABLET FO 20MG (code = '116580' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 12.627: | Regel 12.621: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T - 30 dagen, 1 maal per dag 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 2 stuks |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_niet_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_niet_volgens_afspraak_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 12.653: | Regel 12.640: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_niet_volgens_afspraak_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekkingsverzoek datum |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 30 dagen om 15:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Te verstrekken hoeveelheid |
|style="background-color: white;"|90 stuks | |style="background-color: white;"|90 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|SIMVASTATINE TABLET FO 20MG (code = '67814' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|SIMVASTATINE TABLET FO 20MG (code = '116580' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Relatie | + | |colspan="4"|Relatie medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_niet_volgens_afspraak_MA |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_niet_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_niet_volgens_afspraak_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 12.691: | Regel 12.682: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_niet_volgens_afspraak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 30 dagen om 16:00 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 30 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geneesmiddel - primaire code |
+ | |style="background-color: white;"|SIMVASTATINE SANDOZ TABLET FILMOMHULD 20MG (code = '1592661' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Geneesmiddel - generiekere code | |
− | + | |style="background-color: white;"|SIMVASTATINE TABLET FO 20MG (code = '67814' in codeSystem 'G-Standaard PRK') | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Geneesmiddel - | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|SIMVASTATINE TABLET FO 20MG (code = '116580' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 12.745: | Regel 12.716: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T - 30 dagen, 1 maal per dag 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 12.758: | Regel 12.729: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_niet_volgens_afspraak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_niet_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_niet_volgens_afspraak_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 12.773: | Regel 12.742: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_niet_volgens_afspraak_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 30 dagen om 16:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Verstrekker |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|90 stuks |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|SIMVASTATINE SANDOZ TABLET FILMOMHULD 20MG (code = '1592661' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|SIMVASTATINE TABLET FO 20MG (code = '67814' in codeSystem 'G-Standaard PRK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geneesmiddel - generiekere code |
+ | |style="background-color: white;"|SIMVASTATINE TABLET FO 20MG (code = '116580' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie verstrekkingsverzoek |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_niet_volgens_afspraak_VV |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_niet_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_niet_volgens_afspraak_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 12.826: | Regel 12.780: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_niet_volgens_afspraak_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T - 19 dagen om 10:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Nee | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen, tot en met T - 20 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 30 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
Regel 12.837: | Regel 12.808: | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur is patient |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|SIMVASTATINE TABLET FO 20MG (code = '67814' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|SIMVASTATINE TABLET FO 20MG (code = '116580' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 30 dagen, tot en met T - 20 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|MBH identificatie | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
− | |} | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_niet_volgens_afspraak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_niet_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_niet_volgens_afspraak /><section begin=MBH_MBH_920_geen_gebruik_niet_volgens_afspraak /> | ||
+ | ====Medicamenteuze behandeling MBH_920_geen_gebruik_niet_volgens_afspraak ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_geen_gebruik_niet_volgens_afspraak_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 12.868: | Regel 12.855: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_niet_volgens_afspraak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 14 dagen om 12:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 14 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 12.905: | Regel 12.886: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T - 14 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_niet_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_geen_gebruik_niet_volgens_afspraak_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 12.931: | Regel 12.905: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_niet_volgens_afspraak_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekkingsverzoek datum |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 14 dagen om 12:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Te verstrekken hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|90 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Relatie | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_geen_gebruik_niet_volgens_afspraak_MA | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_niet_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_geen_gebruik_niet_volgens_afspraak_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 12.969: | Regel 12.947: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_niet_volgens_afspraak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 14 dagen om 13:00 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 14 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geneesmiddel - primaire code |
+ | |style="background-color: white;"|HYDROCHLOORTHIAZIDE APOTEX TABLET 12,5MG (code = '2530104' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Geneesmiddel - generiekere code | |
− | + | |style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK') | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Geneesmiddel - | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 13.023: | Regel 12.981: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T - 14 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 13.036: | Regel 12.994: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_niet_volgens_afspraak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_niet_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_geen_gebruik_niet_volgens_afspraak_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 13.051: | Regel 13.007: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_niet_volgens_afspraak_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 14 dagen om 13:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Verstrekker |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|90 stuks |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|HYDROCHLOORTHIAZIDE APOTEX TABLET 12,5MG (code = '2530104' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geneesmiddel - generiekere code |
+ | |style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie verstrekkingsverzoek |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_niet_volgens_afspraak_VV |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_niet_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_geen_gebruik_niet_volgens_afspraak_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 13.107: | Regel 13.045: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_niet_volgens_afspraak_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T - 4 dagen om 08:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Nee | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Nee | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 6 dagen, tot en met T - 5 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 6 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T - 5 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatie gebruik stop type | ||
+ | |style="background-color: white;"|tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
Regel 13.119: | Regel 13.084: | ||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|HYDROCHLOORTHIAZIDE APOTEX TABLET 12,5MG (code = '2530104' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Geneesmiddel - | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 6 dagen, tot en met T - 5 dagen, geneesmiddel niet in gebruik, tijdelijk gestopt |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie toedieningsafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_niet_volgens_afspraak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_niet_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_geen_gebruik_niet_volgens_afspraak /><section begin=MBH_MBH_920_geen_gebruik_volgens_afspraak /> |
+ | ====Medicamenteuze behandeling MBH_920_geen_gebruik_volgens_afspraak ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_geen_gebruik_volgens_afspraak_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 13.149: | Regel 13.120: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_volgens_afspraak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 100 dagen om 08:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 100 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T - 100 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_geen_gebruik_volgens_afspraak_stopMA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 13.215: | Regel 13.170: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_volgens_afspraak_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 20 dagen om 08:20:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen, tot en met T - 20 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 100 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak stop type |
− | + | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 13.281: | Regel 13.195: | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Reden wijzigen of staken | |
− | + | |style="background-color: white;"|Drug treatment not indicated (situation) (code = '183966005' in codeSystem 'SNOMED CT') | |
− | |colspan=" | ||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T | + | |style="background-color: white;"|Vanaf T - 100 dagen, tot en met T - 20 dagen, 1 maal per dag 1 stuk, oraal, definitief gestopt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 13.323: | Regel 13.223: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_volgens_afspraak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_geen_gebruik_volgens_afspraak_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 13.391: | Regel 13.236: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_volgens_afspraak_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekkingsverzoek datum | |colspan="4"|Verstrekkingsverzoek datum | ||
− | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T - 100 dagen om 08:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
Regel 13.404: | Regel 13.249: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Te verstrekken hoeveelheid | |colspan="4"|Te verstrekken hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|90 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Beoogd verstrekker | |colspan="5"|Beoogd verstrekker | ||
Regel 13.417: | Regel 13.262: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_volgens_afspraak_MA |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_geen_gebruik_volgens_afspraak_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 13.433: | Regel 13.278: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_volgens_afspraak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T - 100 dagen om 09:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 100 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 13.454: | Regel 13.296: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|HYDROCHLOORTHIAZIDE APOTEX TABLET 12,5MG (code = '2530104' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 13.470: | Regel 13.312: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T - 100 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 13.483: | Regel 13.325: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_volgens_afspraak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_geen_gebruik_volgens_afspraak_stopTA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 13.496: | Regel 13.338: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_volgens_afspraak_stopTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 20 dagen om 08:20:05 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen, tot en met T - 20 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 100 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T - 20 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak stop type |
− | |style="background-color: white;"| | + | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 13.506: | Regel 13.362: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|HYDROCHLOORTHIAZIDE APOTEX TABLET 12,5MG (code = '2530104' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 100 dagen, tot en met T - 20 dagen, 1 maal per dag 1 stuk, oraal, definitief gestopt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_volgens_afspraak_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_geen_gebruik_volgens_afspraak_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 13.534: | Regel 13.404: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_volgens_afspraak_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Medicatiegebruik datum tijd | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 100 dagen om 09:00 uur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|90 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|HYDROCHLOORTHIAZIDE APOTEX TABLET 12,5MG (code = '2530104' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_geen_gebruik_volgens_afspraak_VV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_geen_gebruik_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_geen_gebruik_volgens_afspraak_MGB | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_geen_gebruik_volgens_afspraak_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T - 10 dagen om 12:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruik indicator | |colspan="4"|Gebruik indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Nee |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Volgens afspraak indicator | |colspan="4"|Volgens afspraak indicator | ||
Regel 13.546: | Regel 13.454: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 19 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 19 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Medicatie gebruik stop type |
− | |style="background-color: white;"| | + | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 13.567: | Regel 13.475: | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur is patient |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T - 19 dagen, geneesmiddel niet in gebruik, definitief gestopt |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 13.594: | Regel 13.496: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_volgens_afspraak_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_geen_gebruik_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |}<section end= | + | |}<section end=MBH_MBH_920_geen_gebruik_volgens_afspraak /><section begin=MBH_MBH_920_zelfzorgmedicatie /> |
− | ====Medicamenteuze behandeling | + | ====Medicamenteuze behandeling MBH_920_zelfzorgmedicatie ==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_zelfzorgmedicatie_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 13.609: | Regel 13.511: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_zelfzorgmedicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieafspraak datum tijd | |colspan="4"|Medicatieafspraak datum tijd | ||
− | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T - 79 dagen om 08:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T, | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 90 dagen, gedurende 30 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 90 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksduur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 13.633: | Regel 13.535: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|CETIRIZINE TABLET 10MG (code = '26298' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|CETIRIZINE TABLET 10MG (code = '71218' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T - 90 dagen, gedurende 30 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Toelichting |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Patiënt koopt zelfzorgmedicatie bij drogist. |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatiegebruik | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"|2 | + | |style="background-color: white;"|MBH_920_zelfzorgmedicatie_MBG (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_zelfzorgmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_zelfzorgmedicatie_MBG |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 13.668: | Regel 13.574: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_zelfzorgmedicatie_MBG (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T - 80 dagen om 20:30:10 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 90 dagen, gedurende 10 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 90 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksduur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
Regel 13.677: | Regel 13.597: | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur is patient |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|PREVALIN ALLERSTOP CETIRIZINE TABLET FILMOMH 10MG (code = '2497905' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Geneesmiddel - | + | |colspan="4"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|CETIRIZINE TABLET 10MG (code = '26298' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|CETIRIZINE TABLET 10MG (code = '71218' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Gebruiksinstructie |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Omschrijving |
+ | |style="background-color: white;"|Vanaf T - 90 dagen, gedurende 10 dagen, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_zelfzorgmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_zelfzorgmedicatie /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="7"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Naamgegevens |
+ | |style="background-color: white;"|Peter van Pulver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Zorgaanbieder |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |} | + | |}<section end=ALLMBHS_XXX_Raamsdonk /> |
+ | ==Patiënt G. XXX_Hemsbergen== | ||
+ | <section begin=XXX_Hemsbergen /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="6"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Initialen |
− | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgebruik | ||
+ | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geslachtsnaam |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Achternaam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hemsbergen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900602 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geboortedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
− | | | + | |}<section end=XXX_Hemsbergen /><section begin=ALLMBHS_XXX_Hemsbergen /><section begin=MBH_MBH_920_variabelefrequentie /> |
− | + | ====Medicamenteuze behandeling MBH_920_variabelefrequentie ==== | |
− | + | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_variabelefrequentie_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 13.817: | Regel 13.720: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 08:00 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 16 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 13.837: | Regel 13.734: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 16 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
Regel 13.861: | Regel 13.744: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T + | + | |style="background-color: white;"|Vanaf T, tot en met T + 16 dagen, 1 à 2 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|2 maal per dag | + | |style="background-color: white;"|1 à 2 maal per dag 1 stuk |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_variabelefrequentie_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 13.958: | Regel 13.773: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelefrequentie_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekkingsverzoek datum | |colspan="4"|Verstrekkingsverzoek datum | ||
− | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
Regel 13.971: | Regel 13.786: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Te verstrekken hoeveelheid | |colspan="4"|Te verstrekken hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|90 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Beoogd verstrekker | |colspan="5"|Beoogd verstrekker | ||
Regel 13.987: | Regel 13.802: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelefrequentie_MA |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_variabelefrequentie_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 14.000: | Regel 13.815: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelefrequentie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T om 09:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 16 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 14.014: | Regel 13.829: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 16 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 14.024: | Regel 13.839: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 14.037: | Regel 13.852: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T + | + | |style="background-color: white;"|Vanaf T, tot en met T + 16 dagen, 1 à 2 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 à 2 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 14.050: | Regel 13.865: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_variabelefrequentie_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 14.063: | Regel 13.878: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelefrequentie_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieverstrekkings datum tijd | |colspan="4"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T om 09:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 14.076: | Regel 13.891: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekte hoeveelheid | |colspan="4"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|90 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie verstrekkingsverzoek | |colspan="4"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelefrequentie_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_variabelefrequentie_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 14.101: | Regel 13.916: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelefrequentie_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatiegebruik datum tijd | |colspan="4"|Medicatiegebruik datum tijd | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 16 dagen om 16:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruik indicator | |colspan="4"|Gebruik indicator | ||
Regel 14.113: | Regel 13.928: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 16 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 14.121: | Regel 13.936: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 16 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 14.145: | Regel 13.960: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 14.155: | Regel 13.970: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T + | + | |style="background-color: white;"|Vanaf T, tot en met T + 16 dagen, 1 à 2 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 à 2 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 14.168: | Regel 13.983: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie toedieningsafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_variabelefrequentie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |}<section end= | + | |}<section end=MBH_MBH_920_variabelefrequentie /><section begin=MBH_MBH_920_interval /> |
− | ====Medicamenteuze behandeling | + | ====Medicamenteuze behandeling MBH_920_interval ==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_interval_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 14.183: | Regel 14.005: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_interval_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieafspraak datum tijd | |colspan="4"|Medicatieafspraak datum tijd | ||
− | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:04 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 14.207: | Regel 14.026: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T, iedere 8 uur 1 stuk , let op! Tijden exact aanhouden., Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|op | + | |style="background-color: white;"|iedere 8 uur 1 stuk , let op! Tijden exact aanhouden. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_interval_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 14.242: | Regel 14.055: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_interval_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekkingsverzoek datum | |colspan="4"|Verstrekkingsverzoek datum | ||
− | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:04 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
Regel 14.255: | Regel 14.068: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Te verstrekken hoeveelheid | |colspan="4"|Te verstrekken hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|90 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Beoogd verstrekker | |colspan="5"|Beoogd verstrekker | ||
Regel 14.271: | Regel 14.084: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_interval_MA |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_interval_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 14.284: | Regel 14.097: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_interval_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T om 09:04 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 14.308: | Regel 14.118: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T, iedere 8 uur 1 stuk , let op! Tijden exact aanhouden., Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|op | + | |style="background-color: white;"|iedere 8 uur 1 stuk , let op! Tijden exact aanhouden. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 14.340: | Regel 14.144: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_interval_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_interval_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 14.353: | Regel 14.157: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_interval_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieverstrekkings datum tijd | |colspan="4"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T om 09:04 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 14.366: | Regel 14.170: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekte hoeveelheid | |colspan="4"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|90 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie verstrekkingsverzoek | |colspan="4"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_interval_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_interval_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 14.391: | Regel 14.195: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_interval_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatiegebruik datum tijd | |colspan="4"|Medicatiegebruik datum tijd | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 16 dagen om 23:59:59 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruik indicator | |colspan="4"|Gebruik indicator | ||
Regel 14.403: | Regel 14.207: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 16 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 14.411: | Regel 14.215: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 16 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 14.435: | Regel 14.239: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T + | + | |style="background-color: white;"|Vanaf T, tot en met T + 16 dagen, iedere 8 uur 1 stuk , let op! Tijden exact aanhouden., Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|op | + | |style="background-color: white;"|iedere 8 uur 1 stuk , let op! Tijden exact aanhouden. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 14.464: | Regel 14.262: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_interval_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |}<section end= | + | |}<section end=MBH_MBH_920_interval /><section begin=MBH_MBH_920_variabelehoeveelheid /> |
− | ====Medicamenteuze behandeling | + | ====Medicamenteuze behandeling MBH_920_variabelehoeveelheid ==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_variabelehoeveelheid_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 14.479: | Regel 14.277: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieafspraak datum tijd | |colspan="4"|Medicatieafspraak datum tijd | ||
− | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T'' | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 28 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 14.500: | Regel 14.301: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 14.510: | Regel 14.311: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, 1 | + | |style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 3 maal per dag 1 à 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 14.516: | Regel 14.317: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|1 | + | |style="background-color: white;"|3 maal per dag 1 à 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_variabelehoeveelheid_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 14.529: | Regel 14.330: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekkingsverzoek datum | |colspan="4"|Verstrekkingsverzoek datum | ||
− | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
Regel 14.542: | Regel 14.343: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Te verstrekken hoeveelheid | |colspan="4"|Te verstrekken hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|100 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Beoogd verstrekker | |colspan="5"|Beoogd verstrekker | ||
Regel 14.558: | Regel 14.359: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid_MA |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_variabelehoeveelheid_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 14.571: | Regel 14.372: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T om 09:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T'' | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 28 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 14.592: | Regel 14.396: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL AURO TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 14.605: | Regel 14.409: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, 1 | + | |style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 3 maal per dag 1 à 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 14.611: | Regel 14.415: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|1 | + | |style="background-color: white;"|3 maal per dag 1 à 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 14.618: | Regel 14.422: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_variabelehoeveelheid_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 14.631: | Regel 14.435: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieverstrekkings datum tijd | |colspan="4"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T om 09:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 14.644: | Regel 14.448: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekte hoeveelheid | |colspan="4"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|100 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL AURO TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie verstrekkingsverzoek | |colspan="4"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_variabelehoeveelheid_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 14.669: | Regel 14.473: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatiegebruik datum tijd | |colspan="4"|Medicatiegebruik datum tijd | ||
Regel 14.713: | Regel 14.517: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 14.723: | Regel 14.527: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, 1 | + | |style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, 3 maal per dag 1 à 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 14.729: | Regel 14.533: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"|1 | + | |style="background-color: white;"|3 maal per dag 1 à 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 14.736: | Regel 14.540: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |}<section end= | + | |}<section end=MBH_MBH_920_variabelehoeveelheid /><section begin=MBH_MBH_920_zonderkeerdosis /> |
− | ====Medicamenteuze behandeling | + | ====Medicamenteuze behandeling MBH_920_zonderkeerdosis ==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_zonderkeerdosis_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 14.751: | Regel 14.555: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_zonderkeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieafspraak datum tijd | |colspan="4"|Medicatieafspraak datum tijd | ||
− | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:12 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T'' | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 28 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 14.772: | Regel 14.579: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 14.782: | Regel 14.589: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 3 maal per dag, aanbrengen, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aanvullende instructie | ||
+ | |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_zonderkeerdosis_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 14.804: | Regel 14.611: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_zonderkeerdosis_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekkingsverzoek datum | |colspan="4"|Verstrekkingsverzoek datum | ||
− | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:12 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
Regel 14.817: | Regel 14.624: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Te verstrekken hoeveelheid | |colspan="4"|Te verstrekken hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Beoogd verstrekker | |colspan="5"|Beoogd verstrekker | ||
Regel 14.833: | Regel 14.640: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_zonderkeerdosis_MA |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_zonderkeerdosis_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 14.846: | Regel 14.653: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_zonderkeerdosis_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T om 09:12 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T'' | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 28 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 14.867: | Regel 14.677: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 14.877: | Regel 14.690: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 3 maal per dag, aanbrengen, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aanvullende instructie | ||
+ | |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 14.893: | Regel 14.706: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_zonderkeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_zonderkeerdosis_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 14.906: | Regel 14.719: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_zonderkeerdosis_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieverstrekkings datum tijd | |colspan="4"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T om 09:12 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 14.919: | Regel 14.732: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekte hoeveelheid | |colspan="4"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie verstrekkingsverzoek | |colspan="4"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_zonderkeerdosis_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_zonderkeerdosis_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 14.944: | Regel 14.757: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_zonderkeerdosis_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatiegebruik datum tijd | |colspan="4"|Medicatiegebruik datum tijd | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 21 dagen om 23:59:59 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruik indicator | |colspan="4"|Gebruik indicator | ||
Regel 14.956: | Regel 14.769: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 21 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 14.964: | Regel 14.777: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 21 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 14.988: | Regel 14.801: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 14.998: | Regel 14.811: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T + | + | |style="background-color: white;"|Vanaf T, tot en met T + 21 dagen, 3 maal per dag, aanbrengen, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aanvullende instructie | ||
+ | |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 15.014: | Regel 14.827: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_zonderkeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |}<section end= | + | |}<section end=MBH_MBH_920_zonderkeerdosis /> |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="7"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Naamgegevens |
+ | |style="background-color: white;"|Peter van Pulver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Zorgaanbieder |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek de Gulle Gaper |
− | |} | + | |}<section end=ALLMBHS_XXX_Hemsbergen /> |
+ | ==Patiënt G. XXX_Hemsbergen== | ||
+ | <section begin=XXX_Hemsbergen /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Naamgegevens |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Initialen |
− | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgebruik |
− | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geslachtsnaam |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Achternaam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hemsbergen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatienummer | ||
+ | |style="background-color: white;"|999900602 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geboortedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
− | |} | + | |}<section end=XXX_Hemsbergen /><section begin=ALLMBHS_XXX_Hemsbergen /><section begin=MBH_MBH_920_bijzonderekeerdosis /> |
+ | ====Medicamenteuze behandeling MBH_920_bijzonderekeerdosis ==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_bijzonderekeerdosis_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 15.130: | Regel 14.927: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_bijzonderekeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 08:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 15.144: | Regel 14.941: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 28 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T + | + | |style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 2 maal per dag 0.5 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Doseerinstructie | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 0.5 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|MBH identificatie | |
− | + | |style="background-color: white;"|MBH_920_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_bijzonderekeerdosis_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 15.199: | Regel 14.980: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_bijzonderekeerdosis_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekkingsverzoek datum |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 08:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Te verstrekken hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|Relatie | + | |colspan="4"|Relatie medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_bijzonderekeerdosis_MA |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_bijzonderekeerdosis_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 15.237: | Regel 15.022: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_bijzonderekeerdosis_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 09:15 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 15.257: | Regel 15.036: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 28 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geneesmiddel - primaire code |
+ | |style="background-color: white;"|NAPROXEN APOTEX TABLET 500MG (code = '1137778' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Geneesmiddel - generiekere code | |
− | + | |style="background-color: white;"|NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK') | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Geneesmiddel - | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T + | + | |style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 2 maal per dag 0.5 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Doseerinstructie | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 0.5 stuk |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 15.310: | Regel 15.072: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_bijzonderekeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_bijzonderekeerdosis_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 15.325: | Regel 15.085: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_bijzonderekeerdosis_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 09:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Verstrekker |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|NAPROXEN APOTEX TABLET 500MG (code = '1137778' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geneesmiddel - generiekere code |
+ | |style="background-color: white;"|NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie verstrekkingsverzoek |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_bijzonderekeerdosis_VV |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_bijzonderekeerdosis_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 15.378: | Regel 15.123: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_bijzonderekeerdosis_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatiegebruik datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T + 14 dagen om 23:59:59 uur |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Gebruik indicator |
+ | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Volgens afspraak indicator | |
− | + | |style="background-color: white;"|Ja | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"| | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 15.434: | Regel 15.143: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 14 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 15.457: | Regel 15.170: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T + | + | |style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, 2 maal per dag 0.5 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
Regel 15.463: | Regel 15.176: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 0.5 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 15.470: | Regel 15.183: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_bijzonderekeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MBH_MBH_920_bijzonderekeerdosis /><section begin=MBH_MBH_920_variabelehoeveelheid2 /> |
− | + | ====Medicamenteuze behandeling MBH_920_variabelehoeveelheid2 ==== | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_variabelehoeveelheid2_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 15.521: | Regel 15.198: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 08:18 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 15.541: | Regel 15.212: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 28 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
Regel 15.565: | Regel 15.222: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72664' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T + | + | |style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 2 maal per dag 10 à 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen, OROMUCOSAAL |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|OROMUCOSAAL (code = '34' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Aanvullende instructie | |
− | + | |style="background-color: white;"|mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') | |
− | |||
− | |||
− | |||
− | |colspan=" | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | | | ||
− | |||
− | |||
− | |||
− | |||
− | | | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 10 à 15 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_variabelehoeveelheid2_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 15.656: | Regel 15.257: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid2_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekkingsverzoek datum | |colspan="4"|Verstrekkingsverzoek datum | ||
− | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:18 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
Regel 15.669: | Regel 15.270: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Te verstrekken hoeveelheid | |colspan="4"|Te verstrekken hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|450 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72664' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Beoogd verstrekker | |colspan="5"|Beoogd verstrekker | ||
Regel 15.685: | Regel 15.286: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid2_MA |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_variabelehoeveelheid2_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 15.698: | Regel 15.299: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T om 09:18 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 15.712: | Regel 15.313: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 28 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 15.722: | Regel 15.323: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|WATERSTOFPEROXIDE 3% CONC VOOR MONDSP FNA MR (code = '261815' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72994' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T + | + | |style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 2 maal per dag 10 à 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen, OROMUCOSAAL |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|OROMUCOSAAL (code = '34' in codeSystem 'G-Standaard Toedieningswegen') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aanvullende instructie | ||
+ | |style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aanvullende instructie | ||
+ | |style="background-color: white;"|mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 10 à 15 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 15.748: | Regel 15.355: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_variabelehoeveelheid2_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 15.761: | Regel 15.368: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid2_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieverstrekkings datum tijd | |colspan="4"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T om 09:18 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 15.774: | Regel 15.381: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekte hoeveelheid | |colspan="4"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|450 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|WATERSTOFPEROXIDE 3% CONC VOOR MONDSP FNA MR (code = '261815' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72994' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie verstrekkingsverzoek | |colspan="4"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid2_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_variabelehoeveelheid2_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 15.799: | Regel 15.406: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid2_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatiegebruik datum tijd | |colspan="4"|Medicatiegebruik datum tijd | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 21 dagen om 23:59:59 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruik indicator | |colspan="4"|Gebruik indicator | ||
Regel 15.811: | Regel 15.418: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 21 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 15.819: | Regel 15.426: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 21 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Informant | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Informant is patient | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
Regel 15.829: | Regel 15.450: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72664' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T + | + | |style="background-color: white;"|Vanaf T, tot en met T + 21 dagen, 2 maal per dag 10 à 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen, OROMUCOSAAL |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|OROMUCOSAAL (code = '34' in codeSystem 'G-Standaard Toedieningswegen') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aanvullende instructie | ||
+ | |style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aanvullende instructie | ||
+ | |style="background-color: white;"|mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 10 à 15 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 15.852: | Regel 15.479: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |}<section end= | + | |}<section end=MBH_MBH_920_variabelehoeveelheid2 /><section begin=MBH_MBH_920_tijdstippen_flexibel /> |
− | ====Medicamenteuze behandeling | + | ====Medicamenteuze behandeling MBH_920_tijdstippen_flexibel ==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_tijdstippen_flexibel_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 15.867: | Regel 15.494: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_tijdstippen_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieafspraak datum tijd | |colspan="4"|Medicatieafspraak datum tijd | ||
− | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:24 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T'' | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 14 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 15.888: | Regel 15.518: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 15.898: | Regel 15.528: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, elke dag om 08:00, 14:00 en 20:00 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 08:00, 14:00 en 20:00 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_tijdstippen_flexibel_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 15.917: | Regel 15.547: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_tijdstippen_flexibel_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekkingsverzoek datum | |colspan="4"|Verstrekkingsverzoek datum | ||
− | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:24 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
Regel 15.930: | Regel 15.560: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Te verstrekken hoeveelheid | |colspan="4"|Te verstrekken hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|42 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Beoogd verstrekker | |colspan="5"|Beoogd verstrekker | ||
Regel 15.946: | Regel 15.576: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_tijdstippen_flexibel_MA |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_tijdstippen_flexibel_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 15.959: | Regel 15.589: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_tijdstippen_flexibel_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T om 09:24 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T'' | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 14 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 15.980: | Regel 15.613: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 15.993: | Regel 15.626: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, elke dag om 08:00, 14:00 en 20:00 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 08:00, 14:00 en 20:00 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 16.006: | Regel 15.639: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_tijdstippen_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_tijdstippen_flexibel_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 16.019: | Regel 15.652: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_tijdstippen_flexibel_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieverstrekkings datum tijd | |colspan="4"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T om 09:24 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 16.032: | Regel 15.665: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekte hoeveelheid | |colspan="4"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|42 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie verstrekkingsverzoek | |colspan="4"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_tijdstippen_flexibel_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_tijdstippen_flexibel_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 16.057: | Regel 15.690: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_tijdstippen_flexibel_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatiegebruik datum tijd | |colspan="4"|Medicatiegebruik datum tijd | ||
− | |style="background-color: white;"|T + 14 dagen om | + | |style="background-color: white;"|T + 14 dagen om 23:59:59 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruik indicator | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Volgens afspraak indicator | ||
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 16.074: | Regel 15.710: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T + 14 dagen | + | |style="background-color: white;"|T + 14 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 16.098: | Regel 15.734: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 16.108: | Regel 15.744: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T + 14 dagen om | + | |style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, elke dag om 08:00, 14:00 en 20:00 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 08:00, 14:00 en 20:00 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 16.121: | Regel 15.757: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_tijdstippen_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |}<section end= | + | |}<section end=MBH_MBH_920_tijdstippen_flexibel /><section begin=MBH_MBH_920_weekdagen /> |
− | ====Medicamenteuze behandeling | + | ====Medicamenteuze behandeling MBH_920_weekdagen ==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_weekdagen_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 16.136: | Regel 15.772: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_weekdagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieafspraak datum tijd | |colspan="4"|Medicatieafspraak datum tijd | ||
− | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:25 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 70 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 16.150: | Regel 15.786: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 70 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
Regel 16.160: | Regel 15.796: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T + | + | |style="background-color: white;"|Vanaf T, tot en met T + 70 dagen, op maandag, woensdag en vrijdag, voor de nacht, aanbrengen, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aanvullende instructie | ||
+ | |style="background-color: white;"|voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aanvullende instructie | ||
+ | |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|op maandag, woensdag en vrijdag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_weekdagen_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 16.189: | Regel 15.831: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_weekdagen_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekkingsverzoek datum | |colspan="4"|Verstrekkingsverzoek datum | ||
− | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:25 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
Regel 16.202: | Regel 15.844: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Te verstrekken hoeveelheid | |colspan="4"|Te verstrekken hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Beoogd verstrekker | |colspan="5"|Beoogd verstrekker | ||
Regel 16.218: | Regel 15.860: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_weekdagen_MA |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_weekdagen_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 16.231: | Regel 15.873: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_weekdagen_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Toedieningsafspraak datum tijd | |colspan="4"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T om 09:25 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 70 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 16.245: | Regel 15.887: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 70 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 16.255: | Regel 15.897: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ALDARA CREME 50MG/G IN SACHET (code = '1198521' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T + | + | |style="background-color: white;"|Vanaf T, tot en met T + 70 dagen, op maandag, woensdag en vrijdag, voor de nacht, aanbrengen, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aanvullende instructie | ||
+ | |style="background-color: white;"|voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aanvullende instructie | ||
+ | |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|op maandag, woensdag en vrijdag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 16.281: | Regel 15.929: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_weekdagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_weekdagen_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 16.294: | Regel 15.942: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_weekdagen_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatieverstrekkings datum tijd | |colspan="4"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T om 09:25 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
Regel 16.307: | Regel 15.955: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekte hoeveelheid | |colspan="4"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ALDARA CREME 50MG/G IN SACHET (code = '1198521' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie verstrekkingsverzoek | |colspan="4"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_weekdagen_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_weekdagen_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 16.332: | Regel 15.980: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_weekdagen_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Medicatiegebruik datum tijd | |colspan="4"|Medicatiegebruik datum tijd | ||
Regel 16.376: | Regel 16.024: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, | + | |style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, op maandag, woensdag en vrijdag, voor de nacht, aanbrengen, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aanvullende instructie | ||
+ | |style="background-color: white;"|voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aanvullende instructie | ||
+ | |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|op maandag, woensdag en vrijdag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Relatie medicatieafspraak | |colspan="5"|Relatie medicatieafspraak | ||
Regel 16.399: | Regel 16.053: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_weekdagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |}<section end= | + | |}<section end=MBH_MBH_920_weekdagen /> |
− | + | {| class="wikitable" width="85%" | |
− | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | |
− | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="7"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Naamgegevens |
+ | |style="background-color: white;"|Peter van Pulver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Zorgaanbieder |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Organisatie naam |
+ | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek de Gulle Gaper |
− | |} | + | |}<section end=ALLMBHS_XXX_Hemsbergen /> |
+ | ==Patiënt G. XXX_Hemsbergen== | ||
+ | <section begin=XXX_Hemsbergen /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Initialen |
− | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgebruik |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geslachtsnaam |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Achternaam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hemsbergen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900602 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geboortedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
− | | | + | |}<section end=XXX_Hemsbergen /><section begin=ALLMBHS_XXX_Hemsbergen /><section begin=MBH_MBH_920_dagdeel /> |
− | + | ====Medicamenteuze behandeling MBH_920_dagdeel ==== | |
− | + | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_dagdeel_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 16.509: | Regel 16.153: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_dagdeel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 08:27 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Ingangsdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
Regel 16.532: | Regel 16.184: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, 1 stuk 's avonds, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 stuk 's avonds |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_dagdeel_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 16.558: | Regel 16.203: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_dagdeel_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekkingsverzoek datum |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 08:27 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Auteur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Te verstrekken hoeveelheid | ||
+ | |style="background-color: white;"|60 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
Regel 16.570: | Regel 16.231: | ||
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Relatie medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_dagdeel_MA |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_dagdeel_TA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_dagdeel_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 09:27 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, 1 stuk 's avonds, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 stuk 's avonds | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_dagdeel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_dagdeel_MVE | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_dagdeel_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T om 09:27 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|60 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_dagdeel_VV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_dagdeel_MGB | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_dagdeel_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T + 14 dagen om 23:59:59 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 14 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Informant | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Informant is patient | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, 1 stuk 's avonds, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 stuk 's avonds | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_dagdeel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_dagdeel /><section begin=MBH_MBH_920_cyclischschema /> | ||
+ | ====Medicamenteuze behandeling MBH_920_cyclischschema ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_cyclischschema_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_cyclischschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 08:33 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="5"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, cyclus van 28 dagen: steeds gedurende 21 dagen 1 maal per dag 1 stuk, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|gedurende 21 dagen 1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Herhaalperiode cyclisch schema | ||
+ | |style="background-color: white;"|28 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_cyclischschema_VV | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_cyclischschema_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T om 08:33 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Te verstrekken hoeveelheid | ||
+ | |style="background-color: white;"|126 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_cyclischschema_MA | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_cyclischschema_TA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_cyclischschema_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 09:33 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="5"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, cyclus van 28 dagen: steeds gedurende 21 dagen 1 maal per dag 1 stuk, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|gedurende 21 dagen 1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Herhaalperiode cyclisch schema | ||
+ | |style="background-color: white;"|28 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_cyclischschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_cyclischschema_MVE | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_cyclischschema_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T om 09:33 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|126 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|MARVELON TABLET (code = '416681' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_cyclischschema_VV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_cyclischschema_MGB | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_cyclischschema_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T + 14 dagen om 23:59:59 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 14 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Informant | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Informant is patient | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="5"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, cyclus van 28 dagen: steeds gedurende 21 dagen 1 maal per dag 1 stuk, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|gedurende 21 dagen 1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Herhaalperiode cyclisch schema | ||
+ | |style="background-color: white;"|28 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_cyclischschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_cyclischschema /><section begin=MBH_MBH_920_afbouwschema /> | ||
+ | ====Medicamenteuze behandeling MBH_920_afbouwschema ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_afbouwschema_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_afbouwschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 08:40 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 41 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 41 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="6"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 41 dagen, eerst gedurende 2 weken 1 maal per dag 3 gram, dan gedurende 3 weken 1 maal per dag 2 gram, dan gedurende 6 dagen 1 maal per dag 1 gram, cutaan | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie 1 | ||
+ | |style="background-color: white;"|eerst gedurende 2 weken 1 maal per dag 3 gram | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie 2 | ||
+ | |style="background-color: white;"|dan gedurende 3 weken 1 maal per dag 2 gram | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie 3 | ||
+ | |style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 1 gram | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_afbouwschema_VV | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_afbouwschema_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T om 08:40 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Te verstrekken hoeveelheid | ||
+ | |style="background-color: white;"|90 gram | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_afbouwschema_MA | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_afbouwschema_TA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_afbouwschema_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 09:40 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 41 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 41 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|AFFUSINE CREME 20MG/G (code = '2292556' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="6"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 41 dagen, eerst gedurende 2 weken 1 maal per dag 3 gram, dan gedurende 3 weken 1 maal per dag 2 gram, dan gedurende 6 dagen 1 maal per dag 1 gram, cutaan | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie 1 | ||
+ | |style="background-color: white;"|eerst gedurende 2 weken 1 maal per dag 3 gram | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie 2 | ||
+ | |style="background-color: white;"|dan gedurende 3 weken 1 maal per dag 2 gram | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie 3 | ||
+ | |style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 1 gram | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_afbouwschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_afbouwschema_MVE | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_afbouwschema_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T om 09:40 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|90 gram | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|AFFUSINE CREME 20MG/G (code = '2292556' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_afbouwschema_VV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_afbouwschema_MGB | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_afbouwschema_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T + 21 dagen om 23:59:59 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 21 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 21 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Informant | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Informant is patient | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="6"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 21 dagen, eerst gedurende 2 weken 1 maal per dag 3 gram, dan gedurende 3 weken 1 maal per dag 2 gram, dan gedurende 6 dagen 1 maal per dag 1 gram, cutaan | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie 1 | ||
+ | |style="background-color: white;"|eerst gedurende 2 weken 1 maal per dag 3 gram | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie 2 | ||
+ | |style="background-color: white;"|dan gedurende 3 weken 1 maal per dag 2 gram | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie 3 | ||
+ | |style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 1 gram | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_afbouwschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_afbouwschema /><section begin=MBH_MBH_920_variabelehoeveelheidenmaximum /> | ||
+ | ====Medicamenteuze behandeling MBH_920_variabelehoeveelheidenmaximum ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_variabelehoeveelheidenmaximum_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 08:45 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 21 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 21 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 21 dagen, Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_variabelehoeveelheidenmaximum_VV | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T om 08:45 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Te verstrekken hoeveelheid | ||
+ | |style="background-color: white;"|120 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum_MA | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_variabelehoeveelheidenmaximum_TA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 09:45 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 21 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 21 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|CODEINEFOSFAAT PCH TABLET 10MG (code = '874965' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 21 dagen, Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_variabelehoeveelheidenmaximum_MVE | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T om 09:45 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|120 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|CODEINEFOSFAAT PCH TABLET 10MG (code = '874965' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum_VV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_variabelehoeveelheidenmaximum_MGB | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T + 21 dagen om 23:59:59 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 21 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 21 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Informant | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Informant is patient | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 21 dagen, Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_variabelehoeveelheidenmaximum /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="7"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener identificatienummer | ||
+ | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgegevens | ||
+ | |style="background-color: white;"|Peter van Pulver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Specialisme | ||
+ | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgaanbieder | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder identificatienummer | ||
+ | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Organisatie naam | ||
+ | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Adresgegevens | ||
+ | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder identificatienummer | ||
+ | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Organisatie naam | ||
+ | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
+ | |}<section end=ALLMBHS_XXX_Hemsbergen /> | ||
+ | ==Patiënt G. XXX_Hemsbergen== | ||
+ | <section begin=XXX_Hemsbergen /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="6"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Initialen | ||
+ | |style="background-color: white;"|G. | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgebruik | ||
+ | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslachtsnaam | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Achternaam | ||
+ | |style="background-color: white;"|XXX_Hemsbergen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatienummer | ||
+ | |style="background-color: white;"|999900602 [BSN] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geboortedatum | ||
+ | |style="background-color: white;"|2 nov 1963 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslacht | ||
+ | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
+ | |}<section end=XXX_Hemsbergen /><section begin=ALLMBHS_XXX_Hemsbergen /><section begin=MBH_MBH_920_toedieningssnelheid /> | ||
+ | ====Medicamenteuze behandeling MBH_920_toedieningssnelheid ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_toedieningssnelheid_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_toedieningssnelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 08:47 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 8 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 8 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 8 dagen, toedieningssnelheid: maximaal 0.2 à 0.5 ml per uur, parenteraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|toedieningssnelheid: maximaal 0.2 à 0.5 ml per uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_toedieningssnelheid_VV | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_toedieningssnelheid_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T om 08:47 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Te verstrekken hoeveelheid | ||
+ | |style="background-color: white;"|100 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_toedieningssnelheid_MA | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_toedieningssnelheid_TA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_toedieningssnelheid_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 09:47 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 8 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 8 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|MORFINEHYDROCHLORIDE 1ML= 5MG EPI CAS 100ML FNA MR (code = '779288' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 8 dagen, toedieningssnelheid: maximaal 0.2 à 0.5 ml per uur, parenteraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|toedieningssnelheid: maximaal 0.2 à 0.5 ml per uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_toedieningssnelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_toedieningssnelheid_MVE | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_toedieningssnelheid_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T om 09:47 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|100 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|MORFINEHYDROCHLORIDE 1ML= 5MG EPI CAS 100ML FNA MR (code = '779288' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_toedieningssnelheid_VV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_toedieningssnelheid_MGB | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_toedieningssnelheid_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T + 8 dagen om 23:59:59 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 8 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 8 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Informant | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Informant is patient | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 8 dagen, toedieningssnelheid: maximaal 0.2 à 0.5 ml per uur, parenteraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|toedieningssnelheid: maximaal 0.2 à 0.5 ml per uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_toedieningssnelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_toedieningssnelheid /><section begin=MBH_MBH_920_toedieningsduur /> | ||
+ | ====Medicamenteuze behandeling MBH_920_toedieningsduur ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_toedieningsduur_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_toedieningsduur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 08:49 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '98477' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, 1 maal per dag 1 stuk, transdermaal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_toedieningsduur_VV | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_toedieningsduur_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T om 08:49 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Te verstrekken hoeveelheid | ||
+ | |style="background-color: white;"|30 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '98477' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_toedieningsduur_MA | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_toedieningsduur_TA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_toedieningsduur_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 09:49 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '98477' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, 1 maal per dag 1 stuk, transdermaal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_toedieningsduur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_toedieningsduur_MVE | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_toedieningsduur_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T om 09:49 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|30 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '98477' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_toedieningsduur_VV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_toedieningsduur_MGB | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_toedieningsduur_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T + 14 dagen om 12:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen om 12:00 uur'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 14 dagen om 12:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Informant | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Informant is patient | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '98477' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 14 dagen om 12:00 uur, 1 maal per dag 1 stuk, transdermaal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_toedieningsduur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_toedieningsduur /><section begin=MBH_MBH_920_zonodig /> | ||
+ | ====Medicamenteuze behandeling MBH_920_zonodig ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_zonodig_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_zonodig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 08:57 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 27 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 27 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR 100MG TAB (code = '3956' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 27 dagen, Zo nodig 1 maal per dag 1 stuk, Oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_zonodig_VV | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_zonodig_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T om 08:57 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Te verstrekken hoeveelheid | ||
+ | |style="background-color: white;"|14 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR 100MG TAB (code = '3956' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_zonodig_MA | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_zonodig_TA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_zonodig_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 09:57 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 27 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 27 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR 100MG TAB (code = '3956' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 27 dagen, Zo nodig 1 maal per dag 1 stuk, Oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_zonodig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_zonodig_MVE | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_zonodig_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T om 09:57 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|14 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR 100MG TAB (code = '3956' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_zonodig_VV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_zonodig_MGB | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_zonodig_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T + 14 dagen om 23:59:59 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 14 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Informant | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Informant is patient | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR 100MG TAB (code = '3956' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, Zo nodig 1 maal per dag 1 stuk, Oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_zonodig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_zonodig /><section begin=MBH_MBH_920_tijdstippen_niet_flexibel /> | ||
+ | ====Medicamenteuze behandeling MBH_920_tijdstippen_niet_flexibel ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_tijdstippen_niet_flexibel_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_tijdstippen_niet_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 09:15 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 7 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 7 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 7 dagen, elke dag om 09:00, 12:00 en 15:00 1 stuk , let op! Tijden exact aanhouden., oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|elke dag om 09:00, 12:00 en 15:00 1 stuk , let op! Tijden exact aanhouden. | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_tijdstippen_niet_flexibel_VV | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_tijdstippen_niet_flexibel_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T om 09:15 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Te verstrekken hoeveelheid | ||
+ | |style="background-color: white;"|21 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_tijdstippen_niet_flexibel_MA | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_tijdstippen_niet_flexibel_TA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_tijdstippen_niet_flexibel_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 10:15 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|elke dag om 09:00, 12:00 en 15:00 1 stuk , let op! Tijden exact aanhouden., oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|elke dag om 09:00, 12:00 en 15:00 1 stuk , let op! Tijden exact aanhouden. | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_tijdstippen_niet_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_tijdstippen_niet_flexibel_MVE | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_tijdstippen_niet_flexibel_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T om 10:17 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|21 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_tijdstippen_niet_flexibel_VV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_920_tijdstippen_niet_flexibel_MGB | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_tijdstippen_niet_flexibel_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T + 7 dagen om 16:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 7 dagen om 15:00 uur'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 7 dagen om 15:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Informant | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Informant is patient | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 7 dagen om 15:00 uur, elke dag om 09:00, 12:00 en 15:00 1 stuk , let op! Tijden exact aanhouden. | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|elke dag om 09:00, 12:00 en 15:00 1 stuk , let op! Tijden exact aanhouden. | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_tijdstippen_niet_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_tijdstippen_niet_flexibel /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="7"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener identificatienummer | ||
+ | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgegevens | ||
+ | |style="background-color: white;"|Peter van Pulver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Specialisme | ||
+ | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgaanbieder | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder identificatienummer | ||
+ | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Organisatie naam | ||
+ | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Adresgegevens | ||
+ | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder identificatienummer | ||
+ | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Organisatie naam | ||
+ | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
+ | |}<section end=ALLMBHS_XXX_Hemsbergen /> | ||
+ | ==Patiënt G. XXX_Hess== | ||
+ | <section begin=XXX_Hess /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="6"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Initialen | ||
+ | |style="background-color: white;"|G. | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgebruik | ||
+ | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslachtsnaam | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Achternaam | ||
+ | |style="background-color: white;"|XXX_Hess | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatienummer | ||
+ | |style="background-color: white;"|999900614 [BSN] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geboortedatum | ||
+ | |style="background-color: white;"|3 nov 1963 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslacht | ||
+ | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | ||
+ | |}<section end=XXX_Hess /><section begin=ALLMBHS_XXX_Hess /><section begin=MBH_MBH_920_magistraalalleingredienten /> | ||
+ | ====Medicamenteuze behandeling MBH_920_magistraalalleingredienten ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Medicatieafspraak MBH_920_magistraalalleingredienten_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="5" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraalalleingredienten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 12:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 31 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Einddatum | ||
+ | |style="background-color: white;"|T + 31 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Geneesmiddel - Product specificatie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="11"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Product naam | ||
+ | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Omschrijving | ||
+ | |style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient code | ||
+ | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Sterkte | ||
+ | |style="background-color: white;"| per | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient code | ||
+ | |style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Sterkte | ||
+ | |style="background-color: white;"| per | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 31 dagen, Zo nodig, cutaan | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsweg | ||
+ | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Doseerinstructie | ||
+ | |style="background-color: white;"|Zo nodig | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Verstrekkingsverzoek MBH_920_magistraalalleingredienten_VV | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="5" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraalalleingredienten_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T om 12:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Te verstrekken hoeveelheid | ||
+ | |style="background-color: white;"|100 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Geneesmiddel - Product specificatie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="11"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Product naam | ||
+ | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Omschrijving | ||
+ | |style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient code | ||
+ | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Sterkte | ||
+ | |style="background-color: white;"| per | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient code | ||
+ | |style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Sterkte | ||
+ | |style="background-color: white;"| per | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_magistraalalleingredienten_MA | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Toedieningsafspraak MBH_920_magistraalalleingredienten_TA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="5" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraalalleingredienten_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 13:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 31 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Einddatum | ||
+ | |style="background-color: white;"|T + 31 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Geneesmiddel - Product specificatie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="11"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Product naam | ||
+ | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Omschrijving | ||
+ | |style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient code | ||
+ | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Sterkte | ||
+ | |style="background-color: white;"| per | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient code | ||
+ | |style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Sterkte | ||
+ | |style="background-color: white;"| per | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 31 dagen, Zo nodig, cutaan | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsweg | ||
+ | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Doseerinstructie | ||
+ | |style="background-color: white;"|Zo nodig | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraalalleingredienten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Medicatieverstrekking MBH_920_magistraalalleingredienten_MVE | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="5" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraalalleingredienten_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T om 13:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|100 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Geneesmiddel - Product specificatie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="11"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Product naam | ||
+ | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Omschrijving | ||
+ | |style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient code | ||
+ | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Sterkte | ||
+ | |style="background-color: white;"| per | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient code | ||
+ | |style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Sterkte | ||
+ | |style="background-color: white;"| per | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_magistraalalleingredienten_VV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Medicatiegebruik MBH_920_magistraalalleingredienten_MGB | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="5" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraalalleingredienten_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T om 21:53 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Einddatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Auteur is patient | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Geneesmiddel - Product specificatie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="11"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Product naam | ||
+ | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Omschrijving | ||
+ | |style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient code | ||
+ | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Sterkte | ||
+ | |style="background-color: white;"| per | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient code | ||
+ | |style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Sterkte | ||
+ | |style="background-color: white;"| per | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T, 2 maal per dag, cutaan | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsweg | ||
+ | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Doseerinstructie | ||
+ | |style="background-color: white;"|2 maal per dag | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Relatie toedieningsafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraalalleingredienten_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_magistraalalleingredienten /><section begin=MBH_MBH_920_magistraalactieveingredient /> | ||
+ | ====Medicamenteuze behandeling MBH_920_magistraalactieveingredient ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Medicatieafspraak MBH_920_magistraalactieveingredient_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="5" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraalactieveingredient_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 12:05 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, tot en met T + 70 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Ingangsdatum | ||
+ | |style="background-color: white;"|T + 1 dag | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Einddatum | ||
+ | |style="background-color: white;"|T + 70 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Geneesmiddel - Product specificatie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="7"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Product naam | ||
+ | |style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Omschrijving | ||
+ | |style="background-color: white;"|Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient code | ||
+ | |style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Sterkte | ||
+ | |style="background-color: white;"| per | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T + 1 dag, tot en met T + 70 dagen, 1 maal per dag, cutaan | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsweg | ||
+ | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Verstrekkingsverzoek MBH_920_magistraalactieveingredient_VV | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="5" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraalactieveingredient_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T om 12:05 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Te verstrekken hoeveelheid | ||
+ | |style="background-color: white;"|100 gram | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Geneesmiddel - Product specificatie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="7"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Product naam | ||
+ | |style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Omschrijving | ||
+ | |style="background-color: white;"|Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient code | ||
+ | |style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Sterkte | ||
+ | |style="background-color: white;"| per | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_magistraalactieveingredient_MA | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Toedieningsafspraak MBH_920_magistraalactieveingredient_TA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="5" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraalactieveingredient_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 13:05 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, tot en met T + 70 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Ingangsdatum | ||
+ | |style="background-color: white;"|T + 1 dag | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Einddatum | ||
+ | |style="background-color: white;"|T + 70 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Geneesmiddel - Product specificatie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="7"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Product naam | ||
+ | |style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Omschrijving | ||
+ | |style="background-color: white;"|Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient code | ||
+ | |style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Sterkte | ||
+ | |style="background-color: white;"| per | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T + 1 dag, tot en met T + 70 dagen, 1 maal per dag, cutaan | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsweg | ||
+ | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraalactieveingredient_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Medicatieverstrekking MBH_920_magistraalactieveingredient_MVE | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="5" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraalactieveingredient_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T om 13:05 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|100 gram | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Geneesmiddel - Product specificatie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="7"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Product naam | ||
+ | |style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Omschrijving | ||
+ | |style="background-color: white;"|Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient code | ||
+ | |style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Sterkte | ||
+ | |style="background-color: white;"| per | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_magistraalactieveingredient_VV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Medicatiegebruik MBH_920_magistraalactieveingredient_MGB | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="5" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraalactieveingredient_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T om 22:08 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Nee | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Einddatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Auteur is patient | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Geneesmiddel - Product specificatie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="7"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Product naam | ||
+ | |style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Omschrijving | ||
+ | |style="background-color: white;"|Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient code | ||
+ | |style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Sterkte | ||
+ | |style="background-color: white;"| per | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T, 3 maal per dag, cutaan | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsweg | ||
+ | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Doseerinstructie | ||
+ | |style="background-color: white;"|3 maal per dag | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Relatie toedieningsafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraalactieveingredient_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_magistraalactieveingredient /><section begin=MBH_MBH_920_magistraal90miljoennr /> | ||
+ | ====Medicamenteuze behandeling MBH_920_magistraal90miljoennr ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Medicatieafspraak MBH_920_magistraal90miljoennr_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="5" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraal90miljoennr_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 12:08 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 30 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Einddatum | ||
+ | |style="background-color: white;"|T + 30 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Geneesmiddel - Product specificatie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="8"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Product code | ||
+ | |style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.9999.77.90000000.1.1111') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Product naam | ||
+ | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Omschrijving | ||
+ | |style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient code | ||
+ | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Sterkte | ||
+ | |style="background-color: white;"| per | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 30 dagen, 1 maal per dag, cutaan | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsweg | ||
+ | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Verstrekkingsverzoek MBH_920_magistraal90miljoennr_VV | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="5" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraal90miljoennr_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T om 12:08 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Te verstrekken hoeveelheid | ||
+ | |style="background-color: white;"|100 gram | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Geneesmiddel - Product specificatie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="8"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Product code | ||
+ | |style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.9999.77.90000000.1.1111') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Product naam | ||
+ | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Omschrijving | ||
+ | |style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient code | ||
+ | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Sterkte | ||
+ | |style="background-color: white;"| per | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_magistraal90miljoennr_MA | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Toedieningsafspraak MBH_920_magistraal90miljoennr_TA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="5" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraal90miljoennr_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 13:08 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 30 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Einddatum | ||
+ | |style="background-color: white;"|T + 30 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Geneesmiddel - Product specificatie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="8"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Product code | ||
+ | |style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.9999.77.90000000.1.1111') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Product naam | ||
+ | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Omschrijving | ||
+ | |style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient code | ||
+ | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Sterkte | ||
+ | |style="background-color: white;"| per | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 30 dagen, 1 maal per dag, cutaan | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsweg | ||
+ | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraal90miljoennr_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Medicatieverstrekking MBH_920_magistraal90miljoennr_MVE | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="5" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraal90miljoennr_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T om 13:08 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|100 gram | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Geneesmiddel - Product specificatie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="8"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Product code | ||
+ | |style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.9999.77.90000000.1.1111') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Product naam | ||
+ | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Omschrijving | ||
+ | |style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient code | ||
+ | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Sterkte | ||
+ | |style="background-color: white;"| per | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_magistraal90miljoennr_VV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Medicatiegebruik MBH_920_magistraal90miljoennr_MGB | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="5" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraal90miljoennr_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Medicatiegebruik datum tijd | ||
+ | |style="background-color: white;"|T om 23:01 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruik indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Einddatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Auteur is patient | ||
+ | |style="background-color: white;"|Ja | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Geneesmiddel - Product specificatie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="8"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Product code | ||
+ | |style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.9999.77.90000000.1.1111') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Product naam | ||
+ | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Omschrijving | ||
+ | |style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient code | ||
+ | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Sterkte | ||
+ | |style="background-color: white;"| per | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T, 1 maal per dag, cutaan | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsweg | ||
+ | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="6"|Relatie toedieningsafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraal90miljoennr_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_magistraal90miljoennr /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="7"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener identificatienummer | ||
+ | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgegevens | ||
+ | |style="background-color: white;"|Peter van Pulver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Specialisme | ||
+ | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgaanbieder | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder identificatienummer | ||
+ | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Organisatie naam | ||
+ | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Adresgegevens | ||
+ | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder identificatienummer | ||
+ | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Organisatie naam | ||
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
+ | |}<section end=ALLMBHS_XXX_Hess /> | ||
+ | ==Patiënt L. van XXX_Meijs== | ||
+ | <section begin=XXX_Meijs /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="7"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Initialen | ||
+ | |style="background-color: white;"|L. | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgebruik | ||
+ | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslachtsnaam | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Voorvoegsels | ||
+ | |style="background-color: white;"|van | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Achternaam | ||
+ | |style="background-color: white;"|XXX_Meijs | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatienummer | ||
+ | |style="background-color: white;"|999900808 [BSN] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geboortedatum | ||
+ | |style="background-color: white;"|26 okt 1985 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslacht | ||
+ | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
+ | |}<section end=XXX_Meijs /><section begin=ALLMBHS_XXX_Meijs /><section begin=MBH_MBH_920_VVandermansMA /> | ||
+ | ====Medicamenteuze behandeling MBH_920_VVandermansMA ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_VVandermansMA_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_VVandermansMA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 14 dagen om 09:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T + 6 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 14 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 6 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 14 dagen, tot en met T + 6 dagen, 1 maal per dag 1 stuk, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_VVandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_VVandermansMA_VV | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_VVandermansMA_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T om 09:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Te verstrekken hoeveelheid | ||
+ | |style="background-color: white;"|6 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_VVandermansMA_MA | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_VVandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_VVandermansMA_andermansVV | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_VVandermansMA_andermansVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T - 14 dagen om 09:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Te verstrekken hoeveelheid | ||
+ | |style="background-color: white;"|21 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_VVandermansMA_MA | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_VVandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_MVEandermansTA_TA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_MVEandermansTA_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 14 dagen om 10:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T + 6 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 14 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 6 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 14 dagen, tot en met T + 6 dagen, 1 maal per dag 1 stuk, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_VVandermansMA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_VVandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_MVEandermansTA_MVE | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_MVEandermansTA_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T om 10:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|6 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_VVandermansMA_VV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_VVandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_MVEandermansTA_andermansMVE | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_MVEandermansTA_andermansMVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T - 14 dagen om 10:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|21 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_VVandermansMA_andermansVV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_VVandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_VVandermansMA /><section begin=MBH_MBH_920_stakenandermansMA /> | ||
+ | ====Medicamenteuze behandeling MBH_920_stakenandermansMA ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_stakenandermansMA_MA2 | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_stakenandermansMA_MA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 09:05 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 5 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak stop type | ||
+ | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Reden wijzigen of staken | ||
+ | |style="background-color: white;"|Drug treatment not indicated (situation) (code = '183966005' in codeSystem 'SNOMED CT') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 5 dagen, tot en met T, 1 maal per dag 1 stuk, Oraal, definitief gestopt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_stakenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_stakenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_stakenandermansMA_MA1 | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_stakenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 5 dagen om 08:45 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 15 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 5 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 15 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 15 dagen, 1 maal per dag 1 stuk, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_stakenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_stakenandermansMA_andermansVV | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_stakenandermansMA_andermansVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T - 5 dagen om 08:45 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Te verstrekken hoeveelheid | ||
+ | |style="background-color: white;"|21 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_stakenandermansMA_MA1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_stakenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_stakenandermansTA_TA2 | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_stakenandermansTA_TA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 10:05 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 5 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak stop type | ||
+ | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 5 dagen, tot en met T, 1 maal per dag 1 stuk, Oraal, definitief gestopt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_stakenandermansMA_MA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_stakenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_stakenandermansTA_TA1 | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_stakenandermansTA_TA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 5 dagen om 09:45 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 15 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 5 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 15 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 15 dagen, 1 maal per dag 1 stuk, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_stakenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_stakenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_stakenandermansTA_andermansMVE | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_stakenandermansTA_andermansMVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T - 5 dagen om 09:45 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|21 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_stakenandermansMA_andermansVV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_stakenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_stakenandermansMA /><section begin=MBH_MBH_920_onderbrekenandermansMA /> | ||
+ | ====Medicamenteuze behandeling MBH_920_onderbrekenandermansMA ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_onderbrekenandermansMA_MA2 | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_onderbrekenandermansMA_MA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 09:07 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 60 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak stop type | ||
+ | |style="background-color: white;"|tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Reden wijzigen of staken | ||
+ | |style="background-color: white;"|Verrichting gepland (code = '405613005' in codeSystem 'SNOMED CT') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 60 dagen, tot en met T, 1 maal per dag 1 stuk, oraal, tijdelijk gestopt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_onderbrekenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_onderbrekenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_onderbrekenandermansMA_MA1 | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_onderbrekenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 60 dagen om 09:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T + 29 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 60 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 29 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 60 dagen, tot en met T + 29 dagen, 1 maal per dag 1 stuk, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_onderbrekenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_onderbrekenandermansMA_andermansVV | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_onderbrekenandermansMA_andermansVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T - 60 dagen om 09:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Te verstrekken hoeveelheid | ||
+ | |style="background-color: white;"|90 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_onderbrekenandermansMA_MA1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_onderbrekenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_onderbrekenandermansTA_TA2 | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_onderbrekenandermansTA_TA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 10:07 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 60 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak stop type | ||
+ | |style="background-color: white;"|tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|APC APOTEX TABLET (code = '795097' in codeSystem 'G-Sandaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 60 dagen, tot en met T, 1 maal per dag 1 stuk, oraal, tijdelijk gestopt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_onderbrekenandermansMA_MA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_onderbrekenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_onderbrekenandermansTA_TA1 | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_onderbrekenandermansTA_TA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 60 dagen om 10:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T + 29 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 60 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 29 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|APC APOTEX TABLET (code = '795097' in codeSystem 'G-Sandaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 60 dagen, tot en met T + 29 dagen, 1 maal per dag 1 stuk, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_onderbrekenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_onderbrekenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_onderbrekenandermansTA_andermansMVE | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_onderbrekenandermansTA_andermansMVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T - 60 dagen om 10:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|90 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|APC APOTEX TABLET (code = '795097' in codeSystem 'G-Sandaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_onderbrekenandermansMA_andermansVV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_onderbrekenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_onderbrekenandermansMA /><section begin=MBH_MBH_920_wijzigenandermansMA /> | ||
+ | ====Medicamenteuze behandeling MBH_920_wijzigenandermansMA ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_wijzigenandermansMA_MA1 | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_wijzigenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 7 dagen om 07:50 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 7 dagen, tot en met T + 13 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 7 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 13 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 7 dagen, tot en met T + 13 dagen, 1 maal per dag 2 stuks, Oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 2 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_wijzigenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_wijzigenandermansMA_MA_techstaken | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_wijzigenandermansMA_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 09:10 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 7 dagen, tot en met T - 1 dag'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 7 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T - 1 dag | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak stop type | ||
+ | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 7 dagen, tot en met T - 1 dag, 1 maal per dag 2 stuks, oraal, definitief gestopt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 2 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_wijzigenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_wijzigenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_wijzigenandermansMA_MA2 | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_wijzigenandermansMA_MA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 09:10 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Reden wijzigen of staken | ||
+ | |style="background-color: white;"|Te sterk effect van medicatie (code = '112251000146103' in codeSystem 'SNOMED CT') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, 1 maal per dag 1 stuk, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_wijzigenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_wijzigenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_wijzigenandermansMA_andermansVV | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_wijzigenandermansMA_andermansVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T - 7 dagen om 07:50 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Te verstrekken hoeveelheid | ||
+ | |style="background-color: white;"|42 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_wijzigenandermansMA_MA1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_wijzigenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_wijzigenandermansTA_TA1 | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_wijzigenandermansTA_TA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 7 dagen om 08:50 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 7 dagen, tot en met T + 13 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 7 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 13 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|FUROSEMIDE MYLAN TABLET 40MG (code = '1529587' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 7 dagen, tot en met T + 13 dagen, 1 maal per dag 2 stuks, Oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 2 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_wijzigenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_wijzigenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_wijzigenandermansTA_TA_techstaken | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_wijzigenandermansTA_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 10:10 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 7 dagen, tot en met T - 1 dag'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 7 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T - 1 dag | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak stop type | ||
+ | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|FUROSEMIDE MYLAN TABLET 40MG (code = '1529587' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 7 dagen, tot en met T - 1 dag, 1 maal per dag 2 stuks, oraal, definitief gestopt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 2 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_wijzigenandermansMA_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_wijzigenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_wijzigenandermansTA_TA2 | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_wijzigenandermansTA_TA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 10:10 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|FUROSEMIDE MYLAN TABLET 40MG (code = '1529587' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, 1 maal per dag 1 stuk, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_wijzigenandermansMA_MA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_wijzigenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_wijzigenandermansTA_andermansMVE | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_wijzigenandermansTA_andermansMVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T - 7 dagen om 08:50 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|42 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|FUROSEMIDE MYLAN TABLET 40MG (code = '1529587' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_wijzigenandermansMA_andermansVV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_wijzigenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_wijzigenandermansMA /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Marcha_van_Partners" title="Intern ID = Marcha_van_Partners">Zorgverlener Marcha_van_Partners</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="7"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener identificatienummer | ||
+ | |style="background-color: white;"|000001115 (in identificerend systeem: UZI Personen) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgegevens | ||
+ | |style="background-color: white;"|Marcha van Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Specialisme | ||
+ | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgaanbieder | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Itis|Zorgaanbieder: Huisartsenpraktijk_Itis]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="7"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener identificatienummer | ||
+ | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgegevens | ||
+ | |style="background-color: white;"|Peter van Pulver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Specialisme | ||
+ | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgaanbieder | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Huisartsenpraktijk_Itis" title="Intern ID = Huisartsenpraktijk_Itis">Zorgaanbieder Huisartsenpraktijk_Itis</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder identificatienummer | ||
+ | |style="background-color: white;"|00005111 (in identificerend systeem: URA) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Organisatie naam | ||
+ | |style="background-color: white;"|Huisartsenpraktijk Itis | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Adresgegevens | ||
+ | |style="background-color: white;"|Werkadres: Langelaan 1 1234ZZ Onze Stad | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder identificatienummer | ||
+ | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Organisatie naam | ||
+ | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Adresgegevens | ||
+ | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder identificatienummer | ||
+ | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Organisatie naam | ||
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
+ | |}<section end=ALLMBHS_XXX_Meijs /> | ||
+ | ==Patiënt M. XXX_Nederveen== | ||
+ | <section begin=XXX_Nederveen /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="6"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Initialen | ||
+ | |style="background-color: white;"|M. | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgebruik | ||
+ | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslachtsnaam | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Achternaam | ||
+ | |style="background-color: white;"|XXX_Nederveen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatienummer | ||
+ | |style="background-color: white;"|999900833 [BSN] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geboortedatum | ||
+ | |style="background-color: white;"|28 okt 1985 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslacht | ||
+ | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
+ | |}<section end=XXX_Nederveen /><section begin=ALLMBHS_XXX_Nederveen /><section begin=MBH_MBH_920_logistiekeverbruiksperiode_start_eind /> | ||
+ | ====Medicamenteuze behandeling MBH_920_logistiekeverbruiksperiode_start_eind ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_logistiekeverbruiksperiode_start_eind_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 11:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T + 10 dagen, tot en met T + 12 maanden'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T + 10 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 12 maanden | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T + 10 dagen, tot en met T + 12 maanden, 1 maal per dag 1 stuk, Oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_logistiekeverbruiksperiode_start_eind_MA_1 | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 10:59:59 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 9 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 9 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 9 dagen, 1 maal per dag 2 stuks, Oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 2 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_logistiekeverbruiksperiode_start_eind_VV | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T om 11:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Aantal herhalingen | ||
+ | |style="background-color: white;"|3 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verbruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T + 10 dagen, tot en met T + 6 maanden | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind_MA | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_logistiekeverbruiksperiode_start_eind_TA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 12:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T + 10 dagen, tot en met T + 12 maanden'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T + 10 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 12 maanden | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T + 10 dagen, tot en met T + 12 maanden, 1 maal per dag 1 stuk, Oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_logistiekeverbruiksperiode_start_eind_TA_1 | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 11:59:59 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 9 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 9 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 9 dagen, 1 maal per dag 2 stuks, Oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 2 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_logistiekeverbruiksperiode_start_eind_MVE | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T om 12:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|100 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind_VV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_logistiekeverbruiksperiode_start_eind /><section begin=MBH_MBH_920_herhalingen /> | ||
+ | ====Medicamenteuze behandeling MBH_920_herhalingen ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_herhalingen_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_herhalingen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 50 dagen om 11:05 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 50 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 50 dagen, 1 maal per dag 1 stuk, Oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_herhalingen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_herhalingen_VV | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_herhalingen_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T - 50 dagen om 11:05 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Te verstrekken hoeveelheid | ||
+ | |style="background-color: white;"|30 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Aantal herhalingen | ||
+ | |style="background-color: white;"|5 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_herhalingen_MA | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_herhalingen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_herhalingen_TA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_herhalingen_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 50 dagen om 12:05 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 50 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 50 dagen, 1 maal per dag 1 stuk, Oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_herhalingen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_herhalingen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_herhalingen_MVE | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_herhalingen_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T - 50 dagen om 12:05 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|30 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_herhalingen_VV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_herhalingen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_herhalingen /><section begin=MBH_MBH_920_afleverlocatie /> | ||
+ | ====Medicamenteuze behandeling MBH_920_afleverlocatie ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_afleverlocatie_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_afleverlocatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 11:07 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, tot en met T + 10 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T + 1 dag | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 10 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T + 1 dag, tot en met T + 10 dagen, 3 maal per dag 1 stuk, Oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|3 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_afleverlocatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_afleverlocatie_VV | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_afleverlocatie_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T om 11:07 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Te verstrekken hoeveelheid | ||
+ | |style="background-color: white;"|30 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Afleverlocatie | ||
+ | |style="background-color: white;"|Dorpsrand 200,1256ZZ Ons Dorp | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_afleverlocatie_MA | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_afleverlocatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_afleverlocatie_TA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_afleverlocatie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 12:07 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, tot en met T + 10 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T + 1 dag | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 10 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T + 1 dag, tot en met T + 10 dagen, 3 maal per dag 1 stuk, Oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|3 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_afleverlocatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_afleverlocatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_afleverlocatie_MVE | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_afleverlocatie_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T om 12:07 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Aanschrijf datum | ||
+ | |style="background-color: white;"|T om 11:07 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|30 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Afleverlocatie | ||
+ | |style="background-color: white;"|Dorpsrand 200,1256ZZ Ons Dorp | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_afleverlocatie_VV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_afleverlocatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_afleverlocatie /><section begin=MBH_MBH_920_logistiekeverbruiksperiode_eind /> | ||
+ | ====Medicamenteuze behandeling MBH_920_logistiekeverbruiksperiode_eind ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_logistiekeverbruiksperiode_eind_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 9 dagen om 11:01 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T + 200 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 9 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 200 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 9 dagen, tot en met T + 200 dagen, 1 maal per dag 1 stuk, Oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_logistiekeverbruiksperiode_eind_VV | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_eind_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T - 9 dagen om 11:01 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verbruiksperiode | ||
+ | |style="background-color: white;"|tot en met T + 200 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_eind_MA | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_logistiekeverbruiksperiode_eind_TA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 9 dagen om 12:01 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T + 200 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 9 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 200 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 9 dagen, tot en met T + 200 dagen, 1 maal per dag 1 stuk, Oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_logistiekeverbruiksperiode_eind_MVE | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_eind_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T - 9 dagen om 12:01 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|100 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Distributievorm | ||
+ | |style="background-color: white;"|GDS (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_eind_VV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_logistiekeverbruiksperiode_eind /><section begin=MBH_MBH_920_logistiekeverbruiksperiode_duur_dagen /> | ||
+ | ====Medicamenteuze behandeling MBH_920_logistiekeverbruiksperiode_duur_dagen ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_logistiekeverbruiksperiode_duur_dagen_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_duur_dagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 11:02 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 150 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 150 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_duur_dagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_logistiekeverbruiksperiode_duur_dagen_VV | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_duur_dagen_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T om 11:02 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verbruiksperiode | ||
+ | |style="background-color: white;"|gedurende 50 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_duur_dagen_MA | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_duur_dagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_logistiekeverbruiksperiode_duur_dagen_TA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_duur_dagen_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 12:02 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 150 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 150 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|PARACETAMOL PCH TABLET 500MG (code = '768901' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_duur_dagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_duur_dagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_logistiekeverbruiksperiode_duur_dagen_MVE | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_duur_dagen_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T om 12:02 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|100 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verbruiksduur | ||
+ | |style="background-color: white;"|50 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|PARACETAMOL PCH TABLET 500MG (code = '768901' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_duur_dagen_VV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_duur_dagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_logistiekeverbruiksperiode_duur_dagen /><section begin=MBH_MBH_920_financiele_indicatiecode /> | ||
+ | ====Medicamenteuze behandeling MBH_920_financiele_indicatiecode ==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_financiele_indicatiecode_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_financiele_indicatiecode_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 11:35 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 13 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Einddatum | ||
+ | |style="background-color: white;"|T + 13 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|OXAZEPAM 10MG TABLET (code = '353' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 13 dagen, 4 maal per dag 1 stuk, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|4 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_financiele_indicatiecode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_financiele_indicatiecode_VV | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_financiele_indicatiecode_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekkingsverzoek datum | ||
+ | |style="background-color: white;"|T om 11:35 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Auteur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Te verstrekken hoeveelheid | ||
+ | |style="background-color: white;"|56 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|OXAZEPAM 10MG TABLET (code = '353' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Beoogd verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Financiele indicatiecode | ||
+ | |style="background-color: white;"|(code = 'OTH' in codeSystem 'NullFlavor'): B2 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_920_financiele_indicatiecode_MA | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_financiele_indicatiecode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |}<section end=MBH_MBH_920_financiele_indicatiecode /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Bertine_van_Doorn" title="Intern ID = Bertine_van_Doorn">Zorgverlener Bertine_van_Doorn</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="7"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener identificatienummer | ||
+ | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgegevens | ||
+ | |style="background-color: white;"|Bertine van Doorn | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Specialisme | ||
+ | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgaanbieder | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder identificatienummer | ||
+ | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Organisatie naam | ||
+ | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Adresgegevens | ||
+ | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder identificatienummer | ||
+ | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Organisatie naam | ||
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
+ | |}<section end=ALLMBHS_XXX_Nederveen /> | ||
+ | |||
+ | [[Categorie:Kwalificatie]] |
Huidige versie van 4 feb 2022 om 14:09
1 Addenda voor inhoudelijke gegevens
1.1 Patiënt B. van XXX_Kester
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | B. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Voorvoegsels | van | |||
Achternaam | XXX_Kester | |||
Identificatienummer | 999911557 [BSN] | |||
Geboortedatum | 2 aug 1954 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.1.1 Medicamenteuze behandeling MBH_920_mg_example-1-KST
Verstrekkingsverzoek MBH_920_mg_example-1_VV1 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_mg_example-1_VV1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T om 08:53 uur | |||
Geannuleerd indicator | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: UZI-000001111-PeterVanPulver | |||
Te verstrekken hoeveelheid | 20 stuks | |||
Geneesmiddel - primaire code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: URA-01236578-ApoGulleGaper | |||
Relatie medicatieafspraak | MBH_920_mg_example-1_MA1 | |||
MBH identificatie | MBH_920_mg_example-1-KST (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.1.2 Medicamenteuze behandeling MBH_920_mg_example-2
Wisselend doseerschema MBH_920_mg_example-2-WDS-1 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_mg_example-2-WDS-1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
Wisselend doseerschema datum tijd | T - 20 dagen om 08:00 uur | |||
Gebruiksperiode | Vanaf T - 20 dagen, tot en met T - 15 dagen | |||
Ingangsdatum | T - 20 dagen | |||
Einddatum | T - 15 dagen | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: UZI-000001111-PeterVanPulver | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 20 dagen, tot en met T - 15 dagen, eerst gedurende 7 dagen 1 maal per dag om 20:00 1 stuk, dan gedurende 3 dagen 1 maal per dag om 20:00 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie 1 | eerst gedurende 7 dagen 1 maal per dag om 20:00 1 stuk | |||
Doseerinstructie 2 | dan gedurende 3 dagen 1 maal per dag om 20:00 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_mg_example-2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.1.3 Medicamenteuze behandeling MBH_920_mg_example-3
Medicatietoediening MBH_920_mg_example-3-MTD-1 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_mg_example-3-MTD-1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
Toedienings datum tijd | T - 30 dagen om 10:30 uur | |||
Afgesproken datum tijd | T - 30 dagen om 10:00 uur | |||
Volgens afspraak indicator | Ja | |||
Toegediende hoeveelheid | ||||
Aantal | 1 | |||
Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
Afgesproken hoeveelheid | ||||
Aantal | 4 | |||
Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
Toedieningsweg | ORAAL (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Toediener | ||||
Zorgverlener | Zie Zorgverlener: UZI-000001111-PeterVanPulver | |||
Geneesmiddel - primaire code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Relatie wisselend doseerschema | ||||
Identificatie | MBH_920_QA1_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
MBH identificatie | MBH_920_mg_example-3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener UZI-000001111-PeterVanPulver | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: URA-00001111-HuisartsenpraktijkPulverPartners | |||
Zorgaanbieder URA-00001111-HuisartsenpraktijkPulverPartners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
Zorgaanbieder URA-01236578-ApoGulleGaper | ||||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
Organisatie naam | Apotheek de Gulle Gaper | |||
Adresgegevens | Werkadres: Dorpsstraat 10 A 1234AA Ons Dorp |
1.2 Patiënt S. XXX_Jankie
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | S. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Jankie | |||
Identificatienummer | 999910437 [BSN] | |||
Geboortedatum | 8 mei 1954 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.2.1 Medicamenteuze behandeling MBH_920_MtdWds
Wisselend doseerschema MBH_920_MtdWds_WDS1 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_MtdWds_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
Wisselend doseerschema datum tijd | T - 20 dagen om 08:00 uur | |||
Gebruiksperiode | Vanaf T - 20 dagen, tot en met T + 9 dagen | |||
Ingangsdatum | T - 20 dagen | |||
Einddatum | T + 9 dagen | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: UZI-000001111-PeterVanPulver | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 20 dagen, tot en met T + 9 dagen, 1 maal per dag 2 stuks, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
Kopie indicator | Nee | |||
Toelichting | toelichting WDS in vrije tekst | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_MtdWds_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Relatie wisselend doseerschema | ||||
Identificatie | MBH_920_MtdWds_WDS0 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
MBH identificatie | MBH_920_MtdWds (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Wisselend doseerschema MBH_920_MtdWds_WDS2 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_MtdWds_WDS2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
Wisselend doseerschema datum tijd | T - 20 dagen om 08:00 uur | |||
Gebruiksperiode | Vanaf T - 20 dagen, gedurende 3 weken | |||
Ingangsdatum | T - 20 dagen | |||
Gebruiksduur | 3 weken | |||
Wisselend doseerschema stop type | definitief gestopt met medicatie (situatie) (code = '113371000146109' in codeSystem 'SNOMED CT') | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: UZI-000001111-PeterVanPulver | |||
Reden wijzigen of staken | Opname (code = '305335007' in codeSystem 'SNOMED CT') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 20 dagen, gedurende 3 weken, 1 maal per dag 2 stuks, Oraal, definitief gestopt | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
Kopie indicator | Ja | |||
Toelichting | toelichting WDS in vrije tekst | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_MtdWds_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Relatie wisselend doseerschema | ||||
Identificatie | MBH_920_MtdWds_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
MBH identificatie | MBH_920_MtdWds (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatietoediening MBH_920_MtdWds_MTD_1 | |||||
Gegevenselement | Waarde | ||||
Identificatie | MBH_920_MtdWds_MTD_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||||
Toedienings datum tijd | 30 jun 2021, om 12:35 | ||||
Afgesproken datum tijd | 30 jun 2021, om 12:00 | ||||
Volgens afspraak indicator | Ja | ||||
Toegediende hoeveelheid | |||||
Aantal | 2 | ||||
Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||||
Afgesproken hoeveelheid | |||||
Aantal | 2 | ||||
Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||
Prik plak locatie | toch maar oraal gegeven | ||||
Toediener | |||||
Mantelzorger | |||||
Contactpersoon | Zie Contactpersoon: ContactPersoonAnnetteDeVries | ||||
Geneesmiddel - primaire code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||||
Toelichting | toelichting in vrije tekst | ||||
Relatie medicatieafspraak | |||||
Identificatie | MBH_920_MtdWds_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||
Relatie toedieningsafspraak | |||||
Identificatie | MBH_920_MtdWds_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||
Relatie wisselend doseerschema | |||||
Identificatie | MBH_920_MtdWds_WDS_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.999.1) | ||||
MBH identificatie | MBH_920_MtdWds (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatietoediening MBH_920_MtdWds_MTD_2 | |||||
Gegevenselement | Waarde | ||||
Identificatie | MBH_920_MtdWds_MTD_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||||
Toedienings datum tijd | 30 jun 2021, om 16:15 | ||||
Afgesproken datum tijd | 30 jun 2021, om 16:00 | ||||
Volgens afspraak indicator | Nee | ||||
Geannuleerd indicator | Ja | ||||
Toegediende hoeveelheid | |||||
Aantal | 2 | ||||
Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||||
Afgesproken hoeveelheid | |||||
Aantal | 6 | ||||
Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||
Toedieningssnelheid | |||||
Waarde | |||||
Nominale waarde | 3 | ||||
Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||||
Tijdseenheid | 1 uur | ||||
Prik plak locatie | toch maar oraal gegeven | ||||
Toediener | |||||
Zorgverlener | Zie Zorgverlener: UZI-000001111-PeterVanPulver | ||||
Medicatie toediening reden van afwijken | Behandeling met geneesmiddel stopgezet (situatie) (code = '274512008' in codeSystem 'SNOMED CT') | ||||
Geneesmiddel - primaire code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||||
Toelichting | toelichting in vrije tekst | ||||
Relatie medicatieafspraak | |||||
Identificatie | MBH_920_MtdWds_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||
Relatie toedieningsafspraak | |||||
Identificatie | MBH_920_MtdWds_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||
Relatie wisselend doseerschema | |||||
Identificatie | MBH_920_MtdWds_WDS_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.999.1) | ||||
MBH identificatie | MBH_920_MtdWds (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatietoediening MBH_920_MtdWds_MTD_3 | |||||
Gegevenselement | Waarde | ||||
Identificatie | MBH_920_MtdWds_MTD_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||||
Toedienings datum tijd | 30 jun 2021, om 16:35 | ||||
Afgesproken datum tijd | 30 jun 2021, om 16:00 | ||||
Volgens afspraak indicator | Nee | ||||
Geannuleerd indicator | Ja | ||||
Toegediende hoeveelheid | |||||
Aantal | 2 | ||||
Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||||
Afgesproken hoeveelheid | |||||
Aantal | 6 | ||||
Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||||
Toedieningssnelheid | |||||
Waarde | |||||
Nominale waarde | 2 | ||||
Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||||
Tijdseenheid | 1 minuut | ||||
Prik plak locatie | toch maar oraal gegeven | ||||
Toediener | |||||
Patient | |||||
Toediener is patient | Ja | ||||
Medicatie toediening reden van afwijken | Niet in staat om medicatie te gebruiken (bevinding) (code = '408366001' in codeSystem 'SNOMED CT') | ||||
Geneesmiddel - primaire code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||||
Toelichting | toelichting in vrije tekst | ||||
Relatie medicatieafspraak | |||||
Identificatie | MBH_920_MtdWds_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||
Relatie toedieningsafspraak | |||||
Identificatie | MBH_920_MtdWds_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||
Relatie wisselend doseerschema | |||||
Identificatie | MBH_920_MtdWds_WDS_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.999.1) | ||||
MBH identificatie | MBH_920_MtdWds (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Contactpersoon ContactPersoonAnnetteDeVries | ||||
Naamgegevens | Annette de Vries | |||
Rol | Eerste relatie/contactpersoon (code = '01' in codeSystem 'COD821-VEKT') | |||
Zorgverlener UZI-000001111-PeterVanPulver | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: URA-00001111-HuisartsenpraktijkPulverPartners | |||
Zorgaanbieder URA-00001111-HuisartsenpraktijkPulverPartners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
1.3 Patiënt S. XXX_Jankie
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | S. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Jankie | |||
Identificatienummer | 999910437 [BSN] | |||
Geboortedatum | 8 mei 1954 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.3.1 Medicamenteuze behandeling MBH_920_TestVVs
Medicatieafspraak MBH_920_arianne_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_arianne_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | 12 dec 2020, om 08:00 | |||
Gebruiksperiode | Vanaf 12 dec 2020, tot en met 10 jan 2021, om 23:59 | |||
Ingangsdatum | 12 dec 2020 | |||
Einddatum | 10 jan 2021, om 23:59 | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf 12 dec 2020, tot en met 10 jan 2021, om 23:59, 2 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 2 maal per dag 1 stuk | |||
Relatie contact | ||||
Identificatienummer | contact#arianne1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.2709) | |||
Relatie zorgepisode | ||||
Identificatienummer | episode#arianne1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.9200) | |||
MBH identificatie | MBH_920_TestVVs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_TestVVs_VV1geannuleerd | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_TestVVs_VV1geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T om 08:53 uur | |||
Geannuleerd indicator | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 20 stuks | |||
Geneesmiddel - primaire code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: URA-01236578-ApoGulleGaper | |||
Relatie medicatieafspraak | MBH_920_TestVVs_MA1 | |||
MBH identificatie | MBH_920_TestVVs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_inf_pers_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_inf_pers_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T - 100 dagen om 07:59:59 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T - 130 dagen, tot en met T - 101 dagen | |||
Ingangsdatum | T - 130 dagen | |||
Einddatum | T - 101 dagen | |||
Medicatie gebruik stop type | definitief gestopt met medicatie (situatie) (code = '113371000146109' in codeSystem 'SNOMED CT') | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Informant | ||||
Contactpersoon | Zie Contactpersoon: ContactPersoonBartJansen | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 130 dagen, tot en met T - 101 dagen, 2 maal per dag 1 dosis, inhalatie, definitief gestopt | |||
Toedieningsweg | inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 2 maal per dag 1 dosis | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_TestVVs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Contactpersoon ContactPersoonBartJansen | ||||
Naamgegevens | Bart Jansen | |||
Rol | Mantelzorger (code = '100001' in codeSystem 'ExtraRolcodes') | |||
Zorgverlener Peter_van_Pulver | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
Zorgaanbieder URA-01236578-ApoGulleGaper | ||||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
Organisatie naam | Apotheek de Gulle Gaper | |||
Adresgegevens | Werkadres: Dorpsstraat 10 A 1234AA Ons Dorp |
1.4 Patiënt B. XXX_Blik
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | B. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Blik | |||
Identificatienummer | 999900389 [BSN] | |||
Geboortedatum | 13 okt 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.4.1 Medicamenteuze behandeling MBH_920_QA1
Medicatieafspraak MBH_920_QA1_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 20 dagen om 08:00 uur | |||
Gebruiksperiode | Vanaf T - 20 dagen, tot en met T + 9 dagen | |||
Ingangsdatum | T - 20 dagen | |||
Einddatum | T + 9 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 2 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_QA1_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA1_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 20 dagen om 08:00 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 60 stuks | |||
Geneesmiddel - primaire code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_QA1_MA | |||
MBH identificatie | MBH_920_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_QA1_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 20 dagen om 09:00 uur | |||
Gebruiksperiode | Vanaf T - 20 dagen, tot en met T + 9 dagen | |||
Ingangsdatum | T - 20 dagen | |||
Einddatum | T + 9 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 2 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_QA1_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA1_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 20 dagen om 09:00 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 60 stuks | |||
Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_QA1_VV | |||
MBH identificatie | MBH_920_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_QA1_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA1_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T - 1 dag om 10:04:23 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T - 20 dagen, tot en met T + 9 dagen | |||
Ingangsdatum | T - 20 dagen | |||
Einddatum | T + 9 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Auteur | ||||
Auteur is patient | Ja | |||
Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 2 maal per dag 1 stuk | |||
Relatie toedieningsafspraak | ||||
Identificatie | MBH_920_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
MBH identificatie | MBH_920_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.4.2 Medicamenteuze behandeling MBH_920_QA2
Medicatieafspraak MBH_920_QA2_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 100 dagen om 08:04 uur | |||
Gebruiksperiode | Vanaf T - 100 dagen, tot en met T - 72 dagen | |||
Ingangsdatum | T - 100 dagen | |||
Einddatum | T - 72 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | SENNOSIDEN A+B STROOP 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | SENNOSIDEN A+B STROOP 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 ml, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 10 ml | |||
MBH identificatie | MBH_920_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_QA2_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA2_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 100 dagen om 08:04 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 300 ml | |||
Geneesmiddel - primaire code | SENNOSIDEN A+B STROOP 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | SENNOSIDEN A+B STROOP 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_QA2_MA | |||
MBH identificatie | MBH_920_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_QA2_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 100 dagen om 09:04 uur | |||
Gebruiksperiode | Vanaf T - 100 dagen, tot en met T - 72 dagen | |||
Ingangsdatum | T - 100 dagen | |||
Einddatum | T - 72 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 ml, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 10 ml | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_QA2_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA2_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 100 dagen om 09:04 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 300 ml | |||
Geneesmiddel - primaire code | XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_QA2_VV | |||
MBH identificatie | MBH_920_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_QA2_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA2_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T - 68 dagen om 12:13:55 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T - 100 dagen, tot en met T - 72 dagen | |||
Ingangsdatum | T - 100 dagen | |||
Einddatum | T - 72 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Auteur | ||||
Auteur is patient | Ja | |||
Geneesmiddel - primaire code | XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 millimeter, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 10 millimeter | |||
Relatie toedieningsafspraak | ||||
Identificatie | MBH_920_QA2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
MBH identificatie | MBH_920_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.4.3 Medicamenteuze behandeling MBH_920_QA3
Medicatieafspraak MBH_920_QA3_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 50 dagen om 08:10 uur | |||
Gebruiksperiode | Vanaf T - 50 dagen, tot en met T - 11 dagen | |||
Ingangsdatum | T - 50 dagen | |||
Einddatum | T - 11 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 2 maal per dag 50 ml | |||
MBH identificatie | MBH_920_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_QA3_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA3_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 50 dagen om 08:10 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 4000 ml | |||
Geneesmiddel - primaire code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_QA3_MA | |||
MBH identificatie | MBH_920_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_QA3_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 50 dagen om 09:10 uur | |||
Gebruiksperiode | Vanaf T - 50 dagen, tot en met T - 11 dagen | |||
Ingangsdatum | T - 50 dagen | |||
Einddatum | T - 11 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 2 maal per dag 50 ml | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_QA3_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA3_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 50 dagen om 09:10 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 4000 ml | |||
Geneesmiddel - primaire code | NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_QA3_VV | |||
MBH identificatie | MBH_920_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_QA3_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA3_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T - 9 dagen om 07:59:59 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T - 50 dagen, tot en met T - 11 dagen | |||
Ingangsdatum | T - 50 dagen | |||
Einddatum | T - 11 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 2 maal per dag 50 ml | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Relatie toedieningsafspraak | ||||
Identificatie | MBH_920_QA3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
MBH identificatie | MBH_920_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.4.4 Medicamenteuze behandeling MBH_920_QA4
Medicatieafspraak MBH_920_QA4_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 10 dagen om 08:12 uur | |||
Gebruiksperiode | Vanaf T - 10 dagen, tot en met T + 19 dagen | |||
Ingangsdatum | T - 10 dagen | |||
Einddatum | T + 19 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_QA4_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA4_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 10 dagen om 08:12 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 30 stuks | |||
Geneesmiddel - primaire code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_QA4_MA | |||
MBH identificatie | MBH_920_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_QA4_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 10 dagen om 09:12 uur | |||
Gebruiksperiode | Vanaf T - 10 dagen, tot en met T + 19 dagen | |||
Ingangsdatum | T - 10 dagen | |||
Einddatum | T + 19 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_QA4_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA4_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 10 dagen om 09:12 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 30 stuks | |||
Geneesmiddel - primaire code | ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_QA4_VV | |||
MBH identificatie | MBH_920_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_QA4_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA4_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T - 2 dagen om 08:12 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T - 10 dagen, tot en met T + 19 dagen | |||
Ingangsdatum | T - 10 dagen | |||
Einddatum | T + 19 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.4.5 Medicamenteuze behandeling MBH_920_QA5
Medicatieafspraak MBH_920_QA5_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA5_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 50 dagen om 08:15 uur | |||
Gebruiksperiode | Vanaf T - 50 dagen, gedurende 7 dagen | |||
Ingangsdatum | T - 50 dagen | |||
Gebruiksduur | 7 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 50 dagen, gedurende 7 dagen, 4 maal per dag 2 stuks, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 4 maal per dag 2 stuks | |||
MBH identificatie | MBH_920_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_QA5_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA5_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 50 dagen om 08:15 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 56 stuks | |||
Geneesmiddel - primaire code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_QA5_MA | |||
MBH identificatie | MBH_920_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_QA5_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA5_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 50 dagen om 09:15 uur | |||
Gebruiksperiode | Vanaf T - 50 dagen, gedurende 7 dagen | |||
Ingangsdatum | T - 50 dagen | |||
Gebruiksduur | 7 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | PARACETAMOL SANDOZ TABLET 500MG (code = '665800' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 50 dagen, gedurende 7 dagen, 4 maal per dag 2 stuks, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 4 maal per dag 2 stuks | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_QA5_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_QA5_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA5_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 50 dagen om 09:15 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 56 stuks | |||
Geneesmiddel - primaire code | PARACETAMOL SANDOZ TABLET 500MG (code = '665800' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_QA5_VV | |||
MBH identificatie | MBH_920_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_QA5_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA5_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T - 43 dagen om 08:00 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T - 50 dagen, gedurende 7 dagen | |||
Ingangsdatum | T - 50 dagen | |||
Gebruiksduur | 7 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | PARACETAMOL SANDOZ TABLET 500MG (code = '665800' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 50 dagen, gedurende 7 dagen, 4 maal per dag 2 stuks, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 4 maal per dag 2 stuks | |||
Relatie toedieningsafspraak | ||||
Identificatie | MBH_920_QA5_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
MBH identificatie | MBH_920_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.4.6 Medicamenteuze behandeling MBH_920_QA6
Medicatieafspraak MBH_920_QA6_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 5 dagen om 08:18 uur | |||
Gebruiksperiode | Vanaf T - 5 dagen, tot en met T + 1 dag | |||
Ingangsdatum | T - 5 dagen | |||
Einddatum | T + 1 dag | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 5 dagen, tot en met T + 1 dag, 3 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 3 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_QA6_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA6_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 5 dagen om 08:18 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 21 stuks | |||
Geneesmiddel - primaire code | OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_QA6_MA | |||
MBH identificatie | MBH_920_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_QA6_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA6_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 5 dagen om 09:18 uur | |||
Gebruiksperiode | Vanaf T - 5 dagen, tot en met T + 1 dag | |||
Ingangsdatum | T - 5 dagen | |||
Einddatum | T + 1 dag | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | OXAZEPAM ACTAVIS TABLET 10MG (code = '613401' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 5 dagen, tot en met T + 1 dag, 3 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 3 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_QA6_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA6_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 5 dagen om 09:18 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 21 stuks | |||
Geneesmiddel - primaire code | OXAZEPAM ACTAVIS TABLET 10MG (code = '613401' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_QA6_VV | |||
MBH identificatie | MBH_920_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_QA6_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_QA6_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T - 2 dagen om 08:59:59 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T - 5 dagen, tot en met T + 1 dag | |||
Ingangsdatum | T - 5 dagen | |||
Einddatum | T + 1 dag | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 5 dagen, tot en met T + 1 dag, 3 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 3 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener Peter_van_Pulver | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
Zorgaanbieder Apotheek_De_Gulle_Gaper | ||||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
Organisatie naam | Apotheek De Gulle Gaper |
1.5 Patiënt C. XXX_Brugge
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | C. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Brugge | |||
Identificatienummer | 999900419 [BSN] | |||
Geboortedatum | 16 okt 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.5.1 Medicamenteuze behandeling MBH_920_start_eind
Medicatieafspraak MBH_920_start_eind_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 10 dagen om 11:20 uur | |||
Gebruiksperiode | Vanaf T - 10 dagen, tot en met T - 5 dagen | |||
Ingangsdatum | T - 10 dagen | |||
Einddatum | T - 5 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 10 dagen, tot en met T - 5 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_start_eind_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_start_eind_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 10 dagen om 11:20 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 5 stuks | |||
Geneesmiddel - primaire code | METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_start_eind_MA | |||
MBH identificatie | MBH_920_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_start_eind_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_start_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 10 dagen om 12:20 uur | |||
Gebruiksperiode | Vanaf T - 10 dagen, tot en met T - 5 dagen | |||
Ingangsdatum | T - 10 dagen | |||
Einddatum | T - 5 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 10 dagen, tot en met T - 5 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_start_eind_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_start_eind_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T om 12:20 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 5 stuks | |||
Geneesmiddel - primaire code | METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_start_eind_VV | |||
MBH identificatie | MBH_920_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_start_eind_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_start_eind_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T - 4 dagen om 10:59:59 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T - 10 dagen, tot en met T - 5 dagen | |||
Ingangsdatum | T - 10 dagen | |||
Einddatum | T - 5 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Auteur | ||||
Auteur is patient | Ja | |||
Geneesmiddel - primaire code | METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 10 dagen, tot en met T - 5 dagen, 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 stuk | |||
Relatie toedieningsafspraak | ||||
Identificatie | MBH_920_start_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
MBH identificatie | MBH_920_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.5.2 Medicamenteuze behandeling MBH_920_start_duur
Medicatieafspraak MBH_920_start_duur_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 20 dagen om 11:30 uur | |||
Gebruiksperiode | Vanaf T - 20 dagen, gedurende 3 weken | |||
Ingangsdatum | T - 20 dagen | |||
Gebruiksduur | 3 weken | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 20 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_start_duur_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_start_duur_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T om 11:30 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 21 stuks | |||
Geneesmiddel - primaire code | LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK') | |||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_start_duur_MA | |||
MBH identificatie | MBH_920_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_start_duur_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_start_duur_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 20 dagen om 12:30 uur | |||
Gebruiksperiode | Vanaf T - 20 dagen, gedurende 3 weken | |||
Ingangsdatum | T - 20 dagen | |||
Gebruiksduur | 3 weken | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK') | |||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 20 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_start_duur_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_start_duur_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 20 dagen om 12:30 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 21 stuks | |||
Geneesmiddel - primaire code | LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK') | |||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_start_duur_VV | |||
MBH identificatie | MBH_920_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_start_duur_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_start_duur_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T - 1 dag om 12:00 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T - 20 dagen | |||
Ingangsdatum | T - 20 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 20 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.5.3 Medicamenteuze behandeling MBH_920_chronisch
Medicatieafspraak MBH_920_chronisch_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 30 dagen om 11:32 uur | |||
Gebruiksperiode | Vanaf T - 30 dagen | |||
Ingangsdatum | T - 30 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 30 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_chronisch_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_chronisch_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 30 dagen om 11:32 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 21 stuks | |||
Geneesmiddel - primaire code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_chronisch_MA | |||
MBH identificatie | MBH_920_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_chronisch_VV_extraVVbestaandeMA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_chronisch_VV_extraVVbestaandeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 10 dagen om 11:35 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 90 stuks | |||
Geneesmiddel - primaire code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_chronisch_MA | |||
MBH identificatie | MBH_920_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_chronisch_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 30 dagen om 12:32 uur | |||
Gebruiksperiode | Vanaf T - 30 dagen | |||
Ingangsdatum | T - 30 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 30 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_chronisch_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_chronisch_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 30 dagen om 12:32 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 21 stuks | |||
Geneesmiddel - primaire code | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_chronisch_VV | |||
MBH identificatie | MBH_920_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_chronisch_MVE_extraMVEbestaandeTA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_chronisch_MVE_extraMVEbestaandeTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 10 dagen om 12:35 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 90 stuks | |||
Geneesmiddel - primaire code | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_chronisch_VV_extraVVbestaandeMA | |||
MBH identificatie | MBH_920_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_chronisch_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_chronisch_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T - 20 dagen om 11:43:12 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T - 30 dagen | |||
Ingangsdatum | T - 30 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Auteur | ||||
Auteur is patient | Ja | |||
Geneesmiddel - primaire code | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 30 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie toedieningsafspraak | ||||
Identificatie | MBH_920_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
MBH identificatie | MBH_920_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.5.4 Medicamenteuze behandeling MBH_920_start_duur2
Medicatieafspraak MBH_920_start_duur2_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 60 dagen om 11:30 uur | |||
Gebruiksperiode | Vanaf T - 60 dagen, gedurende 28 dagen | |||
Ingangsdatum | T - 60 dagen | |||
Gebruiksduur | 28 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 60 dagen, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_start_duur2_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_start_duur2_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 60 dagen om 11:30 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 28 stuks | |||
Geneesmiddel - primaire code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_start_duur2_MA | |||
MBH identificatie | MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_start_duur2_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_start_duur2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 60 dagen om 12:30 uur | |||
Gebruiksperiode | Vanaf T - 60 dagen, gedurende 28 dagen | |||
Ingangsdatum | T - 60 dagen | |||
Gebruiksduur | 28 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 60 dagen, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_start_duur2_TA_techstaken | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_start_duur2_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 50 dagen om 12:30 uur | |||
Gebruiksperiode | Vanaf T - 60 dagen, tot en met T - 51 dagen | |||
Ingangsdatum | T - 60 dagen | |||
Einddatum | T - 51 dagen | |||
Toedieningsafspraak stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 60 dagen, tot en met T - 51 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_start_duur2_TA_anderePRK | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_start_duur2_TA_anderePRK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 50 dagen om 12:35 uur | |||
Gebruiksperiode | Vanaf T - 50 dagen, gedurende 18 dagen | |||
Ingangsdatum | T - 50 dagen | |||
Gebruiksduur | 18 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Reden afspraak | Pantozol niet leverbaar | |||
Geneesmiddel - primaire code | PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 50 dagen, gedurende 18 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_start_duur2_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_start_duur2_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 60 dagen om 12:30 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 28 stuks | |||
Geneesmiddel - primaire code | PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_start_duur2_VV | |||
MBH identificatie | MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_start_duur2_MVE_anderePRK | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_start_duur2_MVE_anderePRK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 50 dagen om 12:36 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 28 stuks | |||
Geneesmiddel - primaire code | PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_start_duur2_VV | |||
MBH identificatie | MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_start_duur2_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_start_duur2_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T - 55 dagen om 15:21:33 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.5.5 Medicamenteuze behandeling MBH_920_dosis_stuks
Medicatieafspraak MBH_920_dosis_stuks_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 130 dagen om 11:35 uur | |||
Gebruiksperiode | Vanaf T - 130 dagen, tot en met T - 101 dagen | |||
Ingangsdatum | T - 130 dagen | |||
Einddatum | T - 101 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 130 dagen, tot en met T - 101 dagen, 2 maal per dag 1 dosis, inhalatie | |||
Toedieningsweg | inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 2 maal per dag 1 dosis | |||
MBH identificatie | MBH_920_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_dosis_stuks_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_dosis_stuks_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 130 dagen om 11:35 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 1 stuk | |||
Geneesmiddel - primaire code | FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_dosis_stuks_MA | |||
MBH identificatie | MBH_920_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_dosis_stuks_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_dosis_stuks_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 130 dagen om 12:35 uur | |||
Gebruiksperiode | Vanaf T - 130 dagen, tot en met T - 101 dagen | |||
Ingangsdatum | T - 130 dagen | |||
Einddatum | T - 101 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | FLIXOTIDE DISKUS INHPDR 100MCG 60DO (code = '1029754' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 130 dagen, tot en met T - 101 dagen, 2 maal per dag 1 dosis, inhalatie | |||
Toedieningsweg | inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 2 maal per dag 1 dosis | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_dosis_stuks_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_dosis_stuks_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 130 dagen om 12:35 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 1 stuk | |||
Geneesmiddel - primaire code | FLIXOTIDE DISKUS INHPDR 100MCG 60DO (code = '1029754' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_dosis_stuks_VV | |||
MBH identificatie | MBH_920_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_dosis_stuks_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_dosis_stuks_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T - 100 dagen om 07:59:59 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | 2 maal per dag 1 dosis, inhalatie | |||
Toedieningsweg | inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 2 maal per dag 1 dosis | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.5.6 Medicamenteuze behandeling MBH_920_nieuweMBHobvTA
Toedieningsafspraak MBH_920_nieuweMBHobvTA_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_nieuweMBHobvTA_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 10 dagen om 10:00 uur | |||
Gebruiksperiode | Vanaf T - 10 dagen, tot en met T - 5 dagen | |||
Ingangsdatum | T - 10 dagen | |||
Einddatum | T - 5 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | PARACETAMOL APOTEX TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | PARACETAMOL TABLET 500MG (code = '67903' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PARACETAMOL TABLET 500MG (code = '2194' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 10 dagen, tot en met T - 5 dagen, Zo nodig 3 maal per dag 2 stuks, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | Zo nodig 3 maal per dag 2 stuks | |||
MBH identificatie | MBH_920_nieuweMBHobvTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_nieuweMBHobvTA_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_nieuweMBHobvTA_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
Medicatieverstrekkings datum tijd | T - 10 dagen om 10:00 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 30 stuks | |||
Geneesmiddel - primaire code | PARACETAMOL APOTEX TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | PARACETAMOL TABLET 500MG (code = '67903' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PARACETAMOL TABLET 500MG (code = '2194' in codeSystem 'G-Standaard GPK') | |||
MBH identificatie | MBH_920_nieuweMBHobvTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_nieuweMBHobvTA_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_nieuweMBHobvTA_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T - 3 dagen om 16:00 uur | |||
Gebruik indicator | Ja | |||
Gebruiksperiode | Vanaf T - 10 dagen om 10:00 uur, tot en met T - 3 dagen om 16:00 uur | |||
Ingangsdatum | T - 10 dagen om 10:00 uur | |||
Einddatum | T - 3 dagen om 16:00 uur | |||
Auteur | ||||
Auteur is patient | Ja | |||
Geneesmiddel - primaire code | PARACETAMOL APOTEX TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | PARACETAMOL TABLET 500MG (code = '67903' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PARACETAMOL TABLET 500MG (code = '2194' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 10 dagen om 10:00 uur, tot en met T - 3 dagen om 16:00 uur, 3 maal per dag 2 stuks, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 3 maal per dag 2 stuks | |||
Relatie toedieningsafspraak | ||||
Identificatie | MBH_920_nieuweMBHobvTA_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
MBH identificatie | MBH_920_nieuweMBHobvTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener Peter_van_Pulver | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
Zorgaanbieder Apotheek_De_Gulle_Gaper | ||||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
Organisatie naam | Apotheek De Gulle Gaper |
1.6 Patiënt M. XXX_Niesing
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | M. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Niesing | |||
Identificatienummer | 999900845 [BSN] | |||
Geboortedatum | 29 okt 1985 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.6.1 Medicamenteuze behandeling MBH_920_HPKvoorschrijven
Medicatieafspraak MBH_920_HPKvoorschrijven_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_HPKvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 170 dagen om 13:00 uur | |||
Gebruiksperiode | Vanaf T - 170 dagen, tot en met T - 21 dagen | |||
Ingangsdatum | T - 170 dagen | |||
Einddatum | T - 21 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 170 dagen, tot en met T - 21 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_HPKvoorschrijven_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_HPKvoorschrijven_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 170 dagen om 13:00 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 150 stuks | |||
Geneesmiddel - primaire code | XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_HPKvoorschrijven_MA | |||
MBH identificatie | MBH_920_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_HPKvoorschrijven_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_HPKvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 170 dagen om 14:00 uur | |||
Gebruiksperiode | Vanaf T - 170 dagen, tot en met T - 21 dagen | |||
Ingangsdatum | T - 170 dagen | |||
Einddatum | T - 21 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 170 dagen, tot en met T - 21 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_HPKvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_HPKvoorschrijven_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_HPKvoorschrijven_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 170 dagen om 14:00 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 150 stuks | |||
Geneesmiddel - primaire code | XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_HPKvoorschrijven_VV | |||
MBH identificatie | MBH_920_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_HPKvoorschrijven_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_HPKvoorschrijven_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T om 22:08 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T, tot en met T | |||
Ingangsdatum | T | |||
Einddatum | T | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Auteur | ||||
Auteur is patient | Ja | |||
Geneesmiddel - primaire code | XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie toedieningsafspraak | ||||
Identificatie | MBH_920_HPKvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
MBH identificatie | MBH_920_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.6.2 Medicamenteuze behandeling MBH_920_ZINRvoorschrijven
Medicatieafspraak MBH_920_ZINRvoorschrijven_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 13:05 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 150 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 150 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr') | |||
Geneesmiddel - generiekere code | INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_ZINRvoorschrijven_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_ZINRvoorschrijven_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T om 13:05 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 150 stuks | |||
Geneesmiddel - primaire code | INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr') | |||
Geneesmiddel - generiekere code | INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_ZINRvoorschrijven_MA | |||
MBH identificatie | MBH_920_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_ZINRvoorschrijven_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_ZINRvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 14:05 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 150 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 150 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr') | |||
Geneesmiddel - generiekere code | INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_ZINRvoorschrijven_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_ZINRvoorschrijven_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T om 14:05 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 150 stuks | |||
Geneesmiddel - primaire code | INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr') | |||
Geneesmiddel - generiekere code | INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_ZINRvoorschrijven_VV | |||
MBH identificatie | MBH_920_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_ZINRvoorschrijven_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_ZINRvoorschrijven_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T om 22:08 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T, tot en met T | |||
Ingangsdatum | T | |||
Einddatum | T | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Auteur | ||||
Auteur is patient | Ja | |||
Geneesmiddel - primaire code | INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr') | |||
Geneesmiddel - generiekere code | INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie toedieningsafspraak | ||||
Identificatie | MBH_920_ZINRvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
MBH identificatie | MBH_920_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener Peter_van_Pulver | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
Zorgaanbieder Apotheek_De_Gulle_Gaper | ||||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
Organisatie naam | Apotheek De Gulle Gaper |
1.7 Patiënt M. XXX_Pherai
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | M. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Pherai | |||
Identificatienummer | 999900870 [BSN] | |||
Geboortedatum | 1 nov 1985 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.7.1 Medicamenteuze behandeling MBH_920_wdsmtd1
Medicatieafspraak MBH_920_wdsmtd1_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 20 dagen om 08:00 uur | |||
Gebruiksperiode | Vanaf T - 20 dagen, tot en met T + 9 dagen | |||
Ingangsdatum | T - 20 dagen | |||
Einddatum | T + 9 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 20 dagen, tot en met T + 9 dagen, 1 maal per dag 2 stuks, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
MBH identificatie | MBH_920_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Wisselend doseerschema MBH_920_wdsmtd1_WDS_opstartschema | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
Wisselend doseerschema datum tijd | T - 20 dagen om 08:00 uur | |||
Gebruiksperiode | Vanaf T - 20 dagen, tot en met T - 15 dagen | |||
Ingangsdatum | T - 20 dagen | |||
Einddatum | T - 15 dagen | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 20 dagen, tot en met T - 15 dagen, eerst gedurende 3 dagen 1 maal per dag om 20:00 2 stuks, dan gedurende 3 dagen 1 maal per dag om 20:00 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie 1 | eerst gedurende 3 dagen 1 maal per dag om 20:00 2 stuks | |||
Doseerinstructie 2 | dan gedurende 3 dagen 1 maal per dag om 20:00 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Wisselend doseerschema MBH_920_wdsmtd1_WDS_trombosedienst | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_wdsmtd1_WDS_trombosedienst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
Wisselend doseerschema datum tijd | T - 15 dagen om 14:30 uur | |||
Gebruiksperiode | Vanaf T - 14 dagen, tot en met T - 5 dagen | |||
Ingangsdatum | T - 14 dagen | |||
Einddatum | T - 5 dagen | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Tanja_de_Bakker | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 14 dagen, tot en met T - 5 dagen, cyclus van 5 dagen: steeds eerst gedurende 2 dagen 1 maal per dag 2 stuks 's avonds, dan gedurende 2 dagen 1 maal per dag 2 stuks 's avonds, dan gedurende 1 dag 1 maal per dag 0 stuks 's avonds, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie 1 | eerst gedurende 2 dagen 1 maal per dag 2 stuks 's avonds | |||
Doseerinstructie 2 | dan gedurende 2 dagen 1 maal per dag 2 stuks 's avonds | |||
Doseerinstructie 3 | dan gedurende 1 dag 1 maal per dag 0 stuks 's avonds | |||
Herhaalperiode cyclisch schema | 5 dagen | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Relatie wisselend doseerschema | ||||
Identificatie | MBH_920_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
MBH identificatie | MBH_920_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Wisselend doseerschema MBH_920_wdsmtd1_WDS_technischestop | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_wdsmtd1_WDS_technischestop (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
Wisselend doseerschema datum tijd | T - 7 dagen om 10:30 uur | |||
Gebruiksperiode | Vanaf T - 14 dagen, tot en met T - 7 dagen | |||
Ingangsdatum | T - 14 dagen | |||
Einddatum | T - 7 dagen | |||
Wisselend doseerschema stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Tanja_de_Bakker | |||
Reden wijzigen of staken | Gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 14 dagen, tot en met T - 7 dagen, cyclus van 5 dagen: steeds eerst gedurende 2 dagen 1 maal per dag 2 stuks 's avonds, dan gedurende 2 dagen 1 maal per dag 2 stuks 's avonds, dan gedurende 1 dag 1 maal per dag 0 stuks 's avonds, Oraal, definitief gestopt | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie 1 | eerst gedurende 2 dagen 1 maal per dag 2 stuks 's avonds | |||
Doseerinstructie 2 | dan gedurende 2 dagen 1 maal per dag 2 stuks 's avonds | |||
Doseerinstructie 3 | dan gedurende 1 dag 1 maal per dag 0 stuks 's avonds | |||
Herhaalperiode cyclisch schema | 5 dagen | |||
Kopie indicator | Nee | |||
Toelichting | Dosering aangepast i.v.m. te lage INR waarde. | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Relatie wisselend doseerschema | ||||
Identificatie | MBH_920_wdsmtd1_WDS_trombosedienst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
MBH identificatie | MBH_920_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Wisselend doseerschema MBH_920_wdsmtd1_WDS_verhoging | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_wdsmtd1_WDS_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
Wisselend doseerschema datum tijd | T - 7 dagen om 10:30 uur | |||
Gebruiksperiode | Vanaf T - 6 dagen, tot en met T + 6 dagen | |||
Ingangsdatum | T - 6 dagen | |||
Einddatum | T + 6 dagen | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Tanja_de_Bakker | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 6 dagen, tot en met T + 6 dagen, cyclus van 5 dagen: steeds eerst gedurende 3 dagen 1 maal per dag om 19:00 2 stuks, dan gedurende 2 dagen 1 maal per dag om 19:00 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie 1 | eerst gedurende 3 dagen 1 maal per dag om 19:00 2 stuks | |||
Doseerinstructie 2 | dan gedurende 2 dagen 1 maal per dag om 19:00 1 stuk | |||
Herhaalperiode cyclisch schema | 5 dagen | |||
Kopie indicator | Nee | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Relatie wisselend doseerschema | ||||
Identificatie | MBH_920_wdsmtd1_WDS_trombosedienst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
MBH identificatie | MBH_920_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_wdsmtd1_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_wdsmtd1_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 20 dagen om 08:00 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 60 stuks | |||
Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_wdsmtd1_MA | |||
MBH identificatie | MBH_920_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_wdsmtd1_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_wdsmtd1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 20 dagen om 09:00 uur | |||
Gebruiksperiode | Vanaf T - 20 dagen, tot en met T + 9 dagen | |||
Ingangsdatum | T - 20 dagen | |||
Einddatum | T + 9 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 20 dagen, tot en met T + 9 dagen, 1 maal per dag 2 stuks, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_wdsmtd1_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_wdsmtd1_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 20 dagen om 09:00 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 60 stuks | |||
Geneesmiddel - primaire code | ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_wdsmtd1_VV | |||
MBH identificatie | MBH_920_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatietoediening MBH_920_wdsmtd1_MTD1 | |||||
Gegevenselement | Waarde | ||||
Identificatie | MBH_920_wdsmtd1_MTD1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||||
Toedienings datum tijd | T - 20 dagen om 20:30 uur | ||||
Afgesproken datum tijd | T - 20 dagen om 20:00 uur | ||||
Volgens afspraak indicator | Ja | ||||
Toegediende hoeveelheid | |||||
Aantal | 1 | ||||
Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||||
Afgesproken hoeveelheid | |||||
Aantal | 2 | ||||
Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||||
Toedieningsweg | ORAAL (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||
Toediener | |||||
Mantelzorger | |||||
Contactpersoon | Zie Contactpersoon: Toos_de_Bakker | ||||
Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||||
Relatie medicatieafspraak | |||||
Identificatie | MBH_920_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||
Relatie wisselend doseerschema | |||||
Identificatie | MBH_920_QA1_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | ||||
MBH identificatie | MBH_920_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatietoediening MBH_920_wdsmtd1_MTD2 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_wdsmtd1_MTD2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
Toedienings datum tijd | T - 19 dagen om 20:00 uur | |||
Afgesproken datum tijd | T - 19 dagen om 20:00 uur | |||
Volgens afspraak indicator | Nee | |||
Toegediende hoeveelheid | ||||
Aantal | 1 | |||
Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
Afgesproken hoeveelheid | ||||
Aantal | 2 | |||
Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Toediener | ||||
Zorgverlener | Zie Zorgverlener: Jantien_Toedien | |||
Medicatie toediening reden van afwijken | Toediening van medicatie geweigerd (code = '406149000' in codeSystem 'SNOMED CT') | |||
Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Relatie wisselend doseerschema | ||||
Identificatie | MBH_920_QA1_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
MBH identificatie | MBH_920_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatietoediening MBH_920_wdsmtd1_MTD3 | |||||
Gegevenselement | Waarde | ||||
Identificatie | MBH_920_wdsmtd1_MTD3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||||
Toedienings datum tijd | T - 17 dagen om 20:00 uur | ||||
Afgesproken datum tijd | T - 17 dagen om 20:00 uur | ||||
Volgens afspraak indicator | Nee | ||||
Geannuleerd indicator | Ja | ||||
Toegediende hoeveelheid | |||||
Aantal | 1 | ||||
Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||||
Afgesproken hoeveelheid | |||||
Aantal | 1 | ||||
Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||
Toediener | |||||
Patient | |||||
Toediener is patient | Ja | ||||
Medicatie toediening reden van afwijken | Niet in staat om medicatie te gebruiken (code = '408366001' in codeSystem 'SNOMED CT') | ||||
Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||||
Toelichting | Geprobeerd, maar niet gelukt met de tablet | ||||
Relatie medicatieafspraak | |||||
Identificatie | MBH_920_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||
Relatie toedieningsafspraak | |||||
Identificatie | MBH_920_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||
MBH identificatie | MBH_920_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatietoediening MBH_920_wdsmtd1_MTD4 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_wdsmtd1_MTD4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
Toedienings datum tijd | T - 16 dagen om 20:05 uur | |||
Afgesproken datum tijd | T - 16 dagen om 20:00 uur | |||
Volgens afspraak indicator | Nee | |||
Toegediende hoeveelheid | ||||
Aantal | 0 | |||
Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
Afgesproken hoeveelheid | ||||
Aantal | 1 | |||
Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Toediener | ||||
Zorgverlener | Zie Zorgverlener: Marleen_van_der_Brand | |||
Medicatie toediening reden van afwijken | Zorgafnemer is niet beschikbaar om medicatie in ontvangst te nemen (code = '153241000146104' in codeSystem 'SNOMED CT') | |||
Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Relatie toedieningsafspraak | ||||
Identificatie | MBH_920_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Relatie wisselend doseerschema | ||||
Identificatie | MBH_920_QA1_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
MBH identificatie | MBH_920_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Contactpersoon Toos_de_Bakker | ||||
Naamgegevens | Toos de Bakker | |||
Rol | Mantelzorger (code = '100001' in codeSystem '2.16.840.1.113883.2.4.3.11.60.40.4.23.1') | |||
Zorgverlener Peter_van_Pulver | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgverlener Tanja_de_Bakker | ||||
Zorgverlener identificatienummer | 222221111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Tanja de Bakker | |||
Specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Trombosedienst_Ons_Dorp | |||
Zorgverlener Jantien_Toedien | ||||
Zorgverlener identificatienummer | 222220000 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Jantien Toedien | |||
Specialisme | Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Thuiszorg_Om_en_Bij | |||
Zorgverlener Marleen_van_der_Brand | ||||
Zorgverlener identificatienummer | 111110000 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Marleen van der Brand | |||
Specialisme | Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Thuiszorg_Om_en_Bij | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
Zorgaanbieder Trombosedienst_Ons_Dorp | ||||
Zorgaanbieder identificatienummer | 11112222 (in identificerend systeem: URA) | |||
Organisatie naam | Trombosedienst Ons Dorp | |||
Afdeling specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Adresgegevens | : Kerkstraat 28 d 1332GH Ons Dorp | |||
Zorgaanbieder Apotheek_De_Gulle_Gaper | ||||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
Organisatie naam | Apotheek De Gulle Gaper | |||
Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
Zorgaanbieder Thuiszorg_Om_en_Bij | ||||
Zorgaanbieder identificatienummer | 11110000 (in identificerend systeem: URA) | |||
Organisatie naam | Thuiszorg Om en Bij | |||
Adresgegevens | : Voorstraat 1 1223BA Ons Dorp | |||
Organisatie type | Thuiszorg (code = 'T2' in codeSystem '2.16.840.1.113883.2.4.15.1060') |
1.8 Patiënt C. XXX_Dijk
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | C. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Dijk | |||
Identificatienummer | 999900456 [BSN] | |||
Geboortedatum | 20 okt 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.8.1 Medicamenteuze behandeling MBH_920_gestopt
Medicatieafspraak MBH_920_gestopt_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 4 maanden om 08:00 uur | |||
Gebruiksperiode | Vanaf T - 4 maanden, tot en met T + 5 maanden | |||
Ingangsdatum | T - 4 maanden | |||
Einddatum | T + 5 maanden | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
Geneesmiddel - primaire code | OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 4 maanden, tot en met T + 5 maanden, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieafspraak MBH_920_gestopt_MA_staken | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_gestopt_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 10 dagen om 18:00 uur | |||
Gebruiksperiode | Vanaf T - 4 maanden, tot en met T - 10 dagen | |||
Ingangsdatum | T - 4 maanden | |||
Einddatum | T - 10 dagen | |||
Medicatieafspraak stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
Reden wijzigen of staken | Geneesmiddelinteractie (code = '79899007' in codeSystem 'SNOMED CT') | |||
Geneesmiddel - primaire code | OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 4 maanden, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_gestopt_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_gestopt_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 4 maanden om 09:00 uur | |||
Gebruiksperiode | Vanaf T - 4 maanden, tot en met T + 5 maanden | |||
Ingangsdatum | T - 4 maanden | |||
Einddatum | T + 5 maanden | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | OMEPRAZOL SANDOZ CAPSULE MSR 20MG (code = '1500570' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 4 maanden, tot en met T + 5 maanden, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_gestopt_TA_staken | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_gestopt_TA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 10 dagen om 19:00 uur | |||
Gebruiksperiode | Vanaf T - 4 maanden, tot en met T - 10 dagen | |||
Ingangsdatum | T - 4 maanden | |||
Einddatum | T - 10 dagen | |||
Toedieningsafspraak stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | OMEPRAZOL SANDOZ CAPSULE MSR 20MG (code = '1500570' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 4 maanden, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_gestopt_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.8.2 Medicamenteuze behandeling MBH_920_gewijzigd
Medicatieafspraak MBH_920_gewijzigd_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 21 dagen om 08:02 uur | |||
Gebruiksperiode | Vanaf T - 21 dagen | |||
Ingangsdatum | T - 21 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
Geneesmiddel - primaire code | METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieafspraak MBH_920_gewijzigd_MA_wijziging | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_gewijzigd_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 2 dagen om 08:02 uur | |||
Gebruiksperiode | Vanaf T - 2 dagen | |||
Ingangsdatum | T - 2 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
Reden wijzigen of staken | Gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT') | |||
Geneesmiddel - primaire code | METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 2 dagen, 2 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 2 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieafspraak MBH_920_gewijzigd_MA_techstaken | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_gewijzigd_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 2 dagen om 08:02 uur | |||
Gebruiksperiode | Vanaf T - 21 dagen, tot en met T - 3 dagen | |||
Ingangsdatum | T - 21 dagen | |||
Einddatum | T - 3 dagen | |||
Medicatieafspraak stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
Geneesmiddel - primaire code | METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 21 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_gewijzigd_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_gewijzigd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 21 dagen om 09:02 uur | |||
Gebruiksperiode | Vanaf T - 21 dagen | |||
Ingangsdatum | T - 21 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_gewijzigd_TA_wijziging | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_gewijzigd_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 2 dagen om 09:02 uur | |||
Gebruiksperiode | Vanaf T - 2 dagen | |||
Ingangsdatum | T - 2 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 2 dagen, 2 maal per dag 2 stuks, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 2 maal per dag 2 stuks | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_gewijzigd_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_gewijzigd_TA_techstaken | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_gewijzigd_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 2 dagen om 09:02 uur | |||
Gebruiksperiode | Vanaf T - 21 dagen, tot en met T - 3 dagen | |||
Ingangsdatum | T - 21 dagen | |||
Einddatum | T - 3 dagen | |||
Toedieningsafspraak stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 21 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_gewijzigd_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.8.3 Medicamenteuze behandeling MBH_920_gewijzigddoorander
Medicatieafspraak MBH_920_gewijzigddoorander_MA_eigen | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 60 dagen om 08:05 uur | |||
Gebruiksperiode | Vanaf T - 60 dagen, tot en met T + 14 dagen | |||
Ingangsdatum | T - 60 dagen | |||
Einddatum | T + 14 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
Geneesmiddel - primaire code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 60 dagen, tot en met T + 14 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieafspraak MBH_920_gewijzigddoorander_MA_wijzigingdoorander | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 3 dagen om 08:10 uur | |||
Gebruiksperiode | Vanaf T - 3 dagen, tot en met T + 30 dagen | |||
Ingangsdatum | T - 3 dagen | |||
Einddatum | T + 30 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Reden wijzigen of staken | Gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT') | |||
Geneesmiddel - primaire code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 3 dagen, tot en met T + 30 dagen, 1 maal per dag 2 stuks, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieafspraak MBH_920_gewijzigddoorander_MA_techstakendoorander | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_gewijzigddoorander_MA_techstakendoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 3 dagen om 08:10 uur | |||
Gebruiksperiode | Vanaf T - 60 dagen, tot en met T - 4 dagen | |||
Ingangsdatum | T - 60 dagen | |||
Einddatum | T - 4 dagen | |||
Medicatieafspraak stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 60 dagen, tot en met T - 4 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_gewijzigddoorander_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_gewijzigddoorander_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 60 dagen om 09:05 uur | |||
Gebruiksperiode | Vanaf T - 60 dagen, tot en met T + 14 dagen | |||
Ingangsdatum | T - 60 dagen | |||
Einddatum | T + 14 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 60 dagen, tot en met T + 14 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_gewijzigddoorander_TA_wijziging | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_gewijzigddoorander_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 3 dagen om 09:10 uur | |||
Gebruiksperiode | Vanaf T - 3 dagen, tot en met T + 30 dagen | |||
Ingangsdatum | T - 3 dagen | |||
Einddatum | T + 30 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 3 dagen, tot en met T + 30 dagen, 1 maal per dag 2 stuks, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_gewijzigddoorander_TA_techstaken | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_gewijzigddoorander_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 3 dagen om 09:10 uur | |||
Gebruiksperiode | Vanaf T - 60 dagen, tot en met T - 4 dagen | |||
Ingangsdatum | T - 60 dagen | |||
Einddatum | T - 4 dagen | |||
Toedieningsafspraak stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 60 dagen, tot en met T - 4 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_gewijzigddoorander_MA_techstakendoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_gewijzigddoorander_MGB_zv | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_gewijzigddoorander_MGB_zv (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T - 3 dagen om 08:08 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T - 60 dagen, tot en met T - 3 dagen | |||
Ingangsdatum | T - 60 dagen | |||
Einddatum | T - 3 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 60 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_gewijzigddoorander_MGB_pat | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_gewijzigddoorander_MGB_pat (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T om 08:08 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T - 3 dagen, tot en met T - 1 dag | |||
Ingangsdatum | T - 3 dagen | |||
Einddatum | T - 1 dag | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Auteur | ||||
Auteur is patient | Ja | |||
Geneesmiddel - primaire code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 3 dagen, tot en met T - 1 dag, 1 maal per dag 2 stuks, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.8.4 Medicamenteuze behandeling MBH_920_onderbroken
Medicatieafspraak MBH_920_onderbroken_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 153 dagen om 08:06 uur | |||
Gebruiksperiode | Vanaf T - 153 dagen, tot en met T + 20 dagen | |||
Ingangsdatum | T - 153 dagen | |||
Einddatum | T + 20 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
Geneesmiddel - primaire code | FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 153 dagen, tot en met T + 20 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieafspraak MBH_920_onderbroken_MA_onderbreken | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_onderbroken_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 100 dagen om 18:12 uur | |||
Gebruiksperiode | Vanaf T - 153 dagen, tot en met T - 100 dagen | |||
Ingangsdatum | T - 153 dagen | |||
Einddatum | T - 100 dagen | |||
Medicatieafspraak stop type | tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT') | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
Reden wijzigen of staken | Verrichting gepland (code = '405613005' in codeSystem 'SNOMED CT') | |||
Geneesmiddel - primaire code | FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 153 dagen, tot en met T - 100 dagen, 1 maal per dag 1 stuk, Oraal, tijdelijk gestopt | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_onderbroken_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_onderbroken_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 153 dagen om 09:06 uur | |||
Gebruiksperiode | Vanaf T - 153 dagen, tot en met T + 20 dagen | |||
Ingangsdatum | T - 153 dagen | |||
Einddatum | T + 20 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | FUROSEMIDE CF TABLET 20MG (code = '1099469' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 153 dagen, tot en met T + 20 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_onderbroken_TA_onderbreken | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_onderbroken_TA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 100 dagen om 19:12 uur | |||
Gebruiksperiode | Vanaf T - 153 dagen, tot en met T - 100 dagen | |||
Ingangsdatum | T - 153 dagen | |||
Einddatum | T - 100 dagen | |||
Toedieningsafspraak stop type | tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT') | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | FUROSEMIDE CF TABLET 20MG (code = '1099469' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 153 dagen, tot en met T - 100 dagen, 1 maal per dag 1 stuk, Oraal, tijdelijk gestopt | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_onderbroken_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.8.5 Medicamenteuze behandeling MBH_920_eigen1
Medicatieafspraak MBH_920_eigen1_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_eigen1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 10 dagen om 18:05 uur | |||
Gebruiksperiode | Vanaf T - 9 dagen, tot en met T + 15 dagen | |||
Ingangsdatum | T - 9 dagen | |||
Einddatum | T + 15 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
Geneesmiddel - primaire code | PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 9 dagen, tot en met T + 15 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_eigen1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_eigen1_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_eigen1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 10 dagen om 18:45 uur | |||
Gebruiksperiode | Vanaf T - 9 dagen, tot en met T + 15 dagen | |||
Ingangsdatum | T - 9 dagen | |||
Einddatum | T + 15 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | PANTOPRAZOL TEVA TABLET MSR 20MG (code = '2002914' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 9 dagen, tot en met T + 15 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_eigen1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_eigen1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_eigen1_MGB_zv | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_eigen1_MGB_zv (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T om 08:08 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T - 9 dagen, tot en met T | |||
Ingangsdatum | T - 9 dagen | |||
Einddatum | T | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
Geneesmiddel - primaire code | PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 9 dagen, tot en met T, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_eigen1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_eigen1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_eigen1_MGB_pat | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_eigen1_MGB_pat (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T om 18:08 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T - 9 dagen, tot en met T | |||
Ingangsdatum | T - 9 dagen | |||
Einddatum | T | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
Auteur | ||||
Auteur is patient | Ja | |||
Geneesmiddel - primaire code | PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 9 dagen, tot en met T, 1 maal per dag 2 stuks, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_eigen1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_eigen1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.8.6 Medicamenteuze behandeling MBH_920_eigen2
Medicatieafspraak MBH_920_eigen2_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_eigen2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 159 dagen om 08:15 uur | |||
Gebruiksperiode | Vanaf T - 159 dagen, gedurende 1 week | |||
Ingangsdatum | T - 159 dagen | |||
Gebruiksduur | 1 week | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
Geneesmiddel - primaire code | AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 159 dagen, gedurende 1 week, 3 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 3 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_eigen2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_eigen2_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_eigen2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 159 dagen om 09:15 uur | |||
Gebruiksperiode | Vanaf T - 159 dagen, gedurende 1 week | |||
Ingangsdatum | T - 159 dagen | |||
Gebruiksduur | 1 week | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 159 dagen, gedurende 1 week, 3 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 3 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_eigen2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_eigen2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.8.7 Medicamenteuze behandeling MBH_920_gebruik
Medicatiegebruik MBH_920_gebruik_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_gebruik_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T - 1 dag om 08:12 uur | |||
Gebruik indicator | Ja | |||
Gebruiksperiode | Vanaf T - 10 dagen, tot en met T - 2 dagen | |||
Ingangsdatum | T - 10 dagen | |||
Einddatum | T - 2 dagen | |||
Auteur | ||||
Auteur is patient | Ja | |||
Geneesmiddel - Product specificatie | ||||
Product naam | Paracetamol 500mg | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 10 dagen, tot en met T - 2 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_gebruik (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.8.8 Medicamenteuze behandeling MBH_920_andermans
Medicatieafspraak MBH_920_andermans_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_andermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 10 dagen om 18:15 uur | |||
Gebruiksperiode | Vanaf T - 9 dagen | |||
Ingangsdatum | T - 9 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 9 dagen, 2 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 2 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_andermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_andermans_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_andermans_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 10 dagen om 19:05 uur | |||
Gebruiksperiode | Vanaf T - 9 dagen | |||
Ingangsdatum | T - 9 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_Jansen_en_Co | |||
Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 9 dagen, 2 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 2 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_andermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_andermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.8.9 Medicamenteuze behandeling MBH_920_toekomstig
Medicatieafspraak MBH_920_toekomstig_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_toekomstig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 1 dag om 08:15 uur | |||
Gebruiksperiode | Vanaf T + 15 dagen, tot en met T + 51 dagen | |||
Ingangsdatum | T + 15 dagen | |||
Einddatum | T + 51 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
Geneesmiddel - primaire code | DOXYCYCLINE 100MG TABLET (code = '19844' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | DOXYCYCLINE 100MG TABLET (code = '22179' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T + 15 dagen, tot en met T + 51 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_toekomstig_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_toekomstig_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 1 dag om 09:15 uur | |||
Gebruiksperiode | Vanaf T + 15 dagen, tot en met T + 51 dagen | |||
Ingangsdatum | T + 15 dagen | |||
Einddatum | T + 51 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | DOXYCYCLINE PCH TABLET 100MG (code = '1141317' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | DOXYCYCLINE 100MG TABLET (code = '19844' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | DOXYCYCLINE 100MG TABLET (code = '22179' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T + 15 dagen, tot en met T + 51 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_toekomstig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.8.10 Medicamenteuze behandeling MBH_920_gestoptandermans
Medicatieafspraak MBH_920_gestoptandermans_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 20 dagen om 08:00 uur | |||
Gebruiksperiode | Vanaf T - 20 dagen, tot en met T + 7 dagen | |||
Ingangsdatum | T - 20 dagen | |||
Einddatum | T + 7 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 20 dagen, tot en met T + 7 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieafspraak MBH_920_gestoptandermans_MA_staken | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_gestoptandermans_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 10 dagen om 18:00 uur | |||
Gebruiksperiode | Vanaf T - 20 dagen, tot en met T - 10 dagen | |||
Ingangsdatum | T - 20 dagen | |||
Einddatum | T - 10 dagen | |||
Medicatieafspraak stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Reden wijzigen of staken | Geneesmiddelinteractie (code = '79899007' in codeSystem 'SNOMED CT') | |||
Geneesmiddel - primaire code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 20 dagen, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_gestoptandermans_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_gestoptandermans_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 20 dagen om 09:00 uur | |||
Gebruiksperiode | Vanaf T - 20 dagen, tot en met T + 7 dagen | |||
Ingangsdatum | T - 20 dagen | |||
Einddatum | T + 7 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_Jansen_en_Co | |||
Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 20 dagen, tot en met T + 7 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_gestoptandermans_TA_staken | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_gestoptandermans_TA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 10 dagen om 19:00 uur | |||
Gebruiksperiode | Vanaf T - 20 dagen, tot en met T - 10 dagen | |||
Ingangsdatum | T - 20 dagen | |||
Einddatum | T - 10 dagen | |||
Toedieningsafspraak stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_Jansen_en_Co | |||
Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 20 dagen, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_gestoptandermans_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener Marcha_van_Partners | ||||
Zorgverlener identificatienummer | 000001115 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Marcha van Partners | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Itis | |||
Zorgverlener Peter_van_Pulver | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgaanbieder Huisartsenpraktijk_Itis | ||||
Zorgaanbieder identificatienummer | 00005111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Itis | |||
Adresgegevens | Werkadres: Langelaan 1 1234ZZ Onze Stad | |||
Zorgaanbieder Apotheek_De_Gulle_Gaper | ||||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
Organisatie naam | Apotheek De Gulle Gaper | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
Zorgaanbieder Apotheek_Jansen_en_Co | ||||
Zorgaanbieder identificatienummer | 99901111 (in identificerend systeem: URA) | |||
Organisatie naam | Apotheek Jansen en Co |
1.9 Patiënt H. XXX_Hoek
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | H. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Hoek | |||
Identificatienummer | 999900638 [BSN] | |||
Geboortedatum | 5 nov 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.9.1 Medicamenteuze behandeling MBH_920_contactepisode
Medicatieafspraak MBH_920_contactepisode_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_contactepisode_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 20 dagen om 08:00 uur | |||
Gebruiksperiode | Vanaf T - 20 dagen, tot en met T + 9 dagen | |||
Ingangsdatum | T - 20 dagen | |||
Einddatum | T + 9 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 20 dagen, tot en met T + 9 dagen, 1 maal per dag 2 stuks, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
Relatie contact | ||||
Identificatienummer | MBH_920_contactepisode_CONTACT1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.2709) | |||
Relatie zorgepisode | ||||
Identificatienummer | MBH_920_contactepisode_EPISODE1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.9200) | |||
MBH identificatie | MBH_920_contactepisode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Wisselend doseerschema MBH_920_contactepisode_WDS_opstartschema | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_contactepisode_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
Wisselend doseerschema datum tijd | T - 20 dagen om 08:00 uur | |||
Gebruiksperiode | Vanaf T - 20 dagen, tot en met T - 15 dagen | |||
Ingangsdatum | T - 20 dagen | |||
Einddatum | T - 15 dagen | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 20 dagen, tot en met T - 15 dagen, eerst gedurende 3 dagen 1 maal per dag om 20:00 2 stuks, dan gedurende 3 dagen 1 maal per dag om 20:00 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie 1 | eerst gedurende 3 dagen 1 maal per dag om 20:00 2 stuks | |||
Doseerinstructie 2 | dan gedurende 3 dagen 1 maal per dag om 20:00 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Relatie contact | ||||
Identificatienummer | MBH_920_contactepisode_CONTACT1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.2709) | |||
Relatie zorgepisode | ||||
Identificatienummer | MBH_920_contactepisode_EPISODE1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.9200) | |||
MBH identificatie | MBH_920_contactepisode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_contactepisode_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_contactepisode_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 20 dagen om 08:00 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 60 stuks | |||
Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_wdsmtd1_MA | |||
MBH identificatie | MBH_920_contactepisode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_contactepisode_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_contactepisode_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 20 dagen om 09:00 uur | |||
Gebruiksperiode | Vanaf T - 20 dagen, tot en met T + 9 dagen | |||
Ingangsdatum | T - 20 dagen | |||
Einddatum | T + 9 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 20 dagen, tot en met T + 9 dagen, 1 maal per dag 2 stuks, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_contactepisode_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_contactepisode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_contactepisode_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_contactepisode_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 20 dagen om 09:00 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 60 stuks | |||
Geneesmiddel - primaire code | ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_contactepisode_VV | |||
MBH identificatie | MBH_920_contactepisode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_contactepisode_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_contactepisode_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T - 10 dagen om 09:56:05 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T - 20 dagen, tot en met T - 9 dagen | |||
Ingangsdatum | T - 20 dagen | |||
Einddatum | T - 9 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 20 dagen, tot en met T - 9 dagen, 1 maal per dag 2 stuks, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_contactepisode_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Relatie contact | ||||
Identificatienummer | MBH_920_contactepisode_CONTACT3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.2709) | |||
Relatie zorgepisode | ||||
Identificatienummer | MBH_920_contactepisode_EPISODE1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.9200) | |||
MBH identificatie | MBH_920_contactepisode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatietoediening MBH_920_contactepisode_MTD1 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_contactepisode_MTD1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
Toedienings datum tijd | T - 20 dagen om 20:30 uur | |||
Afgesproken datum tijd | T - 20 dagen om 20:00 uur | |||
Volgens afspraak indicator | Ja | |||
Toegediende hoeveelheid | ||||
Aantal | 2 | |||
Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
Afgesproken hoeveelheid | ||||
Aantal | 2 | |||
Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
Toedieningsweg | ORAAL (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Toediener | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Relatie wisselend doseerschema | ||||
Identificatie | MBH_920_QA1_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
Relatie contact | ||||
Identificatienummer | MBH_920_contactepisode_CONTACT2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.2709) | |||
Relatie zorgepisode | ||||
Identificatienummer | MBH_920_contactepisode_EPISODE1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.9200) | |||
MBH identificatie | MBH_920_contactepisode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener Peter_van_Pulver | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
Zorgaanbieder Apotheek_De_Gulle_Gaper | ||||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
Organisatie naam | Apotheek De Gulle Gaper | |||
Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
1.10 Patiënt C. XXX_Coenen
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | C. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Coenen | |||
Identificatienummer | 999900420 [BSN] | |||
Geboortedatum | 17 okt 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.10.1 Medicamenteuze behandeling MBH_920_aanvullendeinstructie
Medicatieafspraak MBH_920_aanvullendeinstructie_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_aanvullendeinstructie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 4 maanden om 08:00 uur | |||
Gebruiksperiode | Vanaf T - 4 maanden, tot en met T + 8 maanden | |||
Ingangsdatum | T - 4 maanden | |||
Einddatum | T + 8 maanden | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Geneesmiddel - primaire code | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 4 maanden, tot en met T + 8 maanden, 1 maal per dag 1 stuk, Bij het eten innemen, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Bij het eten innemen | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_aanvullendeinstructie_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_aanvullendeinstructie_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 4 maanden om 08:00 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Te verstrekken hoeveelheid | 180 stuks | |||
Geneesmiddel - primaire code | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_aanvullendeinstructie_MA | |||
MBH identificatie | MBH_920_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_aanvullendeinstructie_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_aanvullendeinstructie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 4 maanden om 09:00 uur | |||
Gebruiksperiode | Vanaf T - 4 maanden, tot en met T + 8 maanden | |||
Ingangsdatum | T - 4 maanden | |||
Einddatum | T + 8 maanden | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 4 maanden, tot en met T + 8 maanden, 1 maal per dag 1 stuk, Bij het eten innemen, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Bij het eten innemen | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_aanvullendeinstructie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_aanvullendeinstructie_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_aanvullendeinstructie_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 4 maanden om 09:00 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 180 stuks | |||
Geneesmiddel - primaire code | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_aanvullendeinstructie_VV | |||
MBH identificatie | MBH_920_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.10.2 Medicamenteuze behandeling MBH_920_toelichting
Medicatieafspraak MBH_920_toelichting_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 21 dagen om 08:02 uur | |||
Gebruiksperiode | Vanaf T - 21 dagen | |||
Ingangsdatum | T - 21 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Toelichting | In overleg met specialist | |||
MBH identificatie | MBH_920_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_toelichting_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_toelichting_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 21 dagen om 08:02 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Te verstrekken hoeveelheid | 30 stuks | |||
Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Toelichting | Extra verstrekkingsverzoek omdat patient medicatie is kwijtgeraakt | |||
Relatie medicatieafspraak | MBH_920_toelichting_MA | |||
MBH identificatie | MBH_920_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_toelichting_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_toelichting_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 21 dagen om 09:02 uur | |||
Gebruiksperiode | Vanaf T - 21 dagen | |||
Ingangsdatum | T - 21 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Toelichting | In overleg met specialist | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_toelichting_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_toelichting_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 21 dagen om 09:02 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 30 stuks | |||
Geneesmiddel - primaire code | FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |||
Toelichting | Extra verstrekkingsverzoek omdat patient medicatie is kwijtgeraakt | |||
Relatie verstrekkingsverzoek | MBH_920_toelichting_VV | |||
MBH identificatie | MBH_920_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_toelichting_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_toelichting_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T om 10:14 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Nee | |||
Gebruiksperiode | Vanaf T - 7 dagen, tot en met T - 1 dag | |||
Ingangsdatum | T - 7 dagen | |||
Einddatum | T - 1 dag | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Geneesmiddel - primaire code | FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 7 dagen, tot en met T - 1 dag, 2 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 2 maal per dag 1 stuk | |||
Toelichting | In verband met bijwerking de afgelopen week minder vaak genomen | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.10.3 Medicamenteuze behandeling MBH_920_redenvanvoorschrijven
Medicatieafspraak MBH_920_redenvanvoorschrijven_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_redenvanvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 13 dagen om 08:05 uur | |||
Gebruiksperiode | Vanaf T - 13 dagen, tot en met T + 14 dagen | |||
Ingangsdatum | T - 13 dagen | |||
Einddatum | T + 14 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Reden van voorschrijven | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Reumatoide artritis | |||
Geneesmiddel - primaire code | Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 13 dagen, tot en met T + 14 dagen, 1 maal per week 5 stuks, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per week 5 stuks | |||
MBH identificatie | MBH_920_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_redenvanvoorschrijven_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_redenvanvoorschrijven_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 13 dagen om 08:05 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Te verstrekken hoeveelheid | 20 stuks | |||
Geneesmiddel - primaire code | Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_redenvanvoorschrijven_MA | |||
MBH identificatie | MBH_920_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_redenvanvoorschrijven_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_redenvanvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 13 dagen om 09:05 uur | |||
Gebruiksperiode | Vanaf T - 13 dagen, tot en met T + 14 dagen | |||
Ingangsdatum | T - 13 dagen | |||
Einddatum | T + 14 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | METHOTREXAAT PCH TABLET 2,5MG (code = '1421778' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 13 dagen, tot en met T + 14 dagen, 1 maal per week 5 stuks, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per week 5 stuks | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_redenvanvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_redenvanvoorschrijven_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_redenvanvoorschrijven_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 13 dagen om 09:05 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 20 stuks | |||
Geneesmiddel - primaire code | METHOTREXAAT PCH TABLET 2,5MG (code = '1421778' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_redenvanvoorschrijven_VV | |||
MBH identificatie | MBH_920_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_redenvanvoorschrijven_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_redenvanvoorschrijven_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T om 15:05 uur | |||
Gebruik indicator | Nee | |||
Volgens afspraak indicator | Nee | |||
Gebruiksperiode | Vanaf T - 5 dagen, tot en met T - 2 dagen | |||
Ingangsdatum | T - 5 dagen | |||
Einddatum | T - 2 dagen | |||
Medicatie gebruik stop type | tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT') | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Geneesmiddel - primaire code | Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 5 dagen, tot en met T - 2 dagen, geneesmiddel niet in gebruik, tijdelijk gestopt | |||
Reden wijzigen of stoppen gebruik | Verrichting gepland (code = '405613005' in codeSystem 'SNOMED CT') | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_redenvanvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.10.4 Medicamenteuze behandeling MBH_920_aanvullendeinformatiewensen
Medicatieafspraak MBH_920_aanvullendeinformatiewensen_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_aanvullendeinformatiewensen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 5 dagen om 08:06 uur | |||
Gebruiksperiode | Vanaf T - 4 dagen, tot en met T + 5 dagen | |||
Ingangsdatum | T - 4 dagen | |||
Einddatum | T + 5 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Geneesmiddel - primaire code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 4 dagen, tot en met T + 5 dagen, 3 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 3 maal per dag 1 stuk | |||
Aanvullende informatie | Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') | |||
MBH identificatie | MBH_920_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_aanvullendeinformatiewensen_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_aanvullendeinformatiewensen_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 5 dagen om 08:06 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Te verstrekken hoeveelheid | 30 stuks | |||
Geneesmiddel - primaire code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Aanvullende wensen | Bezorgen (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2051') | |||
Relatie medicatieafspraak | MBH_920_aanvullendeinformatiewensen_MA | |||
MBH identificatie | MBH_920_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_aanvullendeinformatiewensen_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_aanvullendeinformatiewensen_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 5 dagen om 09:06 uur | |||
Gebruiksperiode | Vanaf T - 4 dagen, tot en met T + 5 dagen | |||
Ingangsdatum | T - 4 dagen | |||
Einddatum | T + 5 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 4 dagen, tot en met T + 5 dagen, 3 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 3 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_aanvullendeinformatiewensen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_aanvullendeinformatiewensen_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_aanvullendeinformatiewensen_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 5 dagen om 09:06 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 30 stuks | |||
Geneesmiddel - primaire code | BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_aanvullendeinformatiewensen_VV | |||
MBH identificatie | MBH_920_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.10.5 Medicamenteuze behandeling MBH_920_Toedieningsweg
Medicatieafspraak MBH_920_Toedieningsweg_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_Toedieningsweg_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 5 dagen om 08:15 uur | |||
Gebruiksperiode | Vanaf T - 5 dagen, tot en met T + 2 dagen | |||
Ingangsdatum | T - 5 dagen | |||
Einddatum | T + 2 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Geneesmiddel - primaire code | DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 5 dagen, tot en met T + 2 dagen, 2 maal per dag 1 druppel, In het rechter oog, oculair | |||
Toedieningsweg | oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): In het rechter oog | |||
Doseerinstructie | 2 maal per dag 1 druppel | |||
Aanvullende informatie | Bewust afwijkende toedieningsweg (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') | |||
MBH identificatie | MBH_920_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_Toedieningsweg_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_Toedieningsweg_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 5 dagen om 08:15 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Te verstrekken hoeveelheid | 1 ml | |||
Geneesmiddel - primaire code | DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_Toedieningsweg_MA | |||
MBH identificatie | MBH_920_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_Toedieningsweg_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_Toedieningsweg_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 5 dagen om 09:15 uur | |||
Gebruiksperiode | Vanaf T - 5 dagen, tot en met T + 2 dagen | |||
Ingangsdatum | T - 5 dagen | |||
Einddatum | T + 2 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | SOFRADEX OORDRUPPELS (code = '644781' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 5 dagen, tot en met T + 2 dagen, 2 maal per dag 1 druppel, In het rechter oog, oculair | |||
Toedieningsweg | oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): In het rechter oog | |||
Doseerinstructie | 2 maal per dag 1 druppel | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_Toedieningsweg_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_Toedieningsweg_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_Toedieningsweg_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 5 dagen om 09:15 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 1 stuk | |||
Geneesmiddel - primaire code | SOFRADEX OORDRUPPELS (code = '644781' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_Toedieningsweg_VV | |||
MBH identificatie | MBH_920_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener Bertine_van_Doorn | ||||
Zorgverlener identificatienummer | 000001112 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Bertine van Doorn | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
Zorgaanbieder Apotheek_De_Gulle_Gaper | ||||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
Organisatie naam | Apotheek De Gulle Gaper |
1.11 Patiënt C. XXX_Coenen
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | C. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Coenen | |||
Identificatienummer | 999900420 [BSN] | |||
Geboortedatum | 17 okt 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.11.1 Medicamenteuze behandeling MBH_920_aanvullendeinstructie
Medicatieafspraak MBH_920_aanvullendeinstructie_MA_staken | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_aanvullendeinstructie_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 10 dagen om 18:00 uur | |||
Gebruiksperiode | Vanaf T - 4 maanden, tot en met T - 10 dagen | |||
Ingangsdatum | T - 4 maanden | |||
Einddatum | T - 10 dagen | |||
Medicatieafspraak stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Reden wijzigen of staken | Geneesmiddelinteractie (code = '79899007' in codeSystem 'SNOMED CT') | |||
Geneesmiddel - primaire code | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 4 maanden, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Bij het eten innemen, Oraal, definitief gestopt | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Bij het eten innemen | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_aanvullendeinstructie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_aanvullendeinstructie_TA_staken | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_aanvullendeinstructie_TA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 10 dagen om 19:00 uur | |||
Gebruiksperiode | Vanaf T - 4 maanden, tot en met T - 10 dagen | |||
Ingangsdatum | T - 4 maanden | |||
Einddatum | T - 10 dagen | |||
Toedieningsafspraak stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_Jansen_en_Co | |||
Geneesmiddel - primaire code | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 4 maanden, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Bij het eten innemen, Oraal, definitief gestopt | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Bij het eten innemen | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_aanvullendeinstructie_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.11.2 Medicamenteuze behandeling MBH_920_toelichting
Medicatieafspraak MBH_920_toelichting_MA_wijzigingmetVV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_toelichting_MA_wijzigingmetVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 2 dagen om 08:02 uur | |||
Gebruiksperiode | Vanaf T - 2 dagen | |||
Ingangsdatum | T - 2 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Reden wijzigen of staken | Gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT') | |||
Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 2 dagen, 1 maal per dag 2 stuks, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieafspraak MBH_920_toelichting_MA_techstaken | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_toelichting_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 2 dagen om 08:02 uur | |||
Gebruiksperiode | Vanaf T - 21 dagen, tot en met T - 3 dagen | |||
Ingangsdatum | T - 21 dagen | |||
Einddatum | T - 3 dagen | |||
Medicatieafspraak stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 21 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_toelichting_VV_extra | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_toelichting_VV_extra (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 2 dagen om 08:02 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Te verstrekken hoeveelheid | 60 stuks | |||
Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_toelichting_MA_wijzigingmetVV | |||
MBH identificatie | MBH_920_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_toelichting_TA_wijzigingmetMVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_toelichting_TA_wijzigingmetMVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 2 dagen om 09:02 uur | |||
Gebruiksperiode | Vanaf T - 2 dagen | |||
Ingangsdatum | T - 2 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 2 dagen, 1 maal per dag 2 stuks, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_toelichting_MA_wijzigingmetVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_toelichting_TA_techstaken | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_toelichting_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 2 dagen om 09:02 uur | |||
Gebruiksperiode | Vanaf T - 21 dagen, tot en met T - 3 dagen | |||
Ingangsdatum | T - 21 dagen | |||
Einddatum | T - 3 dagen | |||
Toedieningsafspraak stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_Jansen_en_Co | |||
Geneesmiddel - primaire code | FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 21 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_toelichting_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_toelichting_MVE_extra | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_toelichting_MVE_extra (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 2 dagen om 09:02 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 60 stuks | |||
Geneesmiddel - primaire code | FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_toelichting_VV_extra | |||
MBH identificatie | MBH_920_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.11.3 Medicamenteuze behandeling MBH_920_redenvanvoorschrijven
Medicatieafspraak MBH_920_redenvanvoorschrijven_MA_wijzigingzonderVV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_redenvanvoorschrijven_MA_wijzigingzonderVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 1 dag om 08:10 uur | |||
Gebruiksperiode | Vanaf T - 1 dag, tot en met T + 14 dagen | |||
Ingangsdatum | T - 1 dag | |||
Einddatum | T + 14 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Reden wijzigen of staken | Te sterk effect van medicatie (code = '112251000146103' in codeSystem 'SNOMED CT') | |||
Reden van voorschrijven | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Reumatoide artritis | |||
Geneesmiddel - primaire code | Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 1 dag, tot en met T + 14 dagen, 1 maal per week 4 stuks, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per week 4 stuks | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_redenvanvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieafspraak MBH_920_redenvanvoorschrijven_MA_techstaken | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_redenvanvoorschrijven_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 1 dag om 08:10 uur | |||
Gebruiksperiode | Vanaf T - 13 dagen, tot en met T - 2 dagen | |||
Ingangsdatum | T - 13 dagen | |||
Einddatum | T - 2 dagen | |||
Medicatieafspraak stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Reden van voorschrijven | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Reumatoide artritis | |||
Geneesmiddel - primaire code | Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 13 dagen, tot en met T - 2 dagen, 1 maal per week 5 stuks, Oraal, definitief gestopt | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per week 5 stuks | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_redenvanvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_redenvanvoorschrijven_TA_wijzigingzonderMVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_redenvanvoorschrijven_TA_wijzigingzonderMVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 1 dag om 09:10 uur | |||
Gebruiksperiode | Vanaf T - 1 dag, tot en met T + 14 dagen | |||
Ingangsdatum | T - 1 dag | |||
Einddatum | T + 14 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_Jansen_en_Co | |||
Geneesmiddel - primaire code | METHOTREXAAT PCH TABLET 2,5MG (code = '1421778' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 1 dag, tot en met T + 14 dagen, 1 maal per week 4 stuks, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per week 4 stuks | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_redenvanvoorschrijven_MA_wijzigingzonderVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_redenvanvoorschrijven_TA_techstaken | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_redenvanvoorschrijven_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 1 dag om 09:10 uur | |||
Gebruiksperiode | Vanaf T - 13 dagen, tot en met T - 2 dagen | |||
Ingangsdatum | T - 13 dagen | |||
Einddatum | T - 2 dagen | |||
Toedieningsafspraak stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_Jansen_en_Co | |||
Geneesmiddel - primaire code | METHOTREXAAT PCH TABLET 2,5MG (code = '1421778' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 13 dagen, tot en met T - 2 dagen, 1 maal per week 5 stuks, Oraal, definitief gestopt | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per week 5 stuks | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_redenvanvoorschrijven_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.11.4 Medicamenteuze behandeling MBH_920_aanvullendeinformatiewensen
Medicatieafspraak MBH_920_aanvullendeinformatiewensen_MA_onderbreken | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_aanvullendeinformatiewensen_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 1 dag om 18:12 uur | |||
Gebruiksperiode | Vanaf T - 4 dagen, tot en met T - 1 dag | |||
Ingangsdatum | T - 4 dagen | |||
Einddatum | T - 1 dag | |||
Medicatieafspraak stop type | tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT') | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Reden wijzigen of staken | Opname in instelling (code = '305335007' in codeSystem 'SNOMED CT') | |||
Geneesmiddel - primaire code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 4 dagen, tot en met T - 1 dag, 3 maal per dag 1 stuk, Oraal, tijdelijk gestopt | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 3 maal per dag 1 stuk | |||
Aanvullende informatie | Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_aanvullendeinformatiewensen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_aanvullendeinformatiewensen_TA_onderbreken | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_aanvullendeinformatiewensen_TA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 1 dag om 19:12 uur | |||
Gebruiksperiode | Vanaf T - 4 dagen, tot en met T - 1 dag | |||
Ingangsdatum | T - 4 dagen | |||
Einddatum | T - 1 dag | |||
Toedieningsafspraak stop type | tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT') | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_Jansen_en_Co | |||
Geneesmiddel - primaire code | BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 4 dagen, tot en met T - 1 dag, 3 maal per dag 1 stuk, Oraal, tijdelijk gestopt | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 3 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_aanvullendeinformatiewensen_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener Bertine_van_Doorn | ||||
Zorgverlener identificatienummer | 000001112 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Bertine van Doorn | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
Zorgaanbieder Apotheek_Jansen_en_Co | ||||
Zorgaanbieder identificatienummer | 99901111 (in identificerend systeem: URA) | |||
Organisatie naam | Apotheek Jansen en Co | |||
Zorgaanbieder Apotheek_De_Gulle_Gaper | ||||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
Organisatie naam | Apotheek De Gulle Gaper |
1.12 Patiënt E. XXX_Doppen
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | E. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Doppen | |||
Identificatienummer | 999900511 [BSN] | |||
Geboortedatum | 24 okt 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.12.1 Medicamenteuze behandeling MBH_920_Lengte_Gewicht
Medicatieafspraak MBH_920_Lengte_Gewicht_MA_1 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_Lengte_Gewicht_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 1 jaar om 07:05 uur | |||
Gebruiksperiode | Vanaf T - 1 jaar | |||
Ingangsdatum | T - 1 jaar | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLETMSR 100MG (code = '103039' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 1 jaar, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_Lengte_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieafspraak MBH_920_Lengte_Gewicht_MA_onderbreken | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_Lengte_Gewicht_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 80 dagen om 15:00 uur | |||
Gebruiksperiode | Vanaf T - 1 jaar, tot en met T - 80 dagen | |||
Ingangsdatum | T - 1 jaar | |||
Einddatum | T - 80 dagen | |||
Medicatieafspraak stop type | tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT') | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Reden wijzigen of staken | Verrichting gepland (code = '405613005' in codeSystem 'SNOMED CT') | |||
Geneesmiddel - primaire code | ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLETMSR 100MG (code = '103039' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 1 jaar, tot en met T - 80 dagen, 1 maal per dag 1 stuk, Oraal, tijdelijk gestopt | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_Lengte_Gewicht_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_Lengte_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_Lengte_Gewicht_VV_1 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_Lengte_Gewicht_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 1 jaar om 07:05 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 180 stuks | |||
Geneesmiddel - primaire code | ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLETMSR 100MG (code = '103039' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_Lengte_Gewicht_MA_1 | |||
MBH identificatie | MBH_920_Lengte_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_Lengte_Gewicht_TA_1 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_Lengte_Gewicht_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 1 jaar om 08:05 uur | |||
Gebruiksperiode | Vanaf T - 1 jaar | |||
Ingangsdatum | T - 1 jaar | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLETMSR 100MG (code = '103039' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 1 jaar, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_Lengte_Gewicht_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_Lengte_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_Lengte_Gewicht_TA_onderbreken | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_Lengte_Gewicht_TA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 80 dagen om 16:00 uur | |||
Gebruiksperiode | Vanaf T - 1 jaar, tot en met T - 80 dagen | |||
Ingangsdatum | T - 1 jaar | |||
Einddatum | T - 80 dagen | |||
Toedieningsafspraak stop type | tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT') | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_Jansen_en_Co | |||
Geneesmiddel - primaire code | ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLETMSR 100MG (code = '103039' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 1 jaar, tot en met T - 80 dagen, 1 maal per dag 1 stuk, Oraal, tijdelijk gestopt | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_Lengte_Gewicht_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_Lengte_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_Lengte_Gewicht_MVE_1 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_Lengte_Gewicht_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 1 jaar om 08:05 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 180 stuks | |||
Geneesmiddel - primaire code | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLETMSR 100MG (code = '103039' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_Lengte_Gewicht_VV_1 | |||
MBH identificatie | MBH_920_Lengte_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener Peter_van_Pulver | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
Zorgaanbieder Apotheek_De_Gulle_Gaper | ||||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
Organisatie naam | Apotheek De Gulle Gaper | |||
Zorgaanbieder Apotheek_Jansen_en_Co | ||||
Zorgaanbieder identificatienummer | 99901111 (in identificerend systeem: URA) | |||
Organisatie naam | Apotheek Jansen en Co |
1.13 Patiënt E. XXX_Doppen
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | E. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Doppen | |||
Identificatienummer | 999900511 [BSN] | |||
Geboortedatum | 24 okt 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.13.1 Medicamenteuze behandeling MBH_920_Lengte_Gewicht_2
Medicatieafspraak MBH_920_Lengte_Gewicht_2_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_Lengte_Gewicht_2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 1 jaar om 07:05 uur | |||
Gebruiksperiode | Vanaf T - 1 jaar, tot en met T - 120 dagen | |||
Ingangsdatum | T - 1 jaar | |||
Einddatum | T - 120 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLETMSR 100MG (code = '103039' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 1 jaar, tot en met T - 120 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_Lengte_Gewicht_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_Lengte_Gewicht_2_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_Lengte_Gewicht_2_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 1 jaar om 07:05 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 125 stuks | |||
Geneesmiddel - primaire code | ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLETMSR 100MG (code = '103039' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_Lengte_Gewicht_2_MA | |||
MBH identificatie | MBH_920_Lengte_Gewicht_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_Lengte_Gewicht_2_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_Lengte_Gewicht_2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 1 jaar om 08:05 uur | |||
Gebruiksperiode | Vanaf T - 1 jaar, tot en met T - 120 dagen | |||
Ingangsdatum | T - 1 jaar | |||
Einddatum | T - 120 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLETMSR 100MG (code = '103039' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 1 jaar, tot en met T - 120 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_Lengte_Gewicht_2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_Lengte_Gewicht_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_Lengte_Gewicht_2_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_Lengte_Gewicht_2_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 1 jaar om 08:05 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 125 stuks | |||
Geneesmiddel - primaire code | ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLETMSR 100MG (code = '103039' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_Lengte_Gewicht_2_VV | |||
MBH identificatie | MBH_920_Lengte_Gewicht_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener Peter_van_Pulver | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
Zorgaanbieder Apotheek_De_Gulle_Gaper | ||||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
Organisatie naam | Apotheek De Gulle Gaper |
1.14 Patiënt M. XXX_Raamsdonk
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | M. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Raamsdonk | |||
Identificatienummer | 999900924 [BSN] | |||
Geboortedatum | 6 nov 1985 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.14.1 Medicamenteuze behandeling MBH_920_volgens_afspraak
Medicatieafspraak MBH_920_volgens_afspraak_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_volgens_afspraak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 20 dagen om 10:00 uur | |||
Gebruiksperiode | Vanaf T - 20 dagen, gedurende 10 dagen | |||
Ingangsdatum | T - 20 dagen | |||
Gebruiksduur | 10 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '86991' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '129720' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 20 dagen, gedurende 10 dagen, 1 maal per dag 2 stuks, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
MBH identificatie | MBH_920_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_volgens_afspraak_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_volgens_afspraak_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 20 dagen om 10:00 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 20 stuks | |||
Geneesmiddel - primaire code | DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '86991' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '129720' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_volgens_afspraak_MA | |||
MBH identificatie | MBH_920_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_volgens_afspraak_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_volgens_afspraak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 20 dagen om 10:30 uur | |||
Gebruiksperiode | Vanaf T - 20 dagen, gedurende 10 dagen | |||
Ingangsdatum | T - 20 dagen | |||
Gebruiksduur | 10 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | PRADAXA CAPSULE 110MG (code = '1929461' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '86991' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '129720' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 20 dagen, gedurende 10 dagen, 1 maal per dag 2 stuks, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_volgens_afspraak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_volgens_afspraak_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_volgens_afspraak_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 20 dagen om 10:30 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 20 stuks | |||
Geneesmiddel - primaire code | PRADAXA CAPSULE 110MG (code = '1929461' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '86991' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '129720' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_volgens_afspraak_VV | |||
MBH identificatie | MBH_920_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_volgens_afspraak_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_volgens_afspraak_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T - 5 dagen om 18:20:05 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T - 20 dagen, gedurende 10 dagen | |||
Ingangsdatum | T - 20 dagen | |||
Gebruiksduur | 10 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Auteur | ||||
Auteur is patient | Ja | |||
Geneesmiddel - primaire code | PRADAXA CAPSULE 110MG (code = '1929461' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '86991' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '129720' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 20 dagen, gedurende 10 dagen, 1 maal per dag 2 stuks, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
Relatie toedieningsafspraak | ||||
Identificatie | MBH_920_volgens_afspraak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
MBH identificatie | MBH_920_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.14.2 Medicamenteuze behandeling MBH_920_niet_volgens_afspraak
Medicatieafspraak MBH_920_niet_volgens_afspraak_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_niet_volgens_afspraak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 30 dagen om 15:30 uur | |||
Gebruiksperiode | Vanaf T - 30 dagen | |||
Ingangsdatum | T - 30 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | SIMVASTATINE TABLET FO 20MG (code = '67814' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | SIMVASTATINE TABLET FO 20MG (code = '116580' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 30 dagen, 1 maal per dag 2 stuks, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
MBH identificatie | MBH_920_niet_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_niet_volgens_afspraak_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_niet_volgens_afspraak_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 30 dagen om 15:30 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 90 stuks | |||
Geneesmiddel - primaire code | SIMVASTATINE TABLET FO 20MG (code = '67814' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | SIMVASTATINE TABLET FO 20MG (code = '116580' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_niet_volgens_afspraak_MA | |||
MBH identificatie | MBH_920_niet_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_niet_volgens_afspraak_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_niet_volgens_afspraak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 30 dagen om 16:00 uur | |||
Gebruiksperiode | Vanaf T - 30 dagen | |||
Ingangsdatum | T - 30 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | SIMVASTATINE SANDOZ TABLET FILMOMHULD 20MG (code = '1592661' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | SIMVASTATINE TABLET FO 20MG (code = '67814' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | SIMVASTATINE TABLET FO 20MG (code = '116580' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 30 dagen, 1 maal per dag 2 stuks, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_niet_volgens_afspraak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_niet_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_niet_volgens_afspraak_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_niet_volgens_afspraak_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 30 dagen om 16:00 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 90 stuks | |||
Geneesmiddel - primaire code | SIMVASTATINE SANDOZ TABLET FILMOMHULD 20MG (code = '1592661' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | SIMVASTATINE TABLET FO 20MG (code = '67814' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | SIMVASTATINE TABLET FO 20MG (code = '116580' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_niet_volgens_afspraak_VV | |||
MBH identificatie | MBH_920_niet_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_niet_volgens_afspraak_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_niet_volgens_afspraak_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T - 19 dagen om 10:00 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Nee | |||
Gebruiksperiode | Vanaf T - 30 dagen, tot en met T - 20 dagen | |||
Ingangsdatum | T - 30 dagen | |||
Einddatum | T - 20 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Auteur | ||||
Auteur is patient | Ja | |||
Geneesmiddel - primaire code | SIMVASTATINE TABLET FO 20MG (code = '67814' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | SIMVASTATINE TABLET FO 20MG (code = '116580' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 30 dagen, tot en met T - 20 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_niet_volgens_afspraak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_niet_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.14.3 Medicamenteuze behandeling MBH_920_geen_gebruik_niet_volgens_afspraak
Medicatieafspraak MBH_920_geen_gebruik_niet_volgens_afspraak_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_geen_gebruik_niet_volgens_afspraak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 14 dagen om 12:30 uur | |||
Gebruiksperiode | Vanaf T - 14 dagen | |||
Ingangsdatum | T - 14 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 14 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_geen_gebruik_niet_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_geen_gebruik_niet_volgens_afspraak_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_geen_gebruik_niet_volgens_afspraak_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 14 dagen om 12:30 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 90 stuks | |||
Geneesmiddel - primaire code | HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_geen_gebruik_niet_volgens_afspraak_MA | |||
MBH identificatie | MBH_920_geen_gebruik_niet_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_geen_gebruik_niet_volgens_afspraak_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_geen_gebruik_niet_volgens_afspraak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 14 dagen om 13:00 uur | |||
Gebruiksperiode | Vanaf T - 14 dagen | |||
Ingangsdatum | T - 14 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | HYDROCHLOORTHIAZIDE APOTEX TABLET 12,5MG (code = '2530104' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 14 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_geen_gebruik_niet_volgens_afspraak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_geen_gebruik_niet_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_geen_gebruik_niet_volgens_afspraak_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_geen_gebruik_niet_volgens_afspraak_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 14 dagen om 13:00 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 90 stuks | |||
Geneesmiddel - primaire code | HYDROCHLOORTHIAZIDE APOTEX TABLET 12,5MG (code = '2530104' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_geen_gebruik_niet_volgens_afspraak_VV | |||
MBH identificatie | MBH_920_geen_gebruik_niet_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_geen_gebruik_niet_volgens_afspraak_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_geen_gebruik_niet_volgens_afspraak_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T - 4 dagen om 08:00 uur | |||
Gebruik indicator | Nee | |||
Volgens afspraak indicator | Nee | |||
Gebruiksperiode | Vanaf T - 6 dagen, tot en met T - 5 dagen | |||
Ingangsdatum | T - 6 dagen | |||
Einddatum | T - 5 dagen | |||
Medicatie gebruik stop type | tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT') | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | HYDROCHLOORTHIAZIDE APOTEX TABLET 12,5MG (code = '2530104' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 6 dagen, tot en met T - 5 dagen, geneesmiddel niet in gebruik, tijdelijk gestopt | |||
Relatie toedieningsafspraak | ||||
Identificatie | MBH_920_geen_gebruik_niet_volgens_afspraak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
MBH identificatie | MBH_920_geen_gebruik_niet_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.14.4 Medicamenteuze behandeling MBH_920_geen_gebruik_volgens_afspraak
Medicatieafspraak MBH_920_geen_gebruik_volgens_afspraak_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_geen_gebruik_volgens_afspraak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 100 dagen om 08:30 uur | |||
Gebruiksperiode | Vanaf T - 100 dagen | |||
Ingangsdatum | T - 100 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 100 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_geen_gebruik_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieafspraak MBH_920_geen_gebruik_volgens_afspraak_stopMA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_geen_gebruik_volgens_afspraak_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 20 dagen om 08:20:05 uur | |||
Gebruiksperiode | Vanaf T - 100 dagen, tot en met T - 20 dagen | |||
Ingangsdatum | T - 100 dagen | |||
Einddatum | T - 20 dagen | |||
Medicatieafspraak stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Reden wijzigen of staken | Drug treatment not indicated (situation) (code = '183966005' in codeSystem 'SNOMED CT') | |||
Geneesmiddel - primaire code | HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 100 dagen, tot en met T - 20 dagen, 1 maal per dag 1 stuk, oraal, definitief gestopt | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_geen_gebruik_volgens_afspraak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_geen_gebruik_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_geen_gebruik_volgens_afspraak_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_geen_gebruik_volgens_afspraak_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 100 dagen om 08:30 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 90 stuks | |||
Geneesmiddel - primaire code | HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_geen_gebruik_volgens_afspraak_MA | |||
MBH identificatie | MBH_920_geen_gebruik_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_geen_gebruik_volgens_afspraak_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_geen_gebruik_volgens_afspraak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 100 dagen om 09:00 uur | |||
Gebruiksperiode | Vanaf T - 100 dagen | |||
Ingangsdatum | T - 100 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | HYDROCHLOORTHIAZIDE APOTEX TABLET 12,5MG (code = '2530104' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 100 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_geen_gebruik_volgens_afspraak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_geen_gebruik_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_geen_gebruik_volgens_afspraak_stopTA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_geen_gebruik_volgens_afspraak_stopTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 20 dagen om 08:20:05 uur | |||
Gebruiksperiode | Vanaf T - 100 dagen, tot en met T - 20 dagen | |||
Ingangsdatum | T - 100 dagen | |||
Einddatum | T - 20 dagen | |||
Toedieningsafspraak stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | HYDROCHLOORTHIAZIDE APOTEX TABLET 12,5MG (code = '2530104' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 100 dagen, tot en met T - 20 dagen, 1 maal per dag 1 stuk, oraal, definitief gestopt | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_geen_gebruik_volgens_afspraak_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_geen_gebruik_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_geen_gebruik_volgens_afspraak_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_geen_gebruik_volgens_afspraak_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 100 dagen om 09:00 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 90 stuks | |||
Geneesmiddel - primaire code | HYDROCHLOORTHIAZIDE APOTEX TABLET 12,5MG (code = '2530104' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_geen_gebruik_volgens_afspraak_VV | |||
MBH identificatie | MBH_920_geen_gebruik_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_geen_gebruik_volgens_afspraak_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_geen_gebruik_volgens_afspraak_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T - 10 dagen om 12:00 uur | |||
Gebruik indicator | Nee | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T - 19 dagen | |||
Ingangsdatum | T - 19 dagen | |||
Medicatie gebruik stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Auteur | ||||
Auteur is patient | Ja | |||
Geneesmiddel - primaire code | HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 19 dagen, geneesmiddel niet in gebruik, definitief gestopt | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_geen_gebruik_volgens_afspraak_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_geen_gebruik_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.14.5 Medicamenteuze behandeling MBH_920_zelfzorgmedicatie
Medicatieafspraak MBH_920_zelfzorgmedicatie_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_zelfzorgmedicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 79 dagen om 08:30 uur | |||
Gebruiksperiode | Vanaf T - 90 dagen, gedurende 30 dagen | |||
Ingangsdatum | T - 90 dagen | |||
Gebruiksduur | 30 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | CETIRIZINE TABLET 10MG (code = '26298' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | CETIRIZINE TABLET 10MG (code = '71218' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 90 dagen, gedurende 30 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Toelichting | Patiënt koopt zelfzorgmedicatie bij drogist. | |||
Relatie medicatiegebruik | ||||
Identificatie | MBH_920_zelfzorgmedicatie_MBG (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
MBH identificatie | MBH_920_zelfzorgmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_zelfzorgmedicatie_MBG | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_zelfzorgmedicatie_MBG (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T - 80 dagen om 20:30:10 uur | |||
Gebruik indicator | Ja | |||
Gebruiksperiode | Vanaf T - 90 dagen, gedurende 10 dagen | |||
Ingangsdatum | T - 90 dagen | |||
Gebruiksduur | 10 dagen | |||
Auteur | ||||
Auteur is patient | Ja | |||
Geneesmiddel - primaire code | PREVALIN ALLERSTOP CETIRIZINE TABLET FILMOMH 10MG (code = '2497905' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | CETIRIZINE TABLET 10MG (code = '26298' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | CETIRIZINE TABLET 10MG (code = '71218' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 90 dagen, gedurende 10 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_zelfzorgmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener Peter_van_Pulver | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
Zorgaanbieder Apotheek_De_Gulle_Gaper | ||||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
Organisatie naam | Apotheek De Gulle Gaper |
1.15 Patiënt G. XXX_Hemsbergen
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Hemsbergen | |||
Identificatienummer | 999900602 [BSN] | |||
Geboortedatum | 2 nov 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.15.1 Medicamenteuze behandeling MBH_920_variabelefrequentie
Medicatieafspraak MBH_920_variabelefrequentie_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_variabelefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 08:00 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 16 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 16 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 16 dagen, 1 à 2 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 à 2 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_variabelefrequentie_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_variabelefrequentie_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T om 08:00 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 90 stuks | |||
Geneesmiddel - primaire code | MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_variabelefrequentie_MA | |||
MBH identificatie | MBH_920_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_variabelefrequentie_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_variabelefrequentie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 09:00 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 16 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 16 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Geneesmiddel - primaire code | MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 16 dagen, 1 à 2 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 à 2 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_variabelefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_variabelefrequentie_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_variabelefrequentie_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T om 09:00 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Verstrekte hoeveelheid | 90 stuks | |||
Geneesmiddel - primaire code | MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_variabelefrequentie_VV | |||
MBH identificatie | MBH_920_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_variabelefrequentie_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_variabelefrequentie_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T + 16 dagen om 16:00 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T, tot en met T + 16 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 16 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 16 dagen, 1 à 2 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 à 2 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_variabelefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Relatie toedieningsafspraak | ||||
Identificatie | MBH_920_variabelefrequentie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
MBH identificatie | MBH_920_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.15.2 Medicamenteuze behandeling MBH_920_interval
Medicatieafspraak MBH_920_interval_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_interval_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 08:04 uur | |||
Gebruiksperiode | Vanaf T | |||
Ingangsdatum | T | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, iedere 8 uur 1 stuk , let op! Tijden exact aanhouden., Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | iedere 8 uur 1 stuk , let op! Tijden exact aanhouden. | |||
MBH identificatie | MBH_920_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_interval_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_interval_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T om 08:04 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 90 stuks | |||
Geneesmiddel - primaire code | AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_interval_MA | |||
MBH identificatie | MBH_920_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_interval_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_interval_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 09:04 uur | |||
Gebruiksperiode | Vanaf T | |||
Ingangsdatum | T | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Geneesmiddel - primaire code | AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, iedere 8 uur 1 stuk , let op! Tijden exact aanhouden., Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | iedere 8 uur 1 stuk , let op! Tijden exact aanhouden. | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_interval_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_interval_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_interval_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T om 09:04 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Verstrekte hoeveelheid | 90 stuks | |||
Geneesmiddel - primaire code | AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_interval_VV | |||
MBH identificatie | MBH_920_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_interval_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_interval_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T + 16 dagen om 23:59:59 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T, tot en met T + 16 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 16 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 16 dagen, iedere 8 uur 1 stuk , let op! Tijden exact aanhouden., Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | iedere 8 uur 1 stuk , let op! Tijden exact aanhouden. | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_interval_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.15.3 Medicamenteuze behandeling MBH_920_variabelehoeveelheid
Medicatieafspraak MBH_920_variabelehoeveelheid_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_variabelehoeveelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 08:10 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 28 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 28 dagen, 3 maal per dag 1 à 2 stuks, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 3 maal per dag 1 à 2 stuks | |||
MBH identificatie | MBH_920_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_variabelehoeveelheid_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_variabelehoeveelheid_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T om 08:10 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 100 stuks | |||
Geneesmiddel - primaire code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_variabelehoeveelheid_MA | |||
MBH identificatie | MBH_920_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_variabelehoeveelheid_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_variabelehoeveelheid_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 09:10 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 28 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Geneesmiddel - primaire code | PARACETAMOL AURO TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 28 dagen, 3 maal per dag 1 à 2 stuks, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 3 maal per dag 1 à 2 stuks | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_variabelehoeveelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_variabelehoeveelheid_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_variabelehoeveelheid_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T om 09:10 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Verstrekte hoeveelheid | 100 stuks | |||
Geneesmiddel - primaire code | PARACETAMOL AURO TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_variabelehoeveelheid_VV | |||
MBH identificatie | MBH_920_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_variabelehoeveelheid_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_variabelehoeveelheid_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T + 14 dagen om 23:59:59 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T, tot en met T + 14 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 14 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 14 dagen, 3 maal per dag 1 à 2 stuks, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 3 maal per dag 1 à 2 stuks | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_variabelehoeveelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.15.4 Medicamenteuze behandeling MBH_920_zonderkeerdosis
Medicatieafspraak MBH_920_zonderkeerdosis_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_zonderkeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 08:12 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 28 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 28 dagen, 3 maal per dag, aanbrengen, cutaan | |||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | |||
Aanvullende instructie | aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | |||
Doseerinstructie | 3 maal per dag | |||
MBH identificatie | MBH_920_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_zonderkeerdosis_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_zonderkeerdosis_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T om 08:12 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 1 stuk | |||
Geneesmiddel - primaire code | Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_zonderkeerdosis_MA | |||
MBH identificatie | MBH_920_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_zonderkeerdosis_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_zonderkeerdosis_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 09:12 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 28 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Geneesmiddel - primaire code | CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 28 dagen, 3 maal per dag, aanbrengen, cutaan | |||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | |||
Aanvullende instructie | aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | |||
Doseerinstructie | 3 maal per dag | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_zonderkeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_zonderkeerdosis_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_zonderkeerdosis_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T om 09:12 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Verstrekte hoeveelheid | 1 stuk | |||
Geneesmiddel - primaire code | CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_zonderkeerdosis_VV | |||
MBH identificatie | MBH_920_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_zonderkeerdosis_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_zonderkeerdosis_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T + 21 dagen om 23:59:59 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T, tot en met T + 21 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 21 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 21 dagen, 3 maal per dag, aanbrengen, cutaan | |||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | |||
Aanvullende instructie | aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | |||
Doseerinstructie | 3 maal per dag | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_zonderkeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener Peter_van_Pulver | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
Zorgaanbieder Apotheek_de_Gulle_Gaper | ||||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
Organisatie naam | Apotheek de Gulle Gaper |
1.16 Patiënt G. XXX_Hemsbergen
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Hemsbergen | |||
Identificatienummer | 999900602 [BSN] | |||
Geboortedatum | 2 nov 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.16.1 Medicamenteuze behandeling MBH_920_bijzonderekeerdosis
Medicatieafspraak MBH_920_bijzonderekeerdosis_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_bijzonderekeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 08:15 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 28 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 28 dagen, 2 maal per dag 0.5 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 2 maal per dag 0.5 stuk | |||
MBH identificatie | MBH_920_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_bijzonderekeerdosis_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_bijzonderekeerdosis_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T om 08:15 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 30 stuks | |||
Geneesmiddel - primaire code | NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_bijzonderekeerdosis_MA | |||
MBH identificatie | MBH_920_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_bijzonderekeerdosis_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_bijzonderekeerdosis_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 09:15 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 28 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Geneesmiddel - primaire code | NAPROXEN APOTEX TABLET 500MG (code = '1137778' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 28 dagen, 2 maal per dag 0.5 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 2 maal per dag 0.5 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_bijzonderekeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_bijzonderekeerdosis_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_bijzonderekeerdosis_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T om 09:15 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Verstrekte hoeveelheid | 30 stuks | |||
Geneesmiddel - primaire code | NAPROXEN APOTEX TABLET 500MG (code = '1137778' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_bijzonderekeerdosis_VV | |||
MBH identificatie | MBH_920_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_bijzonderekeerdosis_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_bijzonderekeerdosis_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T + 14 dagen om 23:59:59 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T, tot en met T + 14 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 14 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 14 dagen, 2 maal per dag 0.5 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 2 maal per dag 0.5 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_bijzonderekeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.16.2 Medicamenteuze behandeling MBH_920_variabelehoeveelheid2
Medicatieafspraak MBH_920_variabelehoeveelheid2_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_variabelehoeveelheid2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 08:18 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 28 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72664' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 28 dagen, 2 maal per dag 10 à 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen, OROMUCOSAAL | |||
Toedieningsweg | OROMUCOSAAL (code = '34' in codeSystem 'G-Standaard Toedieningswegen') | |||
Aanvullende instructie | Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | |||
Aanvullende instructie | mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') | |||
Doseerinstructie | 2 maal per dag 10 à 15 ml | |||
MBH identificatie | MBH_920_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_variabelehoeveelheid2_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_variabelehoeveelheid2_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T om 08:18 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 450 ml | |||
Geneesmiddel - primaire code | WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72664' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_variabelehoeveelheid2_MA | |||
MBH identificatie | MBH_920_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_variabelehoeveelheid2_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_variabelehoeveelheid2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 09:18 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 28 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Geneesmiddel - primaire code | WATERSTOFPEROXIDE 3% CONC VOOR MONDSP FNA MR (code = '261815' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72994' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 28 dagen, 2 maal per dag 10 à 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen, OROMUCOSAAL | |||
Toedieningsweg | OROMUCOSAAL (code = '34' in codeSystem 'G-Standaard Toedieningswegen') | |||
Aanvullende instructie | Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | |||
Aanvullende instructie | mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') | |||
Doseerinstructie | 2 maal per dag 10 à 15 ml | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_variabelehoeveelheid2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_variabelehoeveelheid2_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_variabelehoeveelheid2_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T om 09:18 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Verstrekte hoeveelheid | 450 ml | |||
Geneesmiddel - primaire code | WATERSTOFPEROXIDE 3% CONC VOOR MONDSP FNA MR (code = '261815' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72994' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_variabelehoeveelheid2_VV | |||
MBH identificatie | MBH_920_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_variabelehoeveelheid2_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_variabelehoeveelheid2_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T + 21 dagen om 23:59:59 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T, tot en met T + 21 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 21 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72664' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 21 dagen, 2 maal per dag 10 à 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen, OROMUCOSAAL | |||
Toedieningsweg | OROMUCOSAAL (code = '34' in codeSystem 'G-Standaard Toedieningswegen') | |||
Aanvullende instructie | Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | |||
Aanvullende instructie | mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') | |||
Doseerinstructie | 2 maal per dag 10 à 15 ml | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_variabelehoeveelheid2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.16.3 Medicamenteuze behandeling MBH_920_tijdstippen_flexibel
Medicatieafspraak MBH_920_tijdstippen_flexibel_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_tijdstippen_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 08:24 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 14 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 14 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 14 dagen, elke dag om 08:00, 14:00 en 20:00 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | elke dag om 08:00, 14:00 en 20:00 1 stuk | |||
MBH identificatie | MBH_920_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_tijdstippen_flexibel_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_tijdstippen_flexibel_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T om 08:24 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 42 stuks | |||
Geneesmiddel - primaire code | METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_tijdstippen_flexibel_MA | |||
MBH identificatie | MBH_920_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_tijdstippen_flexibel_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_tijdstippen_flexibel_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 09:24 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 14 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 14 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Geneesmiddel - primaire code | METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 14 dagen, elke dag om 08:00, 14:00 en 20:00 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | elke dag om 08:00, 14:00 en 20:00 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_tijdstippen_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_tijdstippen_flexibel_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_tijdstippen_flexibel_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T om 09:24 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Verstrekte hoeveelheid | 42 stuks | |||
Geneesmiddel - primaire code | METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_tijdstippen_flexibel_VV | |||
MBH identificatie | MBH_920_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_tijdstippen_flexibel_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_tijdstippen_flexibel_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T + 14 dagen om 23:59:59 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T, tot en met T + 14 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 14 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 14 dagen, elke dag om 08:00, 14:00 en 20:00 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | elke dag om 08:00, 14:00 en 20:00 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_tijdstippen_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.16.4 Medicamenteuze behandeling MBH_920_weekdagen
Medicatieafspraak MBH_920_weekdagen_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_weekdagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 08:25 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 70 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 70 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 70 dagen, op maandag, woensdag en vrijdag, voor de nacht, aanbrengen, cutaan | |||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | |||
Aanvullende instructie | voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | |||
Aanvullende instructie | aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | |||
Doseerinstructie | op maandag, woensdag en vrijdag | |||
MBH identificatie | MBH_920_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_weekdagen_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_weekdagen_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T om 08:25 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 30 stuks | |||
Geneesmiddel - primaire code | IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_weekdagen_MA | |||
MBH identificatie | MBH_920_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_weekdagen_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_weekdagen_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 09:25 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 70 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 70 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Geneesmiddel - primaire code | ALDARA CREME 50MG/G IN SACHET (code = '1198521' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 70 dagen, op maandag, woensdag en vrijdag, voor de nacht, aanbrengen, cutaan | |||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | |||
Aanvullende instructie | voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | |||
Aanvullende instructie | aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | |||
Doseerinstructie | op maandag, woensdag en vrijdag | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_weekdagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_weekdagen_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_weekdagen_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T om 09:25 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Verstrekte hoeveelheid | 30 stuks | |||
Geneesmiddel - primaire code | ALDARA CREME 50MG/G IN SACHET (code = '1198521' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_weekdagen_VV | |||
MBH identificatie | MBH_920_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_weekdagen_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_weekdagen_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T + 14 dagen om 23:59:59 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T, tot en met T + 14 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 14 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 14 dagen, op maandag, woensdag en vrijdag, voor de nacht, aanbrengen, cutaan | |||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | |||
Aanvullende instructie | voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | |||
Aanvullende instructie | aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | |||
Doseerinstructie | op maandag, woensdag en vrijdag | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_weekdagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener Peter_van_Pulver | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
Zorgaanbieder Apotheek_de_Gulle_Gaper | ||||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
Organisatie naam | Apotheek de Gulle Gaper |
1.17 Patiënt G. XXX_Hemsbergen
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Hemsbergen | |||
Identificatienummer | 999900602 [BSN] | |||
Geboortedatum | 2 nov 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.17.1 Medicamenteuze behandeling MBH_920_dagdeel
Medicatieafspraak MBH_920_dagdeel_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_dagdeel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 08:27 uur | |||
Gebruiksperiode | Vanaf T | |||
Ingangsdatum | T | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, 1 stuk 's avonds, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 stuk 's avonds | |||
MBH identificatie | MBH_920_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_dagdeel_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_dagdeel_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T om 08:27 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 60 stuks | |||
Geneesmiddel - primaire code | EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_dagdeel_MA | |||
MBH identificatie | MBH_920_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_dagdeel_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_dagdeel_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 09:27 uur | |||
Gebruiksperiode | Vanaf T | |||
Ingangsdatum | T | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Geneesmiddel - primaire code | INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, 1 stuk 's avonds, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 stuk 's avonds | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_dagdeel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_dagdeel_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_dagdeel_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T om 09:27 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Verstrekte hoeveelheid | 60 stuks | |||
Geneesmiddel - primaire code | INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_dagdeel_VV | |||
MBH identificatie | MBH_920_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_dagdeel_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_dagdeel_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T + 14 dagen om 23:59:59 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T, tot en met T + 14 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 14 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 14 dagen, 1 stuk 's avonds, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 stuk 's avonds | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_dagdeel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.17.2 Medicamenteuze behandeling MBH_920_cyclischschema
Medicatieafspraak MBH_920_cyclischschema_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_cyclischschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 08:33 uur | |||
Gebruiksperiode | Vanaf T | |||
Ingangsdatum | T | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, cyclus van 28 dagen: steeds gedurende 21 dagen 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | gedurende 21 dagen 1 maal per dag 1 stuk | |||
Herhaalperiode cyclisch schema | 28 dagen | |||
MBH identificatie | MBH_920_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_cyclischschema_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_cyclischschema_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T om 08:33 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 126 stuks | |||
Geneesmiddel - primaire code | ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_cyclischschema_MA | |||
MBH identificatie | MBH_920_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_cyclischschema_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_cyclischschema_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 09:33 uur | |||
Gebruiksperiode | Vanaf T | |||
Ingangsdatum | T | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Geneesmiddel - primaire code | Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, cyclus van 28 dagen: steeds gedurende 21 dagen 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | gedurende 21 dagen 1 maal per dag 1 stuk | |||
Herhaalperiode cyclisch schema | 28 dagen | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_cyclischschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_cyclischschema_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_cyclischschema_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T om 09:33 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Verstrekte hoeveelheid | 126 stuks | |||
Geneesmiddel - primaire code | MARVELON TABLET (code = '416681' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_cyclischschema_VV | |||
MBH identificatie | MBH_920_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_cyclischschema_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_cyclischschema_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T + 14 dagen om 23:59:59 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T, tot en met T + 14 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 14 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 14 dagen, cyclus van 28 dagen: steeds gedurende 21 dagen 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | gedurende 21 dagen 1 maal per dag 1 stuk | |||
Herhaalperiode cyclisch schema | 28 dagen | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_cyclischschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.17.3 Medicamenteuze behandeling MBH_920_afbouwschema
Medicatieafspraak MBH_920_afbouwschema_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_afbouwschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 08:40 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 41 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 41 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 41 dagen, eerst gedurende 2 weken 1 maal per dag 3 gram, dan gedurende 3 weken 1 maal per dag 2 gram, dan gedurende 6 dagen 1 maal per dag 1 gram, cutaan | |||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie 1 | eerst gedurende 2 weken 1 maal per dag 3 gram | |||
Doseerinstructie 2 | dan gedurende 3 weken 1 maal per dag 2 gram | |||
Doseerinstructie 3 | dan gedurende 6 dagen 1 maal per dag 1 gram | |||
MBH identificatie | MBH_920_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_afbouwschema_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_afbouwschema_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T om 08:40 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 90 gram | |||
Geneesmiddel - primaire code | Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_afbouwschema_MA | |||
MBH identificatie | MBH_920_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_afbouwschema_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_afbouwschema_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 09:40 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 41 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 41 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Geneesmiddel - primaire code | AFFUSINE CREME 20MG/G (code = '2292556' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 41 dagen, eerst gedurende 2 weken 1 maal per dag 3 gram, dan gedurende 3 weken 1 maal per dag 2 gram, dan gedurende 6 dagen 1 maal per dag 1 gram, cutaan | |||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie 1 | eerst gedurende 2 weken 1 maal per dag 3 gram | |||
Doseerinstructie 2 | dan gedurende 3 weken 1 maal per dag 2 gram | |||
Doseerinstructie 3 | dan gedurende 6 dagen 1 maal per dag 1 gram | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_afbouwschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_afbouwschema_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_afbouwschema_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T om 09:40 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Verstrekte hoeveelheid | 90 gram | |||
Geneesmiddel - primaire code | AFFUSINE CREME 20MG/G (code = '2292556' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_afbouwschema_VV | |||
MBH identificatie | MBH_920_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_afbouwschema_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_afbouwschema_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T + 21 dagen om 23:59:59 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T, tot en met T + 21 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 21 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 21 dagen, eerst gedurende 2 weken 1 maal per dag 3 gram, dan gedurende 3 weken 1 maal per dag 2 gram, dan gedurende 6 dagen 1 maal per dag 1 gram, cutaan | |||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie 1 | eerst gedurende 2 weken 1 maal per dag 3 gram | |||
Doseerinstructie 2 | dan gedurende 3 weken 1 maal per dag 2 gram | |||
Doseerinstructie 3 | dan gedurende 6 dagen 1 maal per dag 1 gram | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_afbouwschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.17.4 Medicamenteuze behandeling MBH_920_variabelehoeveelheidenmaximum
Medicatieafspraak MBH_920_variabelehoeveelheidenmaximum_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_variabelehoeveelheidenmaximum_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 08:45 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 21 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 21 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 21 dagen, Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag | |||
MBH identificatie | MBH_920_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_variabelehoeveelheidenmaximum_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_variabelehoeveelheidenmaximum_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T om 08:45 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 120 stuks | |||
Geneesmiddel - primaire code | CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_variabelehoeveelheidenmaximum_MA | |||
MBH identificatie | MBH_920_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_variabelehoeveelheidenmaximum_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_variabelehoeveelheidenmaximum_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 09:45 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 21 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 21 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Geneesmiddel - primaire code | CODEINEFOSFAAT PCH TABLET 10MG (code = '874965' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 21 dagen, Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_variabelehoeveelheidenmaximum_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_variabelehoeveelheidenmaximum_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_variabelehoeveelheidenmaximum_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T om 09:45 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Verstrekte hoeveelheid | 120 stuks | |||
Geneesmiddel - primaire code | CODEINEFOSFAAT PCH TABLET 10MG (code = '874965' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_variabelehoeveelheidenmaximum_VV | |||
MBH identificatie | MBH_920_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_variabelehoeveelheidenmaximum_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_variabelehoeveelheidenmaximum_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T + 21 dagen om 23:59:59 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T, tot en met T + 21 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 21 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 21 dagen, Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_variabelehoeveelheidenmaximum_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener Peter_van_Pulver | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
Zorgaanbieder Apotheek_de_Gulle_Gaper | ||||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
Organisatie naam | Apotheek de Gulle Gaper |
1.18 Patiënt G. XXX_Hemsbergen
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Hemsbergen | |||
Identificatienummer | 999900602 [BSN] | |||
Geboortedatum | 2 nov 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.18.1 Medicamenteuze behandeling MBH_920_toedieningssnelheid
Medicatieafspraak MBH_920_toedieningssnelheid_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_toedieningssnelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 08:47 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 8 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 8 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 8 dagen, toedieningssnelheid: maximaal 0.2 à 0.5 ml per uur, parenteraal | |||
Toedieningsweg | parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | toedieningssnelheid: maximaal 0.2 à 0.5 ml per uur | |||
MBH identificatie | MBH_920_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_toedieningssnelheid_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_toedieningssnelheid_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T om 08:47 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 100 ml | |||
Geneesmiddel - primaire code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_toedieningssnelheid_MA | |||
MBH identificatie | MBH_920_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_toedieningssnelheid_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_toedieningssnelheid_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 09:47 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 8 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 8 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Geneesmiddel - primaire code | MORFINEHYDROCHLORIDE 1ML= 5MG EPI CAS 100ML FNA MR (code = '779288' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 8 dagen, toedieningssnelheid: maximaal 0.2 à 0.5 ml per uur, parenteraal | |||
Toedieningsweg | parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | toedieningssnelheid: maximaal 0.2 à 0.5 ml per uur | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_toedieningssnelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_toedieningssnelheid_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_toedieningssnelheid_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T om 09:47 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Verstrekte hoeveelheid | 100 ml | |||
Geneesmiddel - primaire code | MORFINEHYDROCHLORIDE 1ML= 5MG EPI CAS 100ML FNA MR (code = '779288' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_toedieningssnelheid_VV | |||
MBH identificatie | MBH_920_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_toedieningssnelheid_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_toedieningssnelheid_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatiegebruik datum tijd | T + 8 dagen om 23:59:59 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T, tot en met T + 8 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 8 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 8 dagen, toedieningssnelheid: maximaal 0.2 à 0.5 ml per uur, parenteraal | |||
Toedieningsweg | parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | toedieningssnelheid: maximaal 0.2 à 0.5 ml per uur | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_toedieningssnelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.18.2 Medicamenteuze behandeling MBH_920_toedieningsduur
Medicatieafspraak MBH_920_toedieningsduur_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_toedieningsduur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 08:49 uur | |||
Gebruiksperiode | Vanaf T | |||
Ingangsdatum | T | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '98477' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, 1 maal per dag 1 stuk, transdermaal | |||
Toedieningsweg | transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_toedieningsduur_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_toedieningsduur_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T om 08:49 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 30 stuks | |||
Geneesmiddel - primaire code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '98477' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_toedieningsduur_MA | |||
MBH identificatie | MBH_920_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_toedieningsduur_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_toedieningsduur_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 09:49 uur | |||
Gebruiksperiode | Vanaf T | |||
Ingangsdatum | T | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Geneesmiddel - primaire code | DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '98477' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, 1 maal per dag 1 stuk, transdermaal | |||
Toedieningsweg | transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_toedieningsduur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_toedieningsduur_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_toedieningsduur_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T om 09:49 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Verstrekte hoeveelheid | 30 stuks | |||
Geneesmiddel - primaire code | DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '98477' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_toedieningsduur_VV | |||
MBH identificatie | MBH_920_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_toedieningsduur_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_toedieningsduur_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatiegebruik datum tijd | T + 14 dagen om 12:00 uur | |||
Gebruik indicator | Ja | |||
Gebruiksperiode | Vanaf T, tot en met T + 14 dagen om 12:00 uur | |||
Ingangsdatum | T | |||
Einddatum | T + 14 dagen om 12:00 uur | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '98477' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 14 dagen om 12:00 uur, 1 maal per dag 1 stuk, transdermaal | |||
Toedieningsweg | transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_toedieningsduur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.18.3 Medicamenteuze behandeling MBH_920_zonodig
Medicatieafspraak MBH_920_zonodig_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_zonodig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 08:57 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 27 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 27 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | ACETYLSALICYLZUUR 100MG TAB (code = '3956' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 27 dagen, Zo nodig 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | Zo nodig 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_zonodig_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_zonodig_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T om 08:57 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 14 stuks | |||
Geneesmiddel - primaire code | ACETYLSALICYLZUUR 100MG TAB (code = '3956' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_zonodig_MA | |||
MBH identificatie | MBH_920_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_zonodig_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_zonodig_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 09:57 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 27 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 27 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Geneesmiddel - primaire code | ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR 100MG TAB (code = '3956' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 27 dagen, Zo nodig 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | Zo nodig 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_zonodig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_zonodig_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_zonodig_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T om 09:57 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Verstrekte hoeveelheid | 14 stuks | |||
Geneesmiddel - primaire code | ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR 100MG TAB (code = '3956' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_zonodig_VV | |||
MBH identificatie | MBH_920_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_zonodig_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_zonodig_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T + 14 dagen om 23:59:59 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T, tot en met T + 14 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 14 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | ACETYLSALICYLZUUR 100MG TAB (code = '3956' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 14 dagen, Zo nodig 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | Zo nodig 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_zonodig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.18.4 Medicamenteuze behandeling MBH_920_tijdstippen_niet_flexibel
Medicatieafspraak MBH_920_tijdstippen_niet_flexibel_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_tijdstippen_niet_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 09:15 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 7 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 7 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 7 dagen, elke dag om 09:00, 12:00 en 15:00 1 stuk , let op! Tijden exact aanhouden., oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | elke dag om 09:00, 12:00 en 15:00 1 stuk , let op! Tijden exact aanhouden. | |||
MBH identificatie | MBH_920_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_tijdstippen_niet_flexibel_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_tijdstippen_niet_flexibel_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T om 09:15 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 21 stuks | |||
Geneesmiddel - primaire code | METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_tijdstippen_niet_flexibel_MA | |||
MBH identificatie | MBH_920_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_tijdstippen_niet_flexibel_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_tijdstippen_niet_flexibel_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 10:15 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Geneesmiddel - primaire code | METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | elke dag om 09:00, 12:00 en 15:00 1 stuk , let op! Tijden exact aanhouden., oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | elke dag om 09:00, 12:00 en 15:00 1 stuk , let op! Tijden exact aanhouden. | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_tijdstippen_niet_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_tijdstippen_niet_flexibel_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_tijdstippen_niet_flexibel_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T om 10:17 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | |||
Verstrekte hoeveelheid | 21 stuks | |||
Geneesmiddel - primaire code | METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_tijdstippen_niet_flexibel_VV | |||
MBH identificatie | MBH_920_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_tijdstippen_niet_flexibel_MGB | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_tijdstippen_niet_flexibel_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
Medicatiegebruik datum tijd | T + 7 dagen om 16:00 uur | |||
Gebruik indicator | Ja | |||
Volgens afspraak indicator | Ja | |||
Gebruiksperiode | Vanaf T, tot en met T + 7 dagen om 15:00 uur | |||
Ingangsdatum | T | |||
Einddatum | T + 7 dagen om 15:00 uur | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Informant | ||||
Informant is patient | Ja | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 7 dagen om 15:00 uur, elke dag om 09:00, 12:00 en 15:00 1 stuk , let op! Tijden exact aanhouden. | |||
Doseerinstructie | elke dag om 09:00, 12:00 en 15:00 1 stuk , let op! Tijden exact aanhouden. | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_tijdstippen_niet_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener Peter_van_Pulver | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
Zorgaanbieder Apotheek_de_Gulle_Gaper | ||||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
Organisatie naam | Apotheek de Gulle Gaper |
1.19 Patiënt G. XXX_Hess
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Hess | |||
Identificatienummer | 999900614 [BSN] | |||
Geboortedatum | 3 nov 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.19.1 Medicamenteuze behandeling MBH_920_magistraalalleingredienten
Medicatieafspraak MBH_920_magistraalalleingredienten_MA | |||||
Gegevenselement | Waarde | ||||
Identificatie | MBH_920_magistraalalleingredienten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||
Medicatieafspraak datum tijd | T om 12:00 uur | ||||
Gebruiksperiode | Vanaf T, tot en met T + 31 dagen | ||||
Ingangsdatum | T | ||||
Einddatum | T + 31 dagen | ||||
Voorschrijver | |||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||||
Geneesmiddel - Product specificatie | |||||
Product naam | Ureum 10% in eucerine cum aqua 100gr | ||||
Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | ||||
Ingredient | |||||
Ingredient code | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||||
Sterkte | per | ||||
Ingredient | |||||
Ingredient code | EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | ||||
Sterkte | per | ||||
Gebruiksinstructie | |||||
Omschrijving | Vanaf T, tot en met T + 31 dagen, Zo nodig, cutaan | ||||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||||
Doseerinstructie | Zo nodig | ||||
MBH identificatie | MBH_920_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_magistraalalleingredienten_VV | |||||
Gegevenselement | Waarde | ||||
Identificatie | MBH_920_magistraalalleingredienten_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||||
Verstrekkingsverzoek datum | T om 12:00 uur | ||||
Auteur | |||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||||
Te verstrekken hoeveelheid | 100 ml | ||||
Geneesmiddel - Product specificatie | |||||
Product naam | Ureum 10% in eucerine cum aqua 100gr | ||||
Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | ||||
Ingredient | |||||
Ingredient code | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||||
Sterkte | per | ||||
Ingredient | |||||
Ingredient code | EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | ||||
Sterkte | per | ||||
Beoogd verstrekker | |||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||||
Relatie medicatieafspraak | MBH_920_magistraalalleingredienten_MA | ||||
MBH identificatie | MBH_920_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_magistraalalleingredienten_TA | |||||
Gegevenselement | Waarde | ||||
Identificatie | MBH_920_magistraalalleingredienten_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||
Toedieningsafspraak datum tijd | T om 13:00 uur | ||||
Gebruiksperiode | Vanaf T, tot en met T + 31 dagen | ||||
Ingangsdatum | T | ||||
Einddatum | T + 31 dagen | ||||
Verstrekker | |||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||||
Geneesmiddel - Product specificatie | |||||
Product naam | Ureum 10% in eucerine cum aqua 100gr | ||||
Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | ||||
Ingredient | |||||
Ingredient code | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||||
Sterkte | per | ||||
Ingredient | |||||
Ingredient code | EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | ||||
Sterkte | per | ||||
Gebruiksinstructie | |||||
Omschrijving | Vanaf T, tot en met T + 31 dagen, Zo nodig, cutaan | ||||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||||
Doseerinstructie | Zo nodig | ||||
Relatie medicatieafspraak | |||||
Identificatie | MBH_920_magistraalalleingredienten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||
MBH identificatie | MBH_920_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_magistraalalleingredienten_MVE | |||||
Gegevenselement | Waarde | ||||
Identificatie | MBH_920_magistraalalleingredienten_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||||
Medicatieverstrekkings datum tijd | T om 13:00 uur | ||||
Verstrekker | |||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||||
Verstrekte hoeveelheid | 100 ml | ||||
Geneesmiddel - Product specificatie | |||||
Product naam | Ureum 10% in eucerine cum aqua 100gr | ||||
Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | ||||
Ingredient | |||||
Ingredient code | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||||
Sterkte | per | ||||
Ingredient | |||||
Ingredient code | EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | ||||
Sterkte | per | ||||
Relatie verstrekkingsverzoek | MBH_920_magistraalalleingredienten_VV | ||||
MBH identificatie | MBH_920_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_magistraalalleingredienten_MGB | |||||
Gegevenselement | Waarde | ||||
Identificatie | MBH_920_magistraalalleingredienten_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||
Medicatiegebruik datum tijd | T om 21:53 uur | ||||
Gebruik indicator | Ja | ||||
Volgens afspraak indicator | Ja | ||||
Gebruiksperiode | Vanaf T, tot en met T | ||||
Ingangsdatum | T | ||||
Einddatum | T | ||||
Voorschrijver | |||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||||
Auteur | |||||
Auteur is patient | Ja | ||||
Geneesmiddel - Product specificatie | |||||
Product naam | Ureum 10% in eucerine cum aqua 100gr | ||||
Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | ||||
Ingredient | |||||
Ingredient code | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||||
Sterkte | per | ||||
Ingredient | |||||
Ingredient code | EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | ||||
Sterkte | per | ||||
Gebruiksinstructie | |||||
Omschrijving | Vanaf T, tot en met T, 2 maal per dag, cutaan | ||||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||
Doseerinstructie | 2 maal per dag | ||||
Relatie toedieningsafspraak | |||||
Identificatie | MBH_920_magistraalalleingredienten_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||
MBH identificatie | MBH_920_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.19.2 Medicamenteuze behandeling MBH_920_magistraalactieveingredient
Medicatieafspraak MBH_920_magistraalactieveingredient_MA | |||||
Gegevenselement | Waarde | ||||
Identificatie | MBH_920_magistraalactieveingredient_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||
Medicatieafspraak datum tijd | T om 12:05 uur | ||||
Gebruiksperiode | Vanaf T + 1 dag, tot en met T + 70 dagen | ||||
Ingangsdatum | T + 1 dag | ||||
Einddatum | T + 70 dagen | ||||
Voorschrijver | |||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||||
Geneesmiddel - Product specificatie | |||||
Product naam | Vaseline 20% in cetomacrogolcrème FNA | ||||
Omschrijving | Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr | ||||
Ingredient | |||||
Ingredient code | CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | ||||
Sterkte | per | ||||
Gebruiksinstructie | |||||
Omschrijving | Vanaf T + 1 dag, tot en met T + 70 dagen, 1 maal per dag, cutaan | ||||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||
Doseerinstructie | 1 maal per dag | ||||
MBH identificatie | MBH_920_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_magistraalactieveingredient_VV | |||||
Gegevenselement | Waarde | ||||
Identificatie | MBH_920_magistraalactieveingredient_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||||
Verstrekkingsverzoek datum | T om 12:05 uur | ||||
Auteur | |||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||||
Te verstrekken hoeveelheid | 100 gram | ||||
Geneesmiddel - Product specificatie | |||||
Product naam | Vaseline 20% in cetomacrogolcrème FNA | ||||
Omschrijving | Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr | ||||
Ingredient | |||||
Ingredient code | CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | ||||
Sterkte | per | ||||
Beoogd verstrekker | |||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||||
Relatie medicatieafspraak | MBH_920_magistraalactieveingredient_MA | ||||
MBH identificatie | MBH_920_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_magistraalactieveingredient_TA | |||||
Gegevenselement | Waarde | ||||
Identificatie | MBH_920_magistraalactieveingredient_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||
Toedieningsafspraak datum tijd | T om 13:05 uur | ||||
Gebruiksperiode | Vanaf T + 1 dag, tot en met T + 70 dagen | ||||
Ingangsdatum | T + 1 dag | ||||
Einddatum | T + 70 dagen | ||||
Verstrekker | |||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||||
Geneesmiddel - Product specificatie | |||||
Product naam | Vaseline 20% in cetomacrogolcrème FNA | ||||
Omschrijving | Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr | ||||
Ingredient | |||||
Ingredient code | CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | ||||
Sterkte | per | ||||
Gebruiksinstructie | |||||
Omschrijving | Vanaf T + 1 dag, tot en met T + 70 dagen, 1 maal per dag, cutaan | ||||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||
Doseerinstructie | 1 maal per dag | ||||
Relatie medicatieafspraak | |||||
Identificatie | MBH_920_magistraalactieveingredient_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||
MBH identificatie | MBH_920_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_magistraalactieveingredient_MVE | |||||
Gegevenselement | Waarde | ||||
Identificatie | MBH_920_magistraalactieveingredient_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||||
Medicatieverstrekkings datum tijd | T om 13:05 uur | ||||
Verstrekker | |||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||||
Verstrekte hoeveelheid | 100 gram | ||||
Geneesmiddel - Product specificatie | |||||
Product naam | Vaseline 20% in cetomacrogolcrème FNA | ||||
Omschrijving | Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr | ||||
Ingredient | |||||
Ingredient code | CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | ||||
Sterkte | per | ||||
Relatie verstrekkingsverzoek | MBH_920_magistraalactieveingredient_VV | ||||
MBH identificatie | MBH_920_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_magistraalactieveingredient_MGB | |||||
Gegevenselement | Waarde | ||||
Identificatie | MBH_920_magistraalactieveingredient_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||
Medicatiegebruik datum tijd | T om 22:08 uur | ||||
Gebruik indicator | Ja | ||||
Volgens afspraak indicator | Nee | ||||
Gebruiksperiode | Vanaf T, tot en met T | ||||
Ingangsdatum | T | ||||
Einddatum | T | ||||
Voorschrijver | |||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||||
Auteur | |||||
Auteur is patient | Ja | ||||
Geneesmiddel - Product specificatie | |||||
Product naam | Vaseline 20% in cetomacrogolcrème FNA | ||||
Omschrijving | Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr | ||||
Ingredient | |||||
Ingredient code | CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | ||||
Sterkte | per | ||||
Gebruiksinstructie | |||||
Omschrijving | Vanaf T, tot en met T, 3 maal per dag, cutaan | ||||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||
Doseerinstructie | 3 maal per dag | ||||
Relatie toedieningsafspraak | |||||
Identificatie | MBH_920_magistraalactieveingredient_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||
MBH identificatie | MBH_920_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.19.3 Medicamenteuze behandeling MBH_920_magistraal90miljoennr
Medicatieafspraak MBH_920_magistraal90miljoennr_MA | |||||
Gegevenselement | Waarde | ||||
Identificatie | MBH_920_magistraal90miljoennr_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||
Medicatieafspraak datum tijd | T om 12:08 uur | ||||
Gebruiksperiode | Vanaf T, tot en met T + 30 dagen | ||||
Ingangsdatum | T | ||||
Einddatum | T + 30 dagen | ||||
Voorschrijver | |||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||||
Geneesmiddel - Product specificatie | |||||
Product code | Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.9999.77.90000000.1.1111') | ||||
Product naam | Ureum 10% in eucerine cum aqua 100gr | ||||
Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | ||||
Ingredient | |||||
Ingredient code | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||||
Sterkte | per | ||||
Gebruiksinstructie | |||||
Omschrijving | Vanaf T, tot en met T + 30 dagen, 1 maal per dag, cutaan | ||||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||
Doseerinstructie | 1 maal per dag | ||||
MBH identificatie | MBH_920_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_magistraal90miljoennr_VV | |||||
Gegevenselement | Waarde | ||||
Identificatie | MBH_920_magistraal90miljoennr_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||||
Verstrekkingsverzoek datum | T om 12:08 uur | ||||
Auteur | |||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||||
Te verstrekken hoeveelheid | 100 gram | ||||
Geneesmiddel - Product specificatie | |||||
Product code | Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.9999.77.90000000.1.1111') | ||||
Product naam | Ureum 10% in eucerine cum aqua 100gr | ||||
Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | ||||
Ingredient | |||||
Ingredient code | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||||
Sterkte | per | ||||
Beoogd verstrekker | |||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||||
Relatie medicatieafspraak | MBH_920_magistraal90miljoennr_MA | ||||
MBH identificatie | MBH_920_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_magistraal90miljoennr_TA | |||||
Gegevenselement | Waarde | ||||
Identificatie | MBH_920_magistraal90miljoennr_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||
Toedieningsafspraak datum tijd | T om 13:08 uur | ||||
Gebruiksperiode | Vanaf T, tot en met T + 30 dagen | ||||
Ingangsdatum | T | ||||
Einddatum | T + 30 dagen | ||||
Verstrekker | |||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||||
Geneesmiddel - Product specificatie | |||||
Product code | Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.9999.77.90000000.1.1111') | ||||
Product naam | Ureum 10% in eucerine cum aqua 100gr | ||||
Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | ||||
Ingredient | |||||
Ingredient code | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||||
Sterkte | per | ||||
Gebruiksinstructie | |||||
Omschrijving | Vanaf T, tot en met T + 30 dagen, 1 maal per dag, cutaan | ||||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||
Doseerinstructie | 1 maal per dag | ||||
Relatie medicatieafspraak | |||||
Identificatie | MBH_920_magistraal90miljoennr_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||
MBH identificatie | MBH_920_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_magistraal90miljoennr_MVE | |||||
Gegevenselement | Waarde | ||||
Identificatie | MBH_920_magistraal90miljoennr_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||||
Medicatieverstrekkings datum tijd | T om 13:08 uur | ||||
Verstrekker | |||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||||
Verstrekte hoeveelheid | 100 gram | ||||
Geneesmiddel - Product specificatie | |||||
Product code | Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.9999.77.90000000.1.1111') | ||||
Product naam | Ureum 10% in eucerine cum aqua 100gr | ||||
Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | ||||
Ingredient | |||||
Ingredient code | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||||
Sterkte | per | ||||
Relatie verstrekkingsverzoek | MBH_920_magistraal90miljoennr_VV | ||||
MBH identificatie | MBH_920_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatiegebruik MBH_920_magistraal90miljoennr_MGB | |||||
Gegevenselement | Waarde | ||||
Identificatie | MBH_920_magistraal90miljoennr_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||||
Medicatiegebruik datum tijd | T om 23:01 uur | ||||
Gebruik indicator | Ja | ||||
Volgens afspraak indicator | Ja | ||||
Gebruiksperiode | Vanaf T, tot en met T | ||||
Ingangsdatum | T | ||||
Einddatum | T | ||||
Voorschrijver | |||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||||
Auteur | |||||
Auteur is patient | Ja | ||||
Geneesmiddel - Product specificatie | |||||
Product code | Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.9999.77.90000000.1.1111') | ||||
Product naam | Ureum 10% in eucerine cum aqua 100gr | ||||
Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | ||||
Ingredient | |||||
Ingredient code | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||||
Sterkte | per | ||||
Gebruiksinstructie | |||||
Omschrijving | Vanaf T, tot en met T, 1 maal per dag, cutaan | ||||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||||
Doseerinstructie | 1 maal per dag | ||||
Relatie toedieningsafspraak | |||||
Identificatie | MBH_920_magistraal90miljoennr_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||
MBH identificatie | MBH_920_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener Peter_van_Pulver | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
Zorgaanbieder Apotheek_De_Gulle_Gaper | ||||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
Organisatie naam | Apotheek De Gulle Gaper |
1.20 Patiënt L. van XXX_Meijs
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | L. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Voorvoegsels | van | |||
Achternaam | XXX_Meijs | |||
Identificatienummer | 999900808 [BSN] | |||
Geboortedatum | 26 okt 1985 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.20.1 Medicamenteuze behandeling MBH_920_VVandermansMA
Medicatieafspraak MBH_920_VVandermansMA_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_VVandermansMA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 14 dagen om 09:00 uur | |||
Gebruiksperiode | Vanaf T - 14 dagen, tot en met T + 6 dagen | |||
Ingangsdatum | T - 14 dagen | |||
Einddatum | T + 6 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
Geneesmiddel - primaire code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 14 dagen, tot en met T + 6 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_VVandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_VVandermansMA_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_VVandermansMA_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T om 09:00 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Te verstrekken hoeveelheid | 6 stuks | |||
Geneesmiddel - primaire code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_VVandermansMA_MA | |||
MBH identificatie | MBH_920_VVandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_VVandermansMA_andermansVV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_VVandermansMA_andermansVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 14 dagen om 09:00 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
Te verstrekken hoeveelheid | 21 stuks | |||
Geneesmiddel - primaire code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_VVandermansMA_MA | |||
MBH identificatie | MBH_920_VVandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_MVEandermansTA_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_MVEandermansTA_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 14 dagen om 10:00 uur | |||
Gebruiksperiode | Vanaf T - 14 dagen, tot en met T + 6 dagen | |||
Ingangsdatum | T - 14 dagen | |||
Einddatum | T + 6 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 14 dagen, tot en met T + 6 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_VVandermansMA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_VVandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_MVEandermansTA_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_MVEandermansTA_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T om 10:00 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 6 stuks | |||
Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_VVandermansMA_VV | |||
MBH identificatie | MBH_920_VVandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_MVEandermansTA_andermansMVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_MVEandermansTA_andermansMVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 14 dagen om 10:00 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 21 stuks | |||
Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_VVandermansMA_andermansVV | |||
MBH identificatie | MBH_920_VVandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.20.2 Medicamenteuze behandeling MBH_920_stakenandermansMA
Medicatieafspraak MBH_920_stakenandermansMA_MA2 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_stakenandermansMA_MA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 09:05 uur | |||
Gebruiksperiode | Vanaf T - 5 dagen, tot en met T | |||
Ingangsdatum | T - 5 dagen | |||
Einddatum | T | |||
Medicatieafspraak stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Reden wijzigen of staken | Drug treatment not indicated (situation) (code = '183966005' in codeSystem 'SNOMED CT') | |||
Geneesmiddel - primaire code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 5 dagen, tot en met T, 1 maal per dag 1 stuk, Oraal, definitief gestopt | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_stakenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_stakenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieafspraak MBH_920_stakenandermansMA_MA1 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_stakenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 5 dagen om 08:45 uur | |||
Gebruiksperiode | Vanaf T - 5 dagen, tot en met T + 15 dagen | |||
Ingangsdatum | T - 5 dagen | |||
Einddatum | T + 15 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
Geneesmiddel - primaire code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 5 dagen, tot en met T + 15 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_stakenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_stakenandermansMA_andermansVV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_stakenandermansMA_andermansVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 5 dagen om 08:45 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
Te verstrekken hoeveelheid | 21 stuks | |||
Geneesmiddel - primaire code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_stakenandermansMA_MA1 | |||
MBH identificatie | MBH_920_stakenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_stakenandermansTA_TA2 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_stakenandermansTA_TA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 10:05 uur | |||
Gebruiksperiode | Vanaf T - 5 dagen, tot en met T | |||
Ingangsdatum | T - 5 dagen | |||
Einddatum | T | |||
Toedieningsafspraak stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 5 dagen, tot en met T, 1 maal per dag 1 stuk, Oraal, definitief gestopt | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_stakenandermansMA_MA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_stakenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_stakenandermansTA_TA1 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_stakenandermansTA_TA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 5 dagen om 09:45 uur | |||
Gebruiksperiode | Vanaf T - 5 dagen, tot en met T + 15 dagen | |||
Ingangsdatum | T - 5 dagen | |||
Einddatum | T + 15 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 5 dagen, tot en met T + 15 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_stakenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_stakenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_stakenandermansTA_andermansMVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_stakenandermansTA_andermansMVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 5 dagen om 09:45 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 21 stuks | |||
Geneesmiddel - primaire code | LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_stakenandermansMA_andermansVV | |||
MBH identificatie | MBH_920_stakenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.20.3 Medicamenteuze behandeling MBH_920_onderbrekenandermansMA
Medicatieafspraak MBH_920_onderbrekenandermansMA_MA2 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_onderbrekenandermansMA_MA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 09:07 uur | |||
Gebruiksperiode | Vanaf T - 60 dagen, tot en met T | |||
Ingangsdatum | T - 60 dagen | |||
Einddatum | T | |||
Medicatieafspraak stop type | tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT') | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Reden wijzigen of staken | Verrichting gepland (code = '405613005' in codeSystem 'SNOMED CT') | |||
Geneesmiddel - primaire code | APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 60 dagen, tot en met T, 1 maal per dag 1 stuk, oraal, tijdelijk gestopt | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_onderbrekenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_onderbrekenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieafspraak MBH_920_onderbrekenandermansMA_MA1 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_onderbrekenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 60 dagen om 09:00 uur | |||
Gebruiksperiode | Vanaf T - 60 dagen, tot en met T + 29 dagen | |||
Ingangsdatum | T - 60 dagen | |||
Einddatum | T + 29 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
Geneesmiddel - primaire code | APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 60 dagen, tot en met T + 29 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_onderbrekenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_onderbrekenandermansMA_andermansVV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_onderbrekenandermansMA_andermansVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 60 dagen om 09:00 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
Te verstrekken hoeveelheid | 90 stuks | |||
Geneesmiddel - primaire code | APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_onderbrekenandermansMA_MA1 | |||
MBH identificatie | MBH_920_onderbrekenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_onderbrekenandermansTA_TA2 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_onderbrekenandermansTA_TA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 10:07 uur | |||
Gebruiksperiode | Vanaf T - 60 dagen, tot en met T | |||
Ingangsdatum | T - 60 dagen | |||
Einddatum | T | |||
Toedieningsafspraak stop type | tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT') | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | APC APOTEX TABLET (code = '795097' in codeSystem 'G-Sandaard HPK') | |||
Geneesmiddel - generiekere code | APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 60 dagen, tot en met T, 1 maal per dag 1 stuk, oraal, tijdelijk gestopt | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_onderbrekenandermansMA_MA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_onderbrekenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_onderbrekenandermansTA_TA1 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_onderbrekenandermansTA_TA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 60 dagen om 10:00 uur | |||
Gebruiksperiode | Vanaf T - 60 dagen, tot en met T + 29 dagen | |||
Ingangsdatum | T - 60 dagen | |||
Einddatum | T + 29 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | APC APOTEX TABLET (code = '795097' in codeSystem 'G-Sandaard HPK') | |||
Geneesmiddel - generiekere code | APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 60 dagen, tot en met T + 29 dagen, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_onderbrekenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_onderbrekenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_onderbrekenandermansTA_andermansMVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_onderbrekenandermansTA_andermansMVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 60 dagen om 10:00 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 90 stuks | |||
Geneesmiddel - primaire code | APC APOTEX TABLET (code = '795097' in codeSystem 'G-Sandaard HPK') | |||
Geneesmiddel - generiekere code | APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_onderbrekenandermansMA_andermansVV | |||
MBH identificatie | MBH_920_onderbrekenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.20.4 Medicamenteuze behandeling MBH_920_wijzigenandermansMA
Medicatieafspraak MBH_920_wijzigenandermansMA_MA1 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_wijzigenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 7 dagen om 07:50 uur | |||
Gebruiksperiode | Vanaf T - 7 dagen, tot en met T + 13 dagen | |||
Ingangsdatum | T - 7 dagen | |||
Einddatum | T + 13 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 7 dagen, tot en met T + 13 dagen, 1 maal per dag 2 stuks, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
MBH identificatie | MBH_920_wijzigenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieafspraak MBH_920_wijzigenandermansMA_MA_techstaken | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_wijzigenandermansMA_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 09:10 uur | |||
Gebruiksperiode | Vanaf T - 7 dagen, tot en met T - 1 dag | |||
Ingangsdatum | T - 7 dagen | |||
Einddatum | T - 1 dag | |||
Medicatieafspraak stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 7 dagen, tot en met T - 1 dag, 1 maal per dag 2 stuks, oraal, definitief gestopt | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_wijzigenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_wijzigenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieafspraak MBH_920_wijzigenandermansMA_MA2 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_wijzigenandermansMA_MA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 09:10 uur | |||
Gebruiksperiode | Vanaf T | |||
Ingangsdatum | T | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Reden wijzigen of staken | Te sterk effect van medicatie (code = '112251000146103' in codeSystem 'SNOMED CT') | |||
Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_wijzigenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_wijzigenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_wijzigenandermansMA_andermansVV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_wijzigenandermansMA_andermansVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 7 dagen om 07:50 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Marcha_van_Partners | |||
Te verstrekken hoeveelheid | 42 stuks | |||
Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_wijzigenandermansMA_MA1 | |||
MBH identificatie | MBH_920_wijzigenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_wijzigenandermansTA_TA1 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_wijzigenandermansTA_TA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 7 dagen om 08:50 uur | |||
Gebruiksperiode | Vanaf T - 7 dagen, tot en met T + 13 dagen | |||
Ingangsdatum | T - 7 dagen | |||
Einddatum | T + 13 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | FUROSEMIDE MYLAN TABLET 40MG (code = '1529587' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 7 dagen, tot en met T + 13 dagen, 1 maal per dag 2 stuks, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_wijzigenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_wijzigenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_wijzigenandermansTA_TA_techstaken | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_wijzigenandermansTA_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 10:10 uur | |||
Gebruiksperiode | Vanaf T - 7 dagen, tot en met T - 1 dag | |||
Ingangsdatum | T - 7 dagen | |||
Einddatum | T - 1 dag | |||
Toedieningsafspraak stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | FUROSEMIDE MYLAN TABLET 40MG (code = '1529587' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 7 dagen, tot en met T - 1 dag, 1 maal per dag 2 stuks, oraal, definitief gestopt | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_wijzigenandermansMA_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_wijzigenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_wijzigenandermansTA_TA2 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_wijzigenandermansTA_TA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 10:10 uur | |||
Gebruiksperiode | Vanaf T | |||
Ingangsdatum | T | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | FUROSEMIDE MYLAN TABLET 40MG (code = '1529587' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, 1 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_wijzigenandermansMA_MA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_wijzigenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_wijzigenandermansTA_andermansMVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_wijzigenandermansTA_andermansMVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 7 dagen om 08:50 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 42 stuks | |||
Geneesmiddel - primaire code | FUROSEMIDE MYLAN TABLET 40MG (code = '1529587' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_wijzigenandermansMA_andermansVV | |||
MBH identificatie | MBH_920_wijzigenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener Marcha_van_Partners | ||||
Zorgverlener identificatienummer | 000001115 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Marcha van Partners | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Itis | |||
Zorgverlener Peter_van_Pulver | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgaanbieder Huisartsenpraktijk_Itis | ||||
Zorgaanbieder identificatienummer | 00005111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Itis | |||
Adresgegevens | Werkadres: Langelaan 1 1234ZZ Onze Stad | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
Zorgaanbieder Apotheek_De_Gulle_Gaper | ||||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
Organisatie naam | Apotheek De Gulle Gaper |
1.21 Patiënt M. XXX_Nederveen
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | M. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Nederveen | |||
Identificatienummer | 999900833 [BSN] | |||
Geboortedatum | 28 okt 1985 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.21.1 Medicamenteuze behandeling MBH_920_logistiekeverbruiksperiode_start_eind
Medicatieafspraak MBH_920_logistiekeverbruiksperiode_start_eind_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_logistiekeverbruiksperiode_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 11:00 uur | |||
Gebruiksperiode | Vanaf T + 10 dagen, tot en met T + 12 maanden | |||
Ingangsdatum | T + 10 dagen | |||
Einddatum | T + 12 maanden | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Geneesmiddel - primaire code | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T + 10 dagen, tot en met T + 12 maanden, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_logistiekeverbruiksperiode_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieafspraak MBH_920_logistiekeverbruiksperiode_start_eind_MA_1 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_logistiekeverbruiksperiode_start_eind_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 10:59:59 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 9 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 9 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Geneesmiddel - primaire code | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 9 dagen, 1 maal per dag 2 stuks, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
MBH identificatie | MBH_920_logistiekeverbruiksperiode_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_logistiekeverbruiksperiode_start_eind_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_logistiekeverbruiksperiode_start_eind_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T om 11:00 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Aantal herhalingen | 3 | |||
Geneesmiddel - primaire code | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | |||
Verbruiksperiode | Vanaf T + 10 dagen, tot en met T + 6 maanden | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_logistiekeverbruiksperiode_start_eind_MA | |||
MBH identificatie | MBH_920_logistiekeverbruiksperiode_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_logistiekeverbruiksperiode_start_eind_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_logistiekeverbruiksperiode_start_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 12:00 uur | |||
Gebruiksperiode | Vanaf T + 10 dagen, tot en met T + 12 maanden | |||
Ingangsdatum | T + 10 dagen | |||
Einddatum | T + 12 maanden | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T + 10 dagen, tot en met T + 12 maanden, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_logistiekeverbruiksperiode_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_logistiekeverbruiksperiode_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_logistiekeverbruiksperiode_start_eind_TA_1 | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_logistiekeverbruiksperiode_start_eind_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 11:59:59 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 9 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 9 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 9 dagen, 1 maal per dag 2 stuks, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 2 stuks | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_logistiekeverbruiksperiode_start_eind_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_logistiekeverbruiksperiode_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_logistiekeverbruiksperiode_start_eind_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_logistiekeverbruiksperiode_start_eind_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T om 12:00 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 100 stuks | |||
Geneesmiddel - primaire code | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_logistiekeverbruiksperiode_start_eind_VV | |||
MBH identificatie | MBH_920_logistiekeverbruiksperiode_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.21.2 Medicamenteuze behandeling MBH_920_herhalingen
Medicatieafspraak MBH_920_herhalingen_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_herhalingen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 50 dagen om 11:05 uur | |||
Gebruiksperiode | Vanaf T - 50 dagen | |||
Ingangsdatum | T - 50 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 50 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_herhalingen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_herhalingen_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_herhalingen_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 50 dagen om 11:05 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Te verstrekken hoeveelheid | 30 stuks | |||
Aantal herhalingen | 5 | |||
Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_herhalingen_MA | |||
MBH identificatie | MBH_920_herhalingen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_herhalingen_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_herhalingen_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 50 dagen om 12:05 uur | |||
Gebruiksperiode | Vanaf T - 50 dagen | |||
Ingangsdatum | T - 50 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 50 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_herhalingen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_herhalingen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_herhalingen_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_herhalingen_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 50 dagen om 12:05 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 30 stuks | |||
Geneesmiddel - primaire code | FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_herhalingen_VV | |||
MBH identificatie | MBH_920_herhalingen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.21.3 Medicamenteuze behandeling MBH_920_afleverlocatie
Medicatieafspraak MBH_920_afleverlocatie_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_afleverlocatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 11:07 uur | |||
Gebruiksperiode | Vanaf T + 1 dag, tot en met T + 10 dagen | |||
Ingangsdatum | T + 1 dag | |||
Einddatum | T + 10 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Geneesmiddel - primaire code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T + 1 dag, tot en met T + 10 dagen, 3 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 3 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_afleverlocatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_afleverlocatie_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_afleverlocatie_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T om 11:07 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Te verstrekken hoeveelheid | 30 stuks | |||
Geneesmiddel - primaire code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Afleverlocatie | Dorpsrand 200,1256ZZ Ons Dorp | |||
Relatie medicatieafspraak | MBH_920_afleverlocatie_MA | |||
MBH identificatie | MBH_920_afleverlocatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_afleverlocatie_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_afleverlocatie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 12:07 uur | |||
Gebruiksperiode | Vanaf T + 1 dag, tot en met T + 10 dagen | |||
Ingangsdatum | T + 1 dag | |||
Einddatum | T + 10 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T + 1 dag, tot en met T + 10 dagen, 3 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | 3 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_afleverlocatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_afleverlocatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_afleverlocatie_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_afleverlocatie_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T om 12:07 uur | |||
Aanschrijf datum | T om 11:07 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 30 stuks | |||
Geneesmiddel - primaire code | BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') | |||
Afleverlocatie | Dorpsrand 200,1256ZZ Ons Dorp | |||
Relatie verstrekkingsverzoek | MBH_920_afleverlocatie_VV | |||
MBH identificatie | MBH_920_afleverlocatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.21.4 Medicamenteuze behandeling MBH_920_logistiekeverbruiksperiode_eind
Medicatieafspraak MBH_920_logistiekeverbruiksperiode_eind_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_logistiekeverbruiksperiode_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T - 9 dagen om 11:01 uur | |||
Gebruiksperiode | Vanaf T - 9 dagen, tot en met T + 200 dagen | |||
Ingangsdatum | T - 9 dagen | |||
Einddatum | T + 200 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Geneesmiddel - primaire code | MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 9 dagen, tot en met T + 200 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_logistiekeverbruiksperiode_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_logistiekeverbruiksperiode_eind_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_logistiekeverbruiksperiode_eind_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T - 9 dagen om 11:01 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Geneesmiddel - primaire code | MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | |||
Verbruiksperiode | tot en met T + 200 dagen | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_logistiekeverbruiksperiode_eind_MA | |||
MBH identificatie | MBH_920_logistiekeverbruiksperiode_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_logistiekeverbruiksperiode_eind_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_logistiekeverbruiksperiode_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T - 9 dagen om 12:01 uur | |||
Gebruiksperiode | Vanaf T - 9 dagen, tot en met T + 200 dagen | |||
Ingangsdatum | T - 9 dagen | |||
Einddatum | T + 200 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T - 9 dagen, tot en met T + 200 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_logistiekeverbruiksperiode_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_logistiekeverbruiksperiode_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_logistiekeverbruiksperiode_eind_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_logistiekeverbruiksperiode_eind_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T - 9 dagen om 12:01 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 100 stuks | |||
Geneesmiddel - primaire code | MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | |||
Distributievorm | GDS (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8') | |||
Relatie verstrekkingsverzoek | MBH_920_logistiekeverbruiksperiode_eind_VV | |||
MBH identificatie | MBH_920_logistiekeverbruiksperiode_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.21.5 Medicamenteuze behandeling MBH_920_logistiekeverbruiksperiode_duur_dagen
Medicatieafspraak MBH_920_logistiekeverbruiksperiode_duur_dagen_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_logistiekeverbruiksperiode_duur_dagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 11:02 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 150 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 150 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Geneesmiddel - primaire code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_logistiekeverbruiksperiode_duur_dagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_logistiekeverbruiksperiode_duur_dagen_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_logistiekeverbruiksperiode_duur_dagen_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T om 11:02 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Geneesmiddel - primaire code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |||
Verbruiksperiode | gedurende 50 dagen | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Relatie medicatieafspraak | MBH_920_logistiekeverbruiksperiode_duur_dagen_MA | |||
MBH identificatie | MBH_920_logistiekeverbruiksperiode_duur_dagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_logistiekeverbruiksperiode_duur_dagen_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_logistiekeverbruiksperiode_duur_dagen_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 12:02 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 150 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 150 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - primaire code | PARACETAMOL PCH TABLET 500MG (code = '768901' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal | |||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag 1 stuk | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_logistiekeverbruiksperiode_duur_dagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_logistiekeverbruiksperiode_duur_dagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_logistiekeverbruiksperiode_duur_dagen_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_logistiekeverbruiksperiode_duur_dagen_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T om 12:02 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 100 stuks | |||
Verbruiksduur | 50 dagen | |||
Geneesmiddel - primaire code | PARACETAMOL PCH TABLET 500MG (code = '768901' in codeSystem 'G-Standaard HPK') | |||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |||
Relatie verstrekkingsverzoek | MBH_920_logistiekeverbruiksperiode_duur_dagen_VV | |||
MBH identificatie | MBH_920_logistiekeverbruiksperiode_duur_dagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.21.6 Medicamenteuze behandeling MBH_920_financiele_indicatiecode
Medicatieafspraak MBH_920_financiele_indicatiecode_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_financiele_indicatiecode_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 11:35 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 13 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 13 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Geneesmiddel - primaire code | OXAZEPAM 10MG TABLET (code = '353' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 13 dagen, 4 maal per dag 1 stuk, oraal | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 4 maal per dag 1 stuk | |||
MBH identificatie | MBH_920_financiele_indicatiecode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Verstrekkingsverzoek MBH_920_financiele_indicatiecode_VV | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_financiele_indicatiecode_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
Verstrekkingsverzoek datum | T om 11:35 uur | |||
Auteur | ||||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | |||
Te verstrekken hoeveelheid | 56 stuks | |||
Geneesmiddel - primaire code | OXAZEPAM 10MG TABLET (code = '353' in codeSystem 'G-Standaard PRK') | |||
Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | |||
Beoogd verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Financiele indicatiecode | (code = 'OTH' in codeSystem 'NullFlavor'): B2 | |||
Relatie medicatieafspraak | MBH_920_financiele_indicatiecode_MA | |||
MBH identificatie | MBH_920_financiele_indicatiecode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener Bertine_van_Doorn | ||||
Zorgverlener identificatienummer | 000001112 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Bertine van Doorn | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
Zorgaanbieder Apotheek_De_Gulle_Gaper | ||||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | |||
Organisatie naam | Apotheek De Gulle Gaper |